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ABSTRACT
The D e te rm in a tio n  and P h a rm a c o k in e tic s  o f M ethim azole in  B io lo g ic a l 
F lu id s .
The developm ent o f  m ethim azole th e ra p y , i t s  m echanism  o f a c tio n  and 
p h a rm a c o k in e tic s  in  man have been b r i e f ly  rev iew ed .
S p e c if ic ,  s e n s i t iv e  a n a ly t ic a l  m ethods were developed  f o r  m ethim azole 
and 3 -m e th y l-2 - th io h y d a n to in  u s in g  g as  ch ro m ato g rap h y - m ass 
s p e c tro m e try . T rid e u tro m e th y lim id a z o le  was s u c c e s s fu l ly  s y n th e s is e d  and 
used a s  th e  i n te r n a l  s ta n d a rd .  E x tra c tio n  m ethods were developed  f o r  
th e  s e p a r a t io n  o f m ethim azole from  v a r io u s  b io lo g ic a l  m edia. U sing 
th e s e  s p e c i f ic  m ethods, v a r io u s  c l i n i c a l  in v e s t ig a t io n s  were u n d e rtak en .
Dosage l i n e a r i t y  was shown when th e  p lasm a c o n c e n tra t io n s  and 
k in e t ic s  o f p a t i e n t s  on a low dosage  reg im en  where com pared to  th o se  on 
a h ig h  dosage  reg im en . A lac k  o f accum ula tion  was a ls o  in d ic a te d  a s  th e  
p lasm a c o n c e n tra t io n s  were shown to  be a t  s t e a d y - s ta te .  Plasm a 
c o n c e n tra t io n s  o f m eth im azole cou ld  be c o r r e la te d  w ith  i t s  e f f e c t  on th e  
in h ib i t io n  o f  o r g a n i f ic a t io n .  Thus, th e  g r e a t  d iv e rg e n ce  in  th e  
th e ra p e u t ic  re s p o n s e  to  th e  d rug  in  th y r o to x ic o s is  i s  o b v io u sly  n o t due 
to  d i f f e re n c e s  in  p lasm a p h a rm a c o k in e tic s  o r  th e  e x te n t  o f in h ib i t io n  o f 
o r g a n i f ic a t io n  o f io d in e .
No s ig n i f i c a n t  d i f f e r e n c e s  betw een p h a rm a co k in e tic  p a ra m e te rs  a f t e r  
o r a l  a d m in is t r a t io n  to  e u th y ro id  and h y p e r th y ro id  p a t i e n t s  were 
ob se rv ed . Thus, i t  a p p e a rs  t h a t  th y ro id  horm ones do n o t d e p re s s  o r
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in c re a s e  th e  m etabo lism  o f m ethim azole and th e re fo re  th e r e  a re  no 
p h a rm a co k in e tic  re a s o n s  to  a d ju s t  th e  dose  o f m eth im azole d u rin g  
tre a tm e n t  o f th y r o to x ic o s is .
R e su lts  fo r  i n t r a th y r o id a l  c o n c e n tra t io n s  su p p o rte d  th e  co n cep t t h a t  
m ethim azole i s  a c t iv e ly  c o n c e n tra te d  in  th e  th y ro id  g lan d  by show ing no 
l in e a r i ty  w ith  d o se , an in c re a s e  in  th y ro id /p la sm a  c o n c e n tra t io n  r a t i o s  
w ith  tim e  and a d e c re a se  in  th y ro id /p la s m a  c o n c e n tra t io n  r a t i o  w ith  
in c re a s in g  dose  th u s  in d ic a t in g  a s a tu r a te d  sy s tem . However, r e s u l t s  
fo r  th e  p e rc e n ta g e  in h ib i t io n  o f io d id e  o r g a n i f ic a t io n  a p p e a rs  to  be in  
d i r e c t  c o n f l i c t  w ith  th e  i n t r a th y r o id a l  le v e ls .  I t  i s  l ik e ly  t h a t  th e  
p e rc h lo ra te  d is c h a rg e  t e s t  u n d e re s tim a te s  th e  d u ra tio n  o f a c tio n  o f 
m ethim azole a s  i t  does n o t gauge th e  e x te n t  o f in h ib i t io n  o f co u p lin g  by 
m ethim azole.
The a n a ly s i s  o f in f a n t  p lasm a sam p les  in  c o n ju n c tio n  w ith  m a te rn a l 
p lasm a and m ilk  sa m p les  showed t h a t  th e  m a te rn a l m ilk /p la sm a  
c o n c e n tra t io n  r a t i o  app roached  u n ity  and t h a t  in f a n t  p lasm a le v e ls  o f 
m ethim azole were s ig n i f i c a n t .  However, th e  c l i n ic a l  in d ic e s  showed no 
a b n o rm a li t ie s  in  t h e i r  th y ro id  fu n c tio n . T h e re fo re , w ith  low d o se s  and 
c a re fu l  th y ro id  m o n ito rin g , m eth im azole i s  s u i ta b le  f o r  th e  t re a tm e n t  o f 
h y p e rth y ro id ism  in  b r e a s t - f e e d in g  m o th e rs .
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1.1 REVIEW OF HYPERTHYROIDISM AND THE ACTION OF METHIMAZOLE
1.1.1 In tro d u c tio n
The th y ro id  g la n d  c a r r i e s  ou t a  s p e c i f ic  b io ch em ica l p ro c e s s  in  th e  
fo rm a tio n  and  s e c r e t io n  o f th e  th y ro id  horm ones, two p h y s io lo g ic a l ly  
p o te n t  a m in o -a c id s , L - th y ro x in e  (T4 ) and L - t r i io d o ty ro n in e  <T3 >. These 
horm ones e x e r t  s t im u la to ry  e f f e c t s  on c e l l  m etabolism  and a re  e s s e n t ia l  
f o r  th e  norm al g row th  and developm ent o f th e  body.
A common d is o r d e r  o f th e  th y ro id  g lan d  i s  h y p e rth y ro id ism  in  which 
th e  th y ro id  g lan d  s e c r e te s  e x c e s s iv e  am ounts of th e  th y ro id  horm ones. 
There a re  two fo rm s o f th y ro id  h y p e rfu n c tio n  which a re  rec o g n ised . 
'D iffu se  to x ic  g o i t e r '  ( G raves d is e a s e  o r  Basedow 's d is e a s e  ) i s  
o v e r a c t iv i ty  o f  th e  whole g lan d  and o cc u rs  m ost commonly in  young 
a d u l t s .  The second  c o n d it io n  i s  th e  o v e ra c t iv i ty  o f one o r  more th y ro id  
n o d u les , 'to x ic  n o d u la r  g o i t e r '  , w hich o ccu rs  p r im a r i ly  in  o ld e r  p a t i e n ts  
and u s u a lly  a r i s e s  from  lo n g -s ta n d in g  n o n - to x ic  g o i te r .  Both d is o r d e r s  
can  be s u c c e s s fu l ly  t r e a te d  w ith  a n t i th y r o id  d ru g s  w hich i n te r f e r e  
d i r e c t l y  w ith  th e  s y n th e s i s  o f th e  th y ro id  horm ones.
A lthough i t  h a s  been p re v io u s ly  obse rv ed  t h a t  cabbage p la n ts  c o n ta in  
a g o i tro g e n ic  s u b s ta n c e  (Chesney e t  a l.,1 9 2 8 ; H ercus and P u rv e s ,1 9 3 6 ), 
th e  modern e ra  o f a n t i th y r o id  d rug  th e ra p y  began in  1941 w ith  two 
ind ep en d en t chance  o b s e rv a t io n s . MacKenzie e t  a l .  s tu d y in g  th e  
a n t i b io t i c  e f f e c t s  o f s u lfa g u a n id in e  on i n t e s t i n a l  b a c te r ia  no ted  th y ro id
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h y p e rp la s ia  in  th e  r a t s  exposed to  t h i s  drug . At th e  same tim e, w hile  
s tu d y in g  th e  t a s t e  s e n s a t io n  in  r a t s ,  R ic h te r  and C lisb y  (1942) observed  
g o i te r s  in  th o s e  fed  w ith  p h e n y lth io u re a .
I t  was concluded  t h a t  t h i s  g o i tro g e n ic  a c t i v i t y  was due to  th e  
in h ib i t io n  o f th y ro id  s y n th e s i s  (Astwood e t  a l . ,  1943a; M ackenzie and 
M ackenzie, 1943) and th e  a c t iv e  m oiety  was th io u re a . Astwood e t  a l .  
(1943b, 1945) sc re e n e d  over two hundred  compounds c o n ta in in g  th e  
th io c a rb a m id e  group f o r  a n t i th y r o id  a c t iv i ty a n d  re p o r te d  th e  f i r s t  
s u c c e s s fu l  c l i n i c a l  tre a tm e n t  o f h y p e rth y ro id ism  w ith  th io u r a c i l .
However, t h io u r a c i l  was found to  cause  s id e  e f f e c t s  e s p e c ia l ly  
a g ra n u lo c y to s is  and was abandoned w ith  th e  in tro d u c tio n , in  1946, o f 6 -  
p r o p y l th io u r a c i l  (Astwood e t  a l . )  which d isp la y e d  in c re a se d  a n t i - th y r o id  
a c t i v i t y  w ith  d e c re a sed  to x ic i ty .  M ethim azole, which d isp la y e d  even 
g r e a te r  p o ten cy , was in tro d u c ed  s e v e ra l  y e a rs  l a t e r  (S tan ley  and 
Astwood, 1949) fo llow ed  by ca rb im azo le  ( Lawson e t  a l . ,  1951a,b). 
C arb im azole i s  a  ca rb e th o x y  d e r iv a t iv e  o f m ethim azole, o r ig in a l ly  
developed  in  th e  hope o f o b ta in in g  a lo n g e r  a c t in g  drug  th a n  
m ethim azole. However, ca rb im azo le  i s  now known to  be r a p id ly  and t o t a l l y  
b io a c t iv a te d  to  m eth im azole a f t e r  o r a l  in ta k e  and i t s  a n t i th y r o id  a c tio n  
i s  a t t r ib u t e d  to  m eth im azole i t s e l f .
At p re s e n t  c a rb im azo le  i s  p r im a r i ly  used in  Europe w hereas 
p r o p y l th io u r a c i l  and m ethim azole a re  a d m in is te re d  a lm o s t e x c lu s iv e ly  in  
F o r th  Am erica.
The m ost im p o rta n t c la s s  o f a n t i th y r o id  compounds a re  th e  




T hiourea T h io u ra c il
M e th y lth io u ra c il P ro p y lth io u ra c il
HN NCH
M ethim azole C arbim azole
F ig u re  1.1 The s t r u c tu r e s  o f  th e  th io u re y le n e  a n t i th y r o id  d ru g s  
fo rm e rly  and  c u r r e n t ly  used  in  th e  t re a tm e n t  o f h y p e rth y ro id ism .
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A lthough m ost o f them in c o rp o ra te  th e  e n t i r e  th io u re y le n e  group, in  some, 
one o f th e  n i tro g e n  atom s i s  re p la c e d  by oxygen o r  a n o th e r  su lp h u r  so  
t h a t  on ly  th e  th io c a rb a m id e  g roup i s  common to  a l l .
1.1.2 The F orm ation  o f th e  T hyro id  Hormones
The fo rm a tio n  o f th e  th y ro id  horm ones in v o lv e s
1)The a c t iv e  t r a n s p o r t  o f e x t r a c e l lu la r  io d id e  in to  th e  g lan d ,
2 ) th e  o x id a tio n  o f io d id e  and th e  io d in a tio n  o f ty r o s y l  g ro u p s o f 
th y ro g lo b u lin  fo rm ing  m ono iodo ty ro sine  (MIT) and d i io d o ty ro s in e  (DIT),
3 ) th e  c o u p lin g  o f th e  io d o ty ro s in e s , MIT and DIT, to  form  th e  
io d o th y ro n in e s , t r i io d o th y ro n in e  (T3 ) and te t r a io d o th y ro n in e  ( th y ro x in e , 
Tj )and
4) p r o te o ly s i s  o f th y ro g lo b u lin  and th e  r e le a s e  o f T3 and T^  in to  th e  
b lo o d stream
The pa thw ays o f io d id e  m etabo lism  a re  shown in  F ig u re  1.2.
Iod ine  in g e s te d  in  th e  d i e t  re a c h e s  th e  c i r c u la t io n  in  th e  form  o f 
io d id e . T h is  p lasm a io d id e  i s  l a r g e ly  e x t r a c e l lu la r  and i s  removed 
m ain ly  by th e  k id n ey s  and th e  th y ro id .  The th y ro id  c e l l s  e x t r a c t  io d id e  
from  p lasm a and c o n c e n tra te  i t  in  th e  i n t e r io r  o f th e  c e l l  and in  th e  
c o l lo id .  T h is  io d id e  t r a n s p o r t  m echanism  i s  an energy  dependen t p ro c e s s  
r e q u ir in g  oxygen.
Iod ide  i s  o x id ise d  by hydrogen  p e ro x id e  (Hg 02 ) in  th e  m ic r o v i l l i  of 
th e  a p ic a l  c e l l  membrane. There seem s c o n c lu s iv e  p ro o f  t h a t  th e  NADPH- 
cy tochrom e c re d u c ta s e  i s  one so u rc e  o f H2 02 f o r  th e  p e ro x id a tio n  o f
26
•  to** » THYROID r
/  Tro"»omiao*» \
--------* HPpa
— > * i*->dit
Rroi*oly*''
iI
Figure 1.2 Pathways o f iod ide metabolism by the thyroid gland, 
DeGroot and Siepom niszcze, (1977)
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iod id e (D eG ro o te t a l . ,  1972). The t r a n s f e r  o f red u c in g  e q u iv a le n ts  from 
JfADH to  NADH-cytochrome B re d u c ta s e  and cy tochrom e B i s  a n o th e r  sou rce  
o f H jC^in th e  th y ro id  (O htaki e t  a l . ,  1973). Thus, two and p o s s ib ly  
more enzymes may be in v o lv ed  in  th e  H2 0 2 g e n e ra tio n , s in c e  o th e r  s tu d ie s  
su g g e s t  H2 0 2 p ro d u c tio n  by monoamine o x id ase  (F isc h e r  e t  a l . ,  1966,
1968). The o x id is e d  form  of io d in e  im m edia te ly  becomes c o v a le n tly  bound 
to  p e p tid e - l in k e d  ty r o s y l  g roups in  th e  th y ro g lo b u lin  m olecule a d ja c e n t 
to  i t ,  t o  form  m o n o io d o ty ro sin e  (MIT) and d i io d o ty ro s in e  (DIT).
The io d o th y ro n in e  m olecu les a r e  form ed by th e  a tta c h m e n t o f one 
io d o ty ro s in e  (MIT o r  DIT) to  th e  p h e n o lic  group o f a n ea rb y  DIT 
m olecule. I t  h a s  been su g g e s te d  (DeGroot and Niepom nizcze, 1977) t h a t  
th e  i n i t i a l  io d in a t io n  o f ty r o s y l  r e s id u e s  o ccu rs  on an im m ature TG in  
an u n c o ile d  form  w ith  i t s  ty r o s y l  g ro u p s r e a d i ly  open to  th e  io d in a tio n  
enzym es. D uring th e  n e x t p h ase  o f m a tu ra tio n , th e  m olecule may develop  
a c o ile d  se co n d a ry  s t r u c tu r e  a s  d is u lp h id e  bonds, and io n ic  o r  hydrogen  
bonds a re  form ed, th u s  p la c in g  th e  io d in a t in g  ty r o s y l s  c lo s e  to  one 
a n o th e r  in  n e ig h o u rin g  c o i l s  and f a c i l i t a t i n g  t r a n s f e r  o f an iodophenyl 
group (F igu re  1 .3 ).
The norm al s e c r e to r y  p ro c e s s  b e g in s  w ith  th e  fo rm a tio n  o f an 
i n t r a c e l lu l a r  'c o l lo id  d r o p le t ' by th e  a c t io n  o f th e  m ic r o v i l l i  o f  th e  
c e l l  a p ic a l  membrane. Once in s id e  th e  c e l l ,  th e  d r o p le ts  fu se  w ith  a  
lysosom e, w hich h a s  been m o b ilized  from  th e  c e l l  b a se  tow ard  th e  c e l l  
apex, fo rm ing  a phagosom e. Here, th e  TG i s  p ro b ab ly  co m p le te ly  degraded  
to  i t s  com ponent a m in o -a c id s , and th e  r e le a s e d  T3 and  T4 make t h e i r  way 










m eF ig u re  1.3 A h y p o th e t ic a l  model o f  th e  in tra m o le c u la r  io d o tb y ro s
c o u p lin g  p ro c e s s . De G root and N ieporoniszcze, (1977)
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f la v o p ro te in  d e io d in a se  and th e  l ib e r a te d  io d id e  i s  p a r t i a l l y  r e u t i l iz e d  
and p a r t i a l l y  l o s t  from th e  c e l l .  T h is  in te r n a l  io d id e  c y c le  i s  
im p o rta n t, f o r  th re e  to  f iv e  t im e s  a s  much io d id e  i s  form ed in s id e  th e  
g lan d  each day by d e io d in a se  a c t i v i t y  a s  e n te r s  th e  c e l l  from  th e  serum .
S y n th e s is  and s e c re t io n  o f th y ro id  hormone i s  r e g u la te d  p red o m in a te ly  
by T hyroid  S tim u la tin g  Hormone (TSH) from  th e  p i tu i t a r y  g lan d  (Tong,
1971). The s e c r e t io n  r a t e  o f TSH i s  d e te rm ined  by th e  b a la n c e  betw een 
th e  n e g a tiv e  in f lu e n c e  o f p lasm a T3 and T4 (S te r l in g  and Lazurus, 1977) 
and th e  p o s i t iv e  hypo thalm ic  s tim u lu s , T hyro id  R e leas in g  Hormone (TRH). 
TRH s t im u la te s  b o th  th e  r e le a s e  and th e  s y n th e s i s  o f TSH. TSH 
c o n c e n tra t io n s  in  th e  serum a re  m arkedly  reduced  o r a b s e n t in  p a t i e n ts  
w ith  h y p e rth y ro id ism  due to  G raves ' d is e a s e  o r to x ic  n o d u la r g o i te r .
Normal th y ro id  fu n c tio n  o b v io u sly  r e q u ir e s  an adequate  in ta k e  o f 
io d in e . W ithout i t ,  norm al am ounts o f hormone can n o t be made, 
th y ro t ro p in  i s  s e c re te d  in  e x c e s s , and th e  th y ro id  h y p e r tro p h ie s  in  
re sp o n se  to  th e  need fo r  g r e a te r  e f f ic ie n c y  in  e x tr a c t io n  o f r e s id u a l  
t r a c e s  o f io d id e  from th e  blood
Prolonged  io d in e  d e f ic ie n c y  le a d s  to  p r e f e r e n t ia l  s y n th e s i s  o f T3 
r e l a t i v e  to  T4 , which may be an im p o rta n t io d in e - s p a r in g  m echanism .
High c o n c e n tra t io n s  o f io d id e  ap p ear to  in f lu e n c e  a l l  im p o rta n t a s p e c ts  
o f io d in e  m etabolism  by th e  th y ro id  g lan d . Acute e f f e c t s  o f io d id e  to  
i n h ib i t  o r g a n i f ic a t io n  o f io d id e  in  th e  th y ro id  g lan d  a re  w ell-know n i .e . 
th e  V o lff-C h a ik o ff  E f fe c t  (W olff and C haiko ff, 1948). The in t r a c e l lu l a r  
r a th e r  th a n  th e  e x t r a c e l lu la r  c o n c e n tra t io n  o f th e  an io n  a p p e a rs  to  be 
th e  m ajor d e te rm in a n t and, w ith  tim e , th e  e f f e c t  was found to  be
tem p o rary . T h is  i s  due to  an a u to re g u la to ry  d e c re a se  in  io d in e  
t r a n s p o r t  and a  low ered i n t r a c e l lu l a r  io d id e  c o n c e n tra t io n , a llo w in g  
o rg a n ic  b in d in g  and hormone s y n th e s i s  to  resum e (Braverm an and Ingbar, 
1963).
Iod ide  a ls o  a n ta g o n iz e s  th e  a b i l i t y  o f b o th  th y r o t ro p in  and c y c lic  
AMP to  s t im u la te  e n d o c y to s is  o f c o l lo id ,  p r o te o ly s i s  and hormone 
s e c r e t io n  (P ise ra v  e t  a l . ,  1971).
1.1.3 S i te  o f A ction  o f M ethim azole
The m ain s i t e  o f a c tio n  o f m ethim azole i s  beyond th e  s te p  o f io d id e  
c o n c e n tra t io n , d i r e c t l y  on th e  s y n th e s i s  o f th y ro id  horm ones from  
accum ulated  io d id e . Each s te p  in  horm one s y n th e s i s  i s  a f f e c te d ,  how ever, 
th e  m ain s i t e  o f a c t io n  i s  th e  i n i t i a l  io d in a tio n  o f ty r o s in e  (Burgi and 
H a b e rli, 1977)
A ll th e s e  r e a c t io n  s te p s  le a d in g  to  th y ro id  hormone p ro d u c tio n  a re  
known to  be c a ta ly s e d  by a th y ro id  p e ro x id a se  (TPO) enzyme and 
m ethim azole h a s  been shown to  be an  in h ib i to r  o f TPO in  v i t r o  
(A lexander e t  a l . ,  1959; DeGroot and D avies, 1962; Hosoya, 1963; Mahoney 
and Igo, 1966; M o rris  and Hager, 1966; Yip, 1966; Coval and Taurog,
1967). Thus, th e r e  i s  th e  p o s s ib i l i t y  t h a t  m ethim azole e x e r t s  i t s  
in h ib i to r y  e f f e c t s  by b lo ck in g  a  TPO enzyme in  v iv o .
There have been a  v a r ie ty  o f p roposed  m echanism s f o r  th e  a c tio n  o f 
m ethim azole in  r e l a t i o n  to  TPO (M orris and H ager, 1966; M aloof e t  a l . ,  
1969 ; Taurog, 1976; M ichot e t  a l . ,  1977 and D avidson e t  a l . ,  1978) two
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o f w hich a re  g iven  in  f ig u re s  1.4 and 1.5. A ll o f th e s e  p roposed  
m echanism s c o n ta in  some common p o in ts .  In v ivo , an  i r r e v e r s ib l e  
com plex w ith  TPO can  be form ed in  th e  absence  o f io d id e . There a p p ears  
to  be c o m p e titio n  o f m ethim azole w ith  io d id e  f o r  TPO o r  TPO-H2 02 under 
c e r ta in  c o n d it io n s . The p re sen ce  o f io d id e  a p p e a rs  to  make th e  
in h ib i t io n  o f TPO by m ethim azole r e v e r s ib le  and s tu d ie s  in  v iv o  su g g e s t 












F ig u re  1.4 Mechanism o f a c tio n  o f th io u re y le n e  a n t i th y r o id  d ru g s  on
TPO and t h e i r  r e s u l t in g  o x id a tio n  based  on p ro p o s a ls  by Maloof e t  a l .  
(1969 a ,b ) .
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LOW RATIO OF DRUG TO IODIDE INCREASED RATIO OF DRUG TO IODIDE
INHIB IT ION DRUG IN H IB IT IO N  B y DRUG
V E i l ’ + HzOz [ E - I ] I  E « I"t H20 2
a c t i v a t e d
IO D IN E
- | E - J ]
ACT IVAT F D 
I O D IN E
p n viG j —  O X ID IZ E D  DRUG  
j  J r .  j ]  I P R E F E R R E D  PATHWAY)
IO D IN A T E D  T Y R O S Y L
A INHIBITION OF REACTION I BY DRUG 
LARGELY OVERCOME BY IODIDE 
a  M l  FORMATION OCCURS READILY 
C EXTENSIVE DRUG OXIDATION 
D ESCAPE OF IODINATION FROM 
INHIBITION AFTER LAG PERIOD
A. REACTION 1 LARGELY BLOCKED BY DRUG
B. VERY LOW FORMATION OF [E - l]
C. LITTLE OR NO DRUG OXIDATION
D. NO ESCAPE OF IODINATION FROM 
IN H IB ITIO N
F ig u re  1.5 Scheme p ro p o sed  by Taurog <1976) f o r  th e  mechanism of 
in h ib i t io n  by th io u re y le n e  d ru g s  o f T P O -catalysed  io d in a tio n .
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1.2 REVIEW OF ANALYTICAL METHODS FOR METHIMAZOLE MEASUREMENT
A v a r ie ty  o f chem ical a n a ly t ic a l  m ethods have been used to  s tu d y  
th e  f a te  o f m ethim azole in  b io lo g ic a l  sy s te m s. The te c h n iq u e s  which 
have been used a re  c o lo r im e try , h ig h  perfo rm ance l iq u id  chrom atography 
(H.P.L.C) , g a s - l iq u id  chrom atography  (G.L.C.) and rad io im m unoassay  <RIA). 
An o u tl in e  o f each  m ethod i s  p re se n te d  in  t h i s  l i t e r a t u r e  su rv ey .
The f i r s t  method o f m easurem ent o f m ethim azole was c o lo r im e tr ic .  
T h is  was based  on a co lo u r r e a c t io n  f o r  th io u r a c i l s  (M cA llis te r, 1951 
a ,b ) . I t  e n ta i le d  r e a c tio n  o f th e  m ethim azole t h io l  m oiety  w ith  a 2 :6 - 
d ic h lo ro q u in o n e -c h lo rim id e  re a g e n t. No s tu d ie s  in  humans, however, were 
re p o r te d  b e fo re  P ittm an  e t  a l  (1971) im proved th e  m ethod by chang ing  th e  
c o lo u r r e a c t io n  to  one w ith  N -2 ,6 - tr ic h lo ro -p -b e n z o q u in o n e im in e , and 
e s tim a te d  th e  p lasm a c o n c e n tra tio n  and u r in a ry  e x c re tio n  o f m ethim azole 
in  h e a lth y  e u th y ro id  s u b je c ts .  V ese ll e t  a l  (1975) a ls o  used t h i s  method 
f o r  f u r th e r  human k in e t ic  s tu d ie s  b u t th e  lac k  o f s p e c i f i c i t y  o f t h i s  
m ethod m eant t h a t  s u lp h u r -c o n ta in in g  m e ta b o li te s  o f m ethim azole would 
c o n tr ib u te  to  th e  co lo u r. T h is  would e x p la in  th e  long h a l f - l i f e  value 
o b ta in e d  by V ese ll com pared w ith  th o se  o f l a t e r  a u th o rs  u sin g  more 
s p e c i f ic  m ethods. T h is  problem  of s p e c i f i c i t y  was a l le v ia te d  w ith  th e  
developm ent o f H.P.L.C. a s s a y s .  Meulemans e t  a l.,(1 9 8 0 )  combined th e  2 :6 - 
d ichloroquinone-chlofQ im ide p ro ced u re  and H.P.L.C. to  o b ta in  a s e n s i t iv e  
method f o r  th e  d e te rm in a tio n  o f m ethim azole in  p lasm a. The drug 
com plex was d e te c te d  w ith  a U.V. d e te c to r  a t  a w aveleng th  o f 405nm. The 
s e n s i t i v i t y  o f th e  method a llow ed d e te c tio n  to  c o n c e n tra t io n s  o f 5ng/m l. 
The method d id  n o t employ an in te r n a l  s ta n d a rd  and b o th  a n t i th y r o id
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Table 1.1 Studies of an a ly tica l methods o f measuring methimazole 
concentrations.
Method f i r s t  published Method Use In Human K inetic Studies
M cAllister (1051) C olo riae trlc V essell e t  a l  (1975)
P itta a n  e t  a l <1971> Colorimetric Hallengren e t  a l  (1982)
Skellern  e t a l (1974) HPLC Skellern e t  a l (1977)
Skellern  e t  al<1976) HPLC Melander e t  a l  (1980) 
Johansen e t a l (1982)
Beading and Stevenson (1978) GLC
Skellern  e t  a l (1980a) HPLC Skellern e t a l (1980a,b) 
Low e t a l  (1981)
Floberg e t  a l  (1980) GC-MS Tegler and L indstroa (1980) 
Dahlberg e t  a l (1981) 
Jansson e t  a l (1983a ,b) 
Jansson e t a l (1985)
Meuleaans e t  a l  (1980) HPLC
Cooper e t  a l (1984) B1A Cooper e t  a l  (1984)
Tatsuhara e t  a l (1985) HPLC Okaaura e t  a l (1986)
Hengstaann and Bohn (1985) HPLC Hengstaann and Hohn (1965)
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d ru g s , p r o p y l th io u r a c i l  and ca rb im azo le  were found to  e lu te  from th e  
column w ith  th e  same r e te n t io n  tim e a s  m ethim azole.
S k e lle rn  e t  a l  <1974, 1976, 1980a) a ls o  developed  H.P.L.C. a s s a y s  
cap ab le  o f m easu ring  q u a n t i t i e s  o f m ethim azole in  p lasm a. The i n i t i a l  
method (1974) used  a P o r a s i l  C column (2 f t  X 2.3mm) w ith  n - 
h e x a n e :te tra h y d ro fu ra n  50:50 m obile phase . T h is  m ethod had a l im it  o f 
d e te c tio n  o f on ly  lOOng/ml due to  low column e f f ic ie n c y  and m ethim azole 
n o t be in g  co m p le tly  re so lv e d  from th e  s o lv e n t  peak. C hrom atography was 
im proved by th e  use  o f a  lOum alum ina column (100 X 4.6mm) w ith  a m obile 
p h ase  w hich c o n s is te d  o f 2% m ethanol in  ch lo ro fo rm . However, t h i s  
p ro ced u re  (1976) was s t i l l  on ly  s u i ta b le  fo r  th e  d e te rm in a tio n  o f 
m ethim azole in  p lasm a above a c o n c e n tra t io n  of 0 .lu g /m l. F in a lly ,  th e
rep lacem en t o f benzam ide, th e  i n te r n a l  s ta n d a rd  w ith  p -to lu a m id e  (1980), 
r e s u l te d  in  a  s l i g h t l y  s h o r te r  a n a ly s i s  tim e, bu t had th e  problem  of 
in te r f e r e n c e  caused  by th e o p h y llin e .
H.P.L.C. w ith  e le c tro c h e m ic a l d e te c tio n  h a s  a ls o  been used to  s tu d y  
m eth im azole in  p lasm a and u r in e  sam p les  (T a tsu h a ra  e t  a l .  1985). T h is  
method was c a p ab le  o f d e te c t in g  lO ng/m l o f m ethim azole.
To d a te , th e  m ost s e n s i t iv e  H.P.L.C. m ethod i s  t h a t  d e v ise d  by 
Hengstmann and Hohn(1985) w hich c la im s  d e te c tio n  o f p icogram  am ounts of 
m ethim azole. H.P.L.C. s e p a ra t io n  was perfo rm ed  on a 30 x 0.4cm s ta i n l e s s  
s t e e l  column c o n ta in in g  lOum Bondapack C -18, r e v e r s e  ph ase  m a te r ia l.  
The s o lv e n t  sy stem  c o n s is te d  o f n in e  p a r t s  o f  0.05M p o tass iu m  p hosphate  
b u f fe r  and 1 p a r t  o f m ethano l. l ,5 -d im e th y l-2 -m e rc a p to im id a z o le  was 
employed a s  th e  i n te r n a l  s ta n d a rd  and m ethim azole was back e x tra c te d
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from d ich lo ro m eth an e  in to  0.1N NaOH th u s  in c re a s in g  rec o v e ry  and reduc ing  
in te r fe re n c e  from  p rim ary  and seco n d a ry  p h e n o lic  am ines.
S te n la k e  e t  a l .  (1970) used G.L.C. to  m easure m ethim azole recovered  
from r a t  u r in e . E x tra c te d  m ethim azole was t r e a te d  w ith  m ethyl io d id e  
to  form th e  S -m ethy l m ethim azole d e r iv a t iv e .  R eaction  tim e was c r i t i c a l  
because th e  i n s t a b i l i t y  o f th e  d e r iv a t iv e  cou ld  lead  to  th e  r e te n t io n  of 
f r e e  m ethim azole on th e  column. The s e n s i t v i t y  o f t h i s  a s sa y  was
250ng/m l. Bending and S tevenson  (1978) developed a  m ethod u sing  G.L.C.
w ith  th e rm io n ic  n itro g e n -p h o sp h o ro u s  d e te c tio n  which cou ld  m easure 
m ethim azole down to  le v e ls  o f 30ng/m l. M ethimazole was e x tr a c te d  in to
c h lo ro fo rm  and was added to  tetram ethylam m onium  h y d rox ide . F la sh
m e th y la tio n  by te tr a m e th y l  ammonium hyd ro x id e  o ccu rs  a t  300° C in  th e  
in je c t io n  p o r t .  6 -h y d ro x y p y r id a z in -3  (2H )-one, th e  in te r n a l  s ta n d a rd , was 
added a f t e r  th e  e x tr a c t io n  p rocedu re  because o f poor rec o v e ry  from  th e  
p lasm a in to  ch lo ro fo rm .
The m ost s e n s i t iv e  and s p e c i f ic  method y e t  p u b lish e d  fo r  th e  
d e te rm in a tio n  o f m ethim azole was p re s e n te d  by F loberg  e t  a l .  (1980) u sin g  
a  G.C.-M.S sy stem . The drug  was t r a n s f e r r e d  from th e  sam ple and 
d e r iv a t i s e d  in  one s te p  by e x t r a c t iv e  a lk y la t io n . T h is  r e a c tio n  was 
w ith  e i th e r  benzy l c h lo r id e  o r  p e n ta f lu o ro b e n z y l brom ide. A deu terium - 
la b e l le d  analogue, l - t r id e u te r o m e th y lim id a z o le -2 - th io l  was used a s  th e  
i n te r n a l  s ta n d a rd .  The s e n s i t i v i t y  o f t h i s  m ethod was 2ng/m l w ith  a 
c o e f f ic ie n t  o f v a r ia t io n  o f abou t 6%. However, in  t h i s  tech n iq u e , th e  
ch o ic e  o f d e r iv a t iv e  depends on p r io r  knowledge o f th e  expected  drug 
l e v e l .
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The f in a l  developm ent was p re se n te d  by Cooper e t  a l .  (1984) who 
q u a n tif ie d  m ethim azole by a s im p le , r a p id  and p re c is e  radioim m unoassay. 
A m ethim azole d e r iv a t iv e ,  l-m e th y l-2 -m e rc a p to -5 -c a rb o x y im id a z o le , was 
con juga ted  to  p o rc in e  th y ro g lo b u lin  and a n tib o d ie s  to  th e  con juga te  were 
r a is e d  in  r a b b i t s .  The a s sa y  h a s  a s e n s i t i v i t y  (25ng/m l) which i s  
com parable  to  th o s e  o f th e  c h ro m a to g rap h ic  te c h n iq u e s . The p u ta tiv e  
m ethim azole m e ta b o li te s  3 -m e th y l-2 - th io h y d a n tio n  and 1 -m ethy lim idazo le  
had m inor c r o s s - r e a c t i v i t i e s  o f 2.1% and .5% r e s p e c t iv e ly .
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1.3 CLINICAL PHARMACOKINETICS OF METHIMAZOLE
1.3.1 A bso rp tio n
The m a jo r ity  o f d ru g s  a re  g iven  e x tr a v a s c u la r ly  b u t a re  in te n d e d  to  
a c t  s y s te m ic a lly . B efore th e  drug  can e x e r t  a p h a rm aco lo g ica l e f f e c t ,  
th e  d rug  m ust be ab so rb ed , p r io r  to  d i s t r ib u t io n  to  th e  r e c e p to r  s i t e ,  
where i t  w i l l  e l i c i t  i t s  e f f e c t .
The a b s o rp t io n  s te p  may, th e re fo re ,  be re s p o n s ib le  f o r  n o n - id e a l  drug  
th e ra p y  due to  poor a b s o rp t io n  o r d e la y s  in  th e  a b s o rp t io n  p ro c e s s .
There a re  many e x tr a v a s c u la r  ro u te s  bu t o r a l  a d m in is t ra t io n  i s  th e  
m ost f re q u e n tly  used mode, la rg e ly  because o f i t s  convenience. The 
e x te n t  o f m a te r ia l  in  th e  sy s te m ic  c i r c u la t io n  from an e x tra v a s c u la r  
fo rm u la tio n  com pared w ith  an in tra v e n o u s  fo rm u la tio n  i s  g iven  a s  i t s  
p e rc e n ta g e  a b s o lu te  b io a v a i la b i l ty
There a re  v a r io u s  s te p s  th ro u g h  which a dosage form  h as  to  p a s s  
b e fo re  re a c h in g  th e  sy s te m ic  c i r c u la t io n  i .e .  d i s in te g r a t io n ,  d is s o lu tio n  
and p a ssa g e  th ro u g h  m em branes. The d is s o lu t io n  o f th e  s o l id  i s  o f te n  
th e  r a t e  l im it in g  s te p  to  d rug  a b s o rp t io n  i .e . th e  r a t e  o f a b s o rp tio n  i s  
c o n tro l le d  by how f a s t  th e  drug  d is s o lv e s  in  f lu id s  a t  th e  a b s o rp tio n  
s i t e .
Once in  s o lu t io n  th e  drug  h a s  to  p a s s  to  th e  membrane f o r  a b s o rp tio n  
where in  m ost c a s e s  i t  i s  presum ed to  be t r a n s f e r r e d  a c ro s s  th e  
membrane by p a s s iv e  d if fu s io n . T h is  i s  de te rm ined  by th e  l ip o p h i l ic  
n a tu re  o f th e  drug  and th e  membrane. The m a jo r ity  o f d ru g s  c ro s s  th e
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l ip id  membrane of th e  g a s t r o in t e s t i n a l  t r a c t  in  t h e i r  u n io n ised  form . 
Thus, i t  can  be seen  t h a t  a  drug  which rem ain s  io n is e d  w il l  have poor 
membrane p e rm e a b ility  and t h i s  w i l l  become th e  r a t e  d e te rm in in g  s te p  in  
th e  drug  a b s o rp tio n  p ro c e s s . The a b s o rp t io n  r a t e  i s  r e la te d  n o t on ly  to  
th e  p e rm e a b ility  o f th e  compound th ro u g h  th e  membrane bu t a ls o  to  th e  
s u rfa c e  a re a  a v a i la b le  fo r  t r a n s p o r t .  Hence, i t  i s  im m edia te ly  obvious 
t h a t  th e  sm a ll i n te s t i n e  i s  conducive to  r a p id  t r a n s f e r  o f d ru g s. The 
rem oval o f m a te r ia l  from  th e  a b s o rp t io n  s i t e  in c re a s e s  th e  e f f e c t iv e  
c o n c e n tra tio n .
There a re  a ls o  s e v e ra l  o th e r  p h y s io lo g ic a l  f a c to r s  which may a f f e c t  
b io a v a i la b i l i ty .  As a lre a d y  m entioned, b lood  flow  to  th e  g a s t r o ­
i n t e s t i n a l  t r a c t  can g r e a t ly  a f f e c t  a b s o rp t io n  o f d ru g s. L o g ic a lly  th e  
l e s s  th e  b lood  flow , th e  s lo w er th e  drug  i s  tak en  away which could 
p o s s ib ly  com prom ise a b s o rp tio n .
Any f a c to r  which p re v e n ts  th e  t r a n s f e r  o f d rugs to  th e  sm a ll 
in te s t i n e  cou ld  d e lay  a b s o rp tio n . Some d ru g s  d e c re a se  (p ro p a n th e lin e ) , 
w hereas o th e r s  (m etoclopram ide) in c re a s e  g a s t r i c  em ptying and, 
th e re fo re , may in flu e n c e  th e i r  own a b s o rp t io n  o r t h a t  o f c o -a d m in is te re d  
d ru g s. The p rese n c e  o f food i s  a v e ry  complex f a c to r  w ith  re g a rd  to  
g a s t r i c  em pty ing . Blood flow  to  a l l  p a r t s  o f th e  stom ach and sm a ll 
i n t e s t i n e  a re  in c re a se d  2 to  3 fo ld  a f t e r  feed in g . C onsequently  th e  
p re se n c e  o f food cou ld  in  f a c t  in c re a s e  th e  a b s o rp t io n  r a t e  and maybe 
th e  e x te n t ,  by v i r tu e  o f in c re a se d  blood flow , o f d ru g s  which a re  tak en  
b o th  w ith  and j u s t  b e fo re  food. However, la rg e  volum es o f food ten d  to  
slow  stom ach em ptying c a u sin g  d e la y s  in  a b s o rp t io n  and in c re a se d
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exposure  to  stom ach a c id i ty .  Cold foods ten d  to  d e la y  stom ach em ptying; 
low v i s c o s i ty  l iq u id s  a re  em ptied  more r a p id ly  th a n  h ig h  v i s c o s i ty  
l iq u id s  which a ls o  r e t a r d  drug  movement to  s i t e s  o f a b s o rp t io n . Large 
q u a n t i t i e s  o f e le c t r o ly te s ,  f a t s  and some p r o te in s  ten d  to  slow  th e  r a t e  
o f em ptying w hereas c a rb o h y d ra te s  have no e f f e c t .  F in a l ly  th e  more 
bulky th e  food , th e  s lo w er th e  em pty ing  r a te .  Thus, one can n o t 
g e n e ra lis e  abou t th e  e f f e c t  o f food on th e  r a t e  and e x te n t  o f drug  
a b s o rp t io n .
P re lim in a ry  s tu d ie s  in  two s u b je c ts  a d m in is te re d  o r a l  and in tra v e n o u s  
35d o ses  o f S -m eth im azole in d ic a te d  a lm o s t com plete  a b s o rp t io n  o f th e  
drug  w ith  b io a v a i l a b i l i t i e s  o f 81 and 99% r e s p e c t iv e ly  < A lexander e t  
a l . ,  1969; Shimm ins e t  a l . ,  1969) These r e s u l t s  have been c o rro b o ra te d  
by m easurem ents o f t o t a l  e x c re tio n  o f r a d io a c t iv e  m a te r ia l  in  u r in e  and 
fae c e s  a f t e r  o r a l  a d m in is te ra t io n  o f e i t h e r  35S-m eth im azole  o r 35S- 
carb im azo le  < A lexander e t  a l.,1 9 6 9 ; M archant, 1979 ) The use o f t o t a l  
r a d io la b e l  d a ta  however g iv e s  no in d ic a t io n  a s  to  w hether th e  drug  was 
m etabo lized .
A fte r  o r a l  d o s in g  any lo s s  o f th e  a d m in is te re d  m a te r ia l  by 
m ic ro f lo ra l  m etabo lism  in  th e  lumen p r io r  to  a b s o rp t io n , tra n sm u c o sa l 
m etabolism  o r h e p a tic  m etabolism  i s  term ed  ' f i r s t  p a s s  m etab o lism ' s in c e  
any ab so rb ed  m a te r ia l  m ust f i r s t  p a s s  th e s e  p o te n t ia l  s i t e s  o f 
e lim in a tio n  b e fo re  re a c h in g  th e  sy s te m ic  c i r c u la t io n .  Thus, 
r a d io la b e l le d  s tu d ie s  can on ly  r e a l ly  be used f o r  in fo rm a tio n  on 
a b s o rp t io n  o f th e  t o t a l  drug  r e la te d  m a te r ia l .  To g a in  an e x a c t  m easure 
o f th e  b io a v a i la b i l i ty  o f m ethim azole i t  i s  n e c e s s a ry  to  conduct a
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c ro s s  over s tu d y  m easuring  unchanged drug  in  p lasm a a f t e r  o r a l  and 
in tra v e n o u s  a d m in is t ra t io n s .
S tu d ie s  in  h y p e rth y ro id  and e u th y ro id  p a t i e n ts  a d m in is te re d  bo th  o ra l  
and in tra v e n o u s  m ethim azole (Hengstmann and Hohn, 1985), gave v a lu e s  of 
0.49 and 1.5 r e s p e c tiv e ly .  The value  fo r  h y p e r th y ro id  p a t i e n ts  seem s to  
in d ic a te  f i r s t  p a s s  m etabolism . A va lue  g r e a te r  th a n  one on ly  occu rs  
when drug  d i s p o s i t io n  d i f f e r s  depending  on th e  ro u te  o f a d m in is t ra t io n . 
The e x p la n a tio n  g iven  by th e  a u th o rs  fo r  th e s e  d i f f e r e n t  r e s u l t s  between 
th e  g roups i s  th e  e x is te n c e  o f an unknown m e ta b o lite  o r ig in a t in g  from 
g u t w all m etabolism . T h is m e ta b o lite  i n te r f e r e s  w ith  th e  d e te rm in a tio n  
o f d i s t r ib u t io n  p rocedure  only  in  e u th y ro id  s u b je c ts .  However t h i s  
e x p la n a tio n  seem s h ig h ly  u n lik e ly .
F u r th e r  s tu d ie s  however seem to  ru le  ou t f i r s t  p a s s  m etabo lism . A 
b io a v a i la b i l i ty  o f 0.93 was ach ieved  f o r  a  s tu d y  o f h e a lth y  s u b je c ts  
< Ja n sso n  e t  a l . ,  1985 ). A f u r th e r  s tu d y  o f b o th  norm al and 
h y p e rth y ro id  p a t i e n ts  found th e  AUC to  be very  s im i l i a r  betw een 
in tra v e n o u s  and o ra l  a d m in is t ra t io n  even though th e  d i f f e r e n t  modes o f 
a d m in is t ra t io n  were n o t to  th e  same in d iv id u a ls  (Okamura e t  a l . ,  1986). 
T h erefo re , th e  g e n e ra l, co n c lu s io n  a p p e a rs  to  be t h a t  th e  b io a v a i la b i l i ty  
o f unchanged m ethim azole i s  h ig h , i f  n o t com plete.
Many in v e s t ig a to r s  have c a lc u la te d  th e  tim e  tak e n  to  rea c h  th e  peak 
p lasm a c o n c e n tra tio n  tm ax and th e  peak p lasm a c o n c e n tra tio n  v a lu es  Cmax 
d u rin g  p h arm aco k in e tic  s tu d ie s  fo llo w in g  th e  o r a l  a d m in is t r a t io n  o f 
m ethim azole. These have been l i s t e d  in  Table 1.2. G en e ra lly  th e s e  
s tu d ie s  in d ic a te  f a i r l y  r a p id  a b s o rp tio n , w ith  tmax v a lu e s  ran g in g  from
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Table 1.2 Studies on the peak plasma concentrations of methimazole 
follow ing oral adm inistration.
Authors XK1 tmax (h) Caax(ug/al) Status
Xelander e t  a l. 60mg 2.04+-0.66 1.325+-0.58 EU
I960 12x5ng
Hallengren e t a l. 40ag 1.03+-0.58 0.824+-0.14 EU
1982 1x4Omg 1.02+-0.79 0.830+-0.20 HU
Cooper e t a l . 30 and 60ng 2.0 .65+/- .09 ;1.54+/- .2 EU
1984 1.0 .78+/- .1 ;1.35+/- .01 HU
Skellern e t a l . 60ng 0.5-1.0 1.54-0.45 HU
1980 6x1Omg
P ltta an  e t a l . 60ag 1.0 0.92+/- 0.85 EU
1971 6x10
Okaaura e t a l . 10ag 1.8+/- 1.4 0.213+/- 0.84 EU
1986 2.3+/-0.8 0.299+/-0.92 HU
Jansson e t a l . 10ag 0.48+/-0.18 0.248+/-0.03 EU
1985
Hengstaann and Hobs 40ag 0.83+/-0.24 0.584+/-0.05 HU
1985
Jansson e t  a l . lOag 0.9+/-0.5 0.149+/-0.015 EU
1983
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0.5 to  3 h o u rs  b u t t h a t  th e re  i s  c o n s id e ra b le  in te r in d iv id u a l  v a r ia t io n  
in  b o th  th e  tmax and Cmax v a lu e s  a f t e r  o r a l  a d m in is t r a t io n .
1.3.1.1 C onversion  o f Carbim azole to  M ethim azole
C arbim azole i s  a c a rb e th o x y  d e r iv a t iv e  o f m ethim azole, and was
in tro d u c ed  by Lawson e t  a l  (1951a, 1951b ) w ith  a view to  o b ta in in g  a
lo n g e r a c tin g  a n t i th y r o id  d rug . A ccording to  t h e i r  r e p o r t ,  c a rb im azo le
i s  s ta b l e  in  a c id  s o lu t io n  b u t i s  r e a d i ly  h y d ro ly se d  in  n e u tr a l  o r
a lk a l in e  s o lu t io n . L a te r  s tu d ie s  con firm  t h i s  r a p id  h y d ro ly s is  'in  v iv o '
in  human p lasm a sam ples (S ten lak e  e t  a l . ,  1970; S k e lle rn  e t  a l . ,  1974)
35A m arked accum ulation  o f S - r a d io a c t iv i ty  was found in  th e  r a t
35th y ro id  fo llo w in g  th e  a d m in is t ra t io n  o f S -c a rb im a z o le  (M archant e t  a l . ,
351972), however ch ro m ato g rap h ic  a n a ly s i s  o f th e  S - a c t i v i t y  in  th e
th y ro id  showed t h a t  a l l  th e  ca rb im azo le  had been m e ta b o lised  to
35m ethim azole, s u lp h a te  and p ro te in  bound S
The c o n v e rs io n  o f carb im azo le  to  m ethim azole p resum ab ly  o ccu rs  
r a p id ly  e i t h e r  in  th e  g a s t r o in t e s t i n a l  t r a c t  o r  im m edia te ly  a f t e r  e n try  
in to  th e  c i r c u la t io n  ( Nakashim a e t  a l . ,  1979, S k e lle rn  e t  a l . ,  1980a)
Even th re e  m inu tes a f t e r  in tra v e n o u s  in je c t io n  o f 35S -c a rb im a z o le  to  
r a t s ,  no unchanged 35S -ca rb im azo le , on ly  35S m eth im azole cou ld  be 
d e te c te d  and th u s  Uakashim a e t  a l.,< 1979) have concluded  t h a t  th e  
c o n v e rs io n  o f ca rb im azo le  to  m ethim azole i s  enzym atic .
In v i t r o  s tu d ie s  have d i f f e r e d  over th e  a n t i th y r o id  p o ten cy  o f 
c a rb im azo le . One s tu d y  showed on ly  a s l i g h t  in h ib i to r y  e f f e c t  on th e
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p e ro x id a se  a c t i v i t y  in  human th y ro id  t i s s u e  ( M elander e t  a l . ,  1980) 
w h ile  a n o th e r  showed i t s  po tency  betw een t h a t  o f p ro p y lth io u ra c i l  and 
m ethim azole ( Nakashima e t  a l . ,  1979 ). However, w ith  i t s  r a p id  
c o n v e rs io n  in  v ivo  to  m ethim azole, t h i s  in h e re n t a n t i th y r o id  po tency  i s  
u n im p o rtan t.
No m ajor d if f e re n c e s  in  th e  k in e t ic s  o f m ethim azole a f t e r  d o s in g  
carb im azo le  o r m ethim azole have been re p o r te d  ( M elander e t  a l ,  1980; 
S k e lle rn  e t  a l ,  1974, 1980a; Ja n sso n  e t  a l ,  1983 ) Thus, carb im azo le  
a c t s  in  v ivo  a s  a 'p ro d ru g ' which i s  r a p id ly  and t o t a l l y  b io a c t iv a te d  to  
th e  a c t iv e  m ethim azole and a s  such  o f f e r s  no k in e t ic  o r  dynam ic 
ad v an tage  over m ethim azole.
1.3.2 D is tr ib u tio n
The c o n c e n tra tio n  in  th e  p lasm a w ith  tim e  fo llo w in g  th e  
a d m in is t ra t io n  o f a  s in g le  dose depends on th e  r a t e  and e x te n t  o f 
d i s t r ib u t io n  to  th e  t i s s u e s  and on how ra p id ly  th e  drug  i s  e lim in a te d . 
The c o n c e n tra tio n  ach ieved  a f t e r  d i s t r ib u t io n  i s  com plete i s  a  r e s u l t ,  
n o t on ly  o f th e  dose, b u t a ls o  th e  e x te n t  o f d i s t r ib u t io n  in to  th e  t i s s u e
The r a t e  o f d i s t r ib u t io n  o f a  drug  betw een b lood and t i s s u e  can be 
l im ite d  e i th e r  by p e rfu s io n  o r by d if fu s io n . A p e rfu s io n  r a te - l im ta t io n  
p r e v a i ls  when th e  t i s s u e  membranes a re  p o o rly  p e rfu se d  w ith  b lood  i .e . 
s k in ,  m uscle, f a t .  A d i f f u s io n - r a te  l im ita t io n  o cc u rs  i f  p a ssa g e  o f a 
drug  a c ro s s  th e  t i s s u e  membrane i s  ham pered by th e  d eg ree  o f io n is a t io n  
o f t h a t  drug in  p lasm a. Due to  th e  l ip o id  n a tu re  o f m em branes,
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d i s t r ib u t io n  e q u ilib riu m  w il l  be a t ta in e d  more q u ick ly  when io n is a t io n  i s  
s u p p re s s e d .
The e x te n t  o f d i s t r ib u t io n  i s  de te rm ined  from th e  r e la t io n s h ip  
between th e  c o n c e n tra tio n  of drug  in  p lasm a and th e  known amount of 
drug in  th e  body. The a p p a re n t volume in to  which a drug  d i s t r ib u t e s  in  
th e  body a t  e q u ilib ru im  i s  c a lle d  th e  ' a p p a re n t volume of d i s t r ib u t io n ',  
(V) .
A few s tu d ie s  have been c a r r ie d  ou t con cern in g  th e  volume of 
d i s t r ib u t io n  o f m ethim azole. In th e  s tu d y  o f A lexander e t  a l .  (1969) 
u s in g  r a d io a c t iv e  35S-m ethim azole, v a lu e s  o f 34.2 and 35.7 L were found 
in  two p a t ie n ts  a f t e r  in tra v en o u s  a d m in is t ra t io n . S k e lle rn  and co - 
w orkers (1980a) c a lc u la te d  th e  t o t a l  volume o f d i s t r ib u t io n  to  be 41.9 L 
a f t e r  o r a l  a d m in is tra t io n  o f e i th e r  60mg carb im azo le  o r  m ethim azole to  
f i f t e e n  h y p e rth y ro id  p a t ie n ts .  To g a in  a t ru e  e s tim a te  o f th e  volume of 
d i s t r ib u t io n  however, s tu d ie s  m ust be perfo rm ed  a f t e r  in tra v e n o u s  
in je c tio n  w ith  drug le v e ls  m easured by a s p e c i f ic  a n a ly t ic a l  tech n iq u e .
In r e c e n t  y e a rs  such s tu d ie s  have been u n d e rtak en  by v a r io u s  
in v e s t ig a to r s .  Using th e  GC-MS a s sa y  developed by F lo b erg  e t  a l . ,  1980; 
Ja n sso n  e t  a l .  (1985) e s tim a te d  th e  a p p a re n t volume o f d i s t r ib u t io n  fo r  
seven  norm al p a t i e n ts  fo llo w in g  a s in g le  in tra v e n o u s  b o lu s  in je c t io n  of 
lOmg o f m ethim azole. The v a lu es  ( 26.5-63L  ), ro u g h ly  eq u a lled  th e  t o t a l  
body w a te r a s  d id  a  s im i la r  s tu d y  by Hengstmann and Hohn (1985). Using
H.P.L.C. w ith  e le c tro c h e m ic a l d e te c tio n , a  va lue  o f 56+ /-6L  was determ ined  
fo llo w in g  an in tra v e n o u s  in je c tio n  o f 4 Omg m ethim azole to  e ig h t  
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c a lc u la te d  th e  volume of d i s t r ib u t io n  a f t e r  in tra v e n o u s  a d m in is t ra t io n  of 
lOmg m ethim azole to  f iv e  norm al (86-179L) and f i f t e e n  h y p e rth y ro id  (34- 
166L) p a t ie n ts .  These v a lu es , which a re  much h ig h e r  th a n  p rev io u s  
s tu d ie s ,  su g g e s t t h a t  m ethim azole i s  more w idely  d i s t r ib u te d .
The e x te n t o f d is t r ib u t io n  th roughou t th e  body i s  dependen t on t h a t  
p a r t i c u la r  d ru g 's  p h y sico -ch em ica l p r o p e r t ie s .  S tudy ing  th e  c h e m is try  
o f m ethim azole, i t  can be seen  th a t  in  plasm a <pH7.4) i t  w i l l  be 
u n io n ise d  and th e re fo re  f re e  to  move a c ro s s  th e  l ip id  membrane in to  
t i s s u e s .  A lso, m ethim azole d is p la y s  n e g lib le  p ro te in  b in d in g  and th u s  
th e  p e rc e n ta g e  o f th e  dose a v a ila b le  fo r  d i s t r ib u t io n  w il l  be h igh .
Thus, m ethim azole would be expected  to  d i s t r ib u t e  q u ite  w idely . However, 
m ethim azole i s  n o t co n sid e red  to  be h ig h ly  bound to  t i s s u e  p r o te in s ,  a 
c o n d itio n  which produces la rg e  a p p a re n t volumes o f d i s t r ib u t io n .  A lso, 
f o r  sm a ll l ip id  so lu b le  compounds l ik e  m ethim azole, th e  tim e  to  
e q u i l ib r a te  te n d s  to  be p e rfu s io n  r a t e  l im ite d . H ighly p e rfu se d  t i s s u e s  
ten d  to  e q u i l ib r a te  r a p id ly ;  p o o rly  p e rfu se d  t i s s u e s  s lo w ly . As 
m ethim azole i s  r a p id ly  e lim in a te d , d i s t r ib u t io n  e q u ilib r iu m  may n o t have 
been ach ieved  in  more p o o rly  p e rfu sed  t i s s u e s  such  a s  m uscle and f a t .
1.3.2.1 P la c e n ta l  T ra n s fe r  o f M ethimazole
Again, because o f i t s  l ip id  s o lu b i l i ty ,  low p ro te in  b in d in g  and 
su p p re sse d  io n iz a tio n , m ethim azole can leave  th e  m a te rn a l c i r c u la t io n  and 
c ro s s  th e  p la c e n ta  becoming a r i s k  to  f o e ta l  th y ro id  fu n c tio n . These 
a ssum ption  were confirm ed by M archant e t  a l.,(1 9 7 7 ) . The p la c e n ta l
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35t r a n s f e r  o f S-m ethim azole and carb im azo le  was m easured in  e u th y ro id  
women undergo ing  th e ra p e u tic  a b o r tio n  a f t e r  8 to  18 weeks o f p regancy ,
By com paring m a te rn a l and fo e ta l  serum c o n c e n tra tio n s  a t  d e liv e ry  two 
h o u rs  a f t e r  o ra l  a d m in is tra t io n  i t  was found t h a t  th e  fo e ta l:m a te rn a l  
r a t i o  was 0.72 to  1.09
U n fo rtu n a te ly , a d d it io n  of th y ro x in e  o r t r i - io d o th y r o n in e  seem s of 
l i t t l e  va lu e  a s  th e  p la c e n ta  i s  r e l a t iv e ly  im perm eable to  th y ro id  
horm ones and th e  supplem ent may in c re a s e  th e  dose o f m ethim azole needed 
to  c o n tro l  th e  m ate rn a l h y p e rth y ro id ism .
1.3.2.2 C o n c e n tra tio n  in  th e  T hyroid
The d i s t r ib u t io n  o f m ethim azole in  th e  human th y ro id  h a s  been s tu d ie d  
fo llo w in g  s in g le  o ra l  doses  o f 35S-m ethim azole and ca rb im azo le  in  
p a t i e n ts  re q u ir in g  thy ro idectom y ( H archan t e t  a l . ,  1972; L azarus e t  a l . ,  
1975 ). These s tu d ie s  have shown th a t  m ethim azole i s  a c t iv e ly  
c o n c e n tra te d  by th e  th y ro id  g lan d . T hyro id /serum  r a t i o s  were g r e a te r  
th a n  1 in  th y ro to x ic  and norm al th y ro id  t i s s u e .  In norm al th y ro id  
t i s s u e  e ig h t  to  tw elve  hours a f t e r  a d m in is t ra t io n , g r e a te r  th a n  90% of 
io d in e  o rg a n i f ic a t io n  was in h ib i te d . In th y ro to x ic  t i s s u e  th e  mean 
in h ib i t io n  was 80% a t  e ig h t  h ou rs  and a c o n s id e ra b le  in te r in d iv id u a l  
v a r i a t io n  was seen  in  a n t i th y r o id  e f f e c t  a t  th e  same drug  dose .
A much more m arked th y ro id a l  accum ulation  o f m ethim azole was found 
by Ja n sso n  e t  a l .  (1983b). Using a GC-MS m ethod, th e y  s tu d ie d  
in t r a th y r o id a l  c o n c e n tra tio n s  in  tw en ty  e u th y ro id  p a t i e n t s  w ith  G rave 's
50
d ise a s e . On tre a tm e n t w ith  carb im azo le  and th y ro x in e  th ey  found th y ro id  
to  serum  r a t i o s  o f 5, th re e  to  s ix  h o u rs  and 61, sev en teen  to  tw en ty  
h o u rs  a f t e r  th e  l a s t  o r a l  dose. These s tu d ie s  in d ic a te  t h a t  on ly  a 
sm a ll p ro p o rtio n  o f a  dose i s  tak en  up in  th e  th y ro id  g lan d  o f a p a t ie n t  
re c e iv in g  con tinuous th e ra p y . Ja n sso n  e t  a l .  p o s tu la te d  t h a t  t h i s  could  
be due to  s e l f - i n h ib i t io n  o f th y ro id a l  up take  by m ethim azole and m ight 
e x p la in  why th ey  could  n o t d em o n stra te  a  s t a t i s t i c a l  d i f f e re n c e  in  
in t r a th y r o id a l  m ethim azole c o n c e n tra tio n s  betw een p a t i e n ts  r e c e iv in g  30 - 
45mg o f carb im azo le  and th o se  re c e iv in g  15-20mg. A lso, th e  mean 
in t r a th y r o id a l  drug  c o n c e n tra tio n s  d id  n o t d i f f e r  betw een th e  group 
re c e iv in g  th e  f in a l  dose th re e  to  s ix  h o u rs  p re o p e ra tiv e ly  and th e  group 
ta k in g  th e  f in a l  dose seven teen  to  tw en ty  h ou rs  b e fo re  e x c is io n . T h is 
in d ic a te s  t h a t  th e  e lim in a tio n  o f m ethim azole from  th e  th y ro id  g lan d  i s  
much lo n g er th a n  th e  e lim in a tio n  from  th e  p e r ip h e ra l  c i r c u la t io n .
1.3.3 E lim in a tio n
E lim in a tio n  i s  d e fin ed  a s  th e  i r r e v e r s ib l e  lo s s  o f s u b s ta n c e s  from 
th e  s i t e  o f m easurem ent w ith in  th e  body. The r a t e  o f e lim in a tio n  i s  
o f te n  ex p re sse d  a s  th e  e lim in a tio n  h a l f - l i f e  (tte) i .e .  th e  tim e  tak e n  fo r  
th e  c o n c e n tra tio n  to  d e c rease  by one h a lf .  T h is  p a ra m ete r  i s  
m easureab le  only  when e lim in a tio n  i s  th e  m ajor d i s p o s i t io n  e n t i ty  i .e . 
th e  te rm in a l phase  o f th e  c o n c e n tra tio n  v e rs u s  tim e  p r o f i le .  The tte 
v a lu e s  p u b lish e d  fo r  m ethim azole a re  g iv en  in  T able  1 .4 . Drugs may be 
e lim in a te d  by one o f many ro u te s  e .g . m etabo lism , e x c re tio n , b i l i a r y
s e c re tio n , in to  s a l iv a ,  in to  sw eat, in to  m ilk ; th e  f i r s t  two u su a lly  
c o n s t i tu te  th e  m ajor ro u te s  o f e lim in a tio n .
1.3.3.1 Renal E x c re tio n
The r e n a l  ro u te  i s  th e  u ltim a te  in  e lim in a tio n  o f some d ru g s  and m ost 
m e ta b o li te s . In f a c t  a l l  low m olecu lar w eight compounds which a re  n o t 
bound to  h igh  m olecular w eight p ro te in s  a re  g lo m eru la r f i l t r a t e d .  Some 
compounds a re  a ls o  a c tiv e ly  s e c re te d  from plasm a in to  th e  tu b u la r  lumen, 
m ain ly  a long  th e  prox im al tubu le . The e x te n t o f p ro te in  b in d in g  h as  no 
e f f e c t  on s e c re tio n .
V ater i s  reab so rb ed  along  th e  len g th  o f th e  k idney  tu b u le . T h is  
w a te r r e a b s o rp tio n  le a d s  to  d rugs which were f i l t e r e d  and p e rh ap s  
se c re te d , be ing  hundred tim es  more c o n c e n tra te d  by th e  d i s t a l - c o l l e c t in g  
tu b u le s . Thus, because of th e  p o s s ib le  c o n c e n tra tio n  g ra d ie n t  th e re  i s  a 
tendency  fo r  th e  d rugs to  be rea b so rb ed . The degree  o f r e a b s o rp tio n  i s  
p ro p o r t io n a l  to  th e  degree o f io n iz a tio n  o f th e  compound.
The amount o f m ethim azole e x c re te d  unchanged in  th e  u r in e  of 
eu th y ro id  and hyper th y ro id  s u b je c ts  h as  v a rie d  from 5 and 12% o f th e  
a d m in is te re d  dose (M archant, 1979; P ittm an  e t  a l . ,  1971; Okamura e t  a l . ,  
1986). A lso th e  e lim in a tio n  of m ethim azole rem ained  u n a lte re d  in  
p a t i e n ts  w ith  r e n a l  im pairm ent (Jansson  e t  a l . ,  1985). These r e s u l t s  
exclude  r e n a l  e x c re tio n  a s  a m ajor pathw ay o f e lim in a tio n  o f unchanged 
d rug . However, ch rom atog raph ic  a n a ly s is  o f th e  r a d io a c t iv i t y  in  u r in e  
48 h ou rs  a f t e r  35S-m ethim azole a d m in is tra t io n  showed fo u r  35S-
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Table 1.4 Studies on tine elimination Ibalf— life of methimazole
Study SUbJecte Method
Alexander e t  a l . (1969) HBTIT 13 J Total r / a
IBS 2®-7
P lt ta a n  a t  aL  (1971) lis ts 6 4 C o lo rlae trlc
Crooks a t  a l . (1973) TfflT 1M Total r / a
TBS 1 1 2
Skellern  a t  a l. (1974) 3EC 3 .5 -4 4 HPLC
V esall e t  a l. (1975) 4ET 6-9+/-0J6 Color la e t r lc
15H 9.3+/-L4
Balzer e t  a l. (1975) 5BT 28 Total r / a
7E1 20
Bending and Stevenson (1976) 1HT 3.7 GLC
Xelander e t  a l . (1980) 11 ED 3.7+/-1.6 HPLC
Skellern  e t  a l.(1980) 1511 3 .1+ /-04 HPLC
Johansen e t  a l.(1982) 511 4.9+/-2.0 HPLC
Jansson e t  a l. (1963)
Cooper e t  a l .  (1984) 5HT 6 4 HU
611 6.0
Jansson a t  a l.(1985) 1411 5 .3+ /-05 GC-XS
Hengstaann and Bohn (1985) 3BT 6.1+/-0.3 HPLC
211 5.1+/-0.1
Okaaura e t a l. (1986) ^511 20.7*/-9 j6 HPLC
15HT 16J5+/-L2.9
1 EU = normal
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compounds: unchanged m ethim azole <7%); an unknown m ajor p o la r  m e ta b o lite  
(about 50%) n o t bound to  e i th e r  g lu cu ro n ic  o r s u lp h u r ic  a c id ; in o rg a n ic  
s u lp h a te  (6%); and a m inor 35S -m e ta b o li te  (1.5%)
[ M archant, 1979]. A nother m inor m e ta b o lite  was a ls o  id e n t i f ie d ,  t h i s  
tim e  by th in  la y e r  chrom atography  and H.P.L.C. (S k e lle rn  e t  a l . ,  1977). 
S k e lle rn  e t  a l .  showed t h a t  sm a ll am ounts o f 3 -m e th y l-2 - th io h y d a n to in  
cou ld  be d em o n stra ted  in  u r in e  and a ls o  p lasm a and th y ro id  t i s s u e  a f t e r  
a d m in is t r a t io n  o f e i th e r  carb im azo le  o r  m ethim azole. Thus, i t  i s  f a i r  to  
sa y  t h a t  th e  m e ta b o li te s  a re  r e n a l ly  c le a re d  w ith  th e  m ain m e ta b o lite  
be ing  a s tr o n g ly  p o la r  n o n -g lu cu ro n id e  compound. As th e  re a d s o rp tio n  
i s  p ro p o r t io n a l  to  th e  io n is a t io n  o f th e  compound, t h i s  n o n - l ip id  
so lu b le , p o la r  m e ta b o lite  would show v e ry  l i t t l e  re a d s o rp tio n  a lo n g  th e  
d i s t a l  tu b u le .
1.3.3.2 M etabolism
As a lre a d y  m entioned, m etabolism  i s  c o n s id e re d  to  be th e  m ajor ro u te  
o f e lim in a tio n . G enera lly  m etabolism  i s  c o n s id e re d  to  occur in  th e  
l iv e r .  However i t  can a ls o  ta k e  p lac e  in  th e  g u t w a ll, p lasm a, k id n ey s  
and o th e r  t i s s u e s .  M etabolism  o ccu rs  because th e  body re c o g n is e s  th e  
m olecule a s  'f o re ig n ' and, i f  i t  i s  unab le  to  e lim in a te  i t  unchanged, can 
a l t e r  i t  in to  a  form  which i s  more s o lu b le  in  p h y s io lo g ic a l  f lu id s  and 
hence more r e a d i ly  e x c re te d . G en era lly , t h i s  means in c re a s in g  i t s  w ater 
s o lu b i l i t y .  The a c id i ty  o f th e  m olecule may be in c re a s e d  and t h i s  w il l  
a id  s o lu b i l i t y  because m ost p h y s io lo g ic a l  f lu id s  a re  s l i g h t l y  b a s ic .
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Two s tu d ie s  in  p a t ie n ts  w ith  h e p a tic  im pairm ent b o th  showed a 
p ro longed  e lim in a tio n  h a l f - l i f e  o f m ethim azole (Jan sso n  e t  a l . ,  1985; 
Cooper e t  a l . ,  1984). These o b s e rv a tio n s  in d ic a te  t h a t  th e  m ajor 
e lim in a tio n  ro u te  i s  h e p a tic  m etabolism .
The b i l i a r y  e x c re tio n  of equ im olar d o ses  o f 35S-m eth im azole and 
33S -carb im azo le  (Papapetrou e t  a l.,1 9 7 2 ) and a dose o f ^C -m eth im azole 
(S i ta r  and T h o rn h ill, 1973) h a s  been s tu d ie d  in  r a t s .  The t o t a l  amount 
o f 35S r a d io a c t iv i ty  e x c re te d  in  th e  b i le  5 hou rs a f t e r  35S-m eth im azole 
and carb im azo le  was 21.1 + /-2 .8  and 31.71+-8.16%  o f th e  dose, 
re s p e c t iv e ly .  In c o n t r a s t ,  th e  t o t a l  amount o f 14C - r a d io a c t iv i ty  e x c re te d  
in  10 h ou rs  was only  9% of th e  dose which p ro b ab ly  r e f l e c t s  th e  b i l i a r y  
e x c re tio n  o f a  g r e a te r  number o f m ethim azole m e ta b o li te s  c o n ta in in g  
su lp h u r th a n  ca rbon . I t  i s  a ls o  in te r e s t in g  to  n o te  t h a t  h e p a tic  
cytochrom e oxygenases were cap ab le  o f o x id is in g  m ethim azole to  3 - 
m e th y l-2 - th io h y d a n to in  and N -m ethy lim idaza le  (Neal and Lee,1978). 
C onversion  o f m ethim azole to  3 -m e th y l-2 - th io h y d a n to in  in v o lv e s  th e  
p ro d u c tio n  o f a new chem ical group on th e  m olecule. T h is  k in d  o f 
m etabolism  i s  u su a lly  c o n s is te n t  betw een d i f f e r e n t  s p e c ie s , v a ry in g  only  
in  q u a n ti ty . The o x id a tio n  a t  th e  o le f in ic  carbon  atom g iv e s  in c re a se d  
w a te r s o lu b i l i ty  and th e re fo re  in c re a se d  e lim in a tio n . The m etabolism  
p ro b ab ly  o ccu rs  in  th e  endoplasm ic re ticu lu m  o f l iv e r  c e l l s  by enzymes 
known c o l le c t iv e ly  a s  Cytochrome P -450.
In s tu d ie s  o f 35S-m ethim azole much more drug  i s  e x c re te d  in  th e  b i le  
th a n  in  th e  fa e c e s  (A lexander e t  a l.,1 9 6 9 ) . Thus i t  would seem l ik e ly  
t h a t  an e n te ro h e p a tic  c i r c u la t io n  o ccu rs  fo r  m ethim azole a n d /o r  i t s
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m e ta b o lite s  and in d ic a te s  t h a t  th e  m a jo r ity  o f th e  r a d io a c t iv i ty  e x c re te d  
in  th e  b i le  may be reab so rb ed  and f in a l ly  e x c re te d  by th e  k idney . Indeed 
th e  h a l f - l i f e  o f 3 -m e th y l-2 - th io h y d a n to in  was c a lc u la te d  to  be 13.5 
hours (S k e lle rn  e t  a l.,1 9 8 0 a ); i .e . a t  l e a s t  th re e  tim e s  lo n g e r  th an  
m ethim azole which c e r ta in ly  p o in ts  to  th e  p o s s ib i l i ty  o f e n te ro h e p a tic  
c y c lin g . T h is  could  be v e r i f ie d  by an im al ex p erim en ts  in v o lv in g  
c a n n u la tio n  o f th e  common b i le  d u c t. An an im al i s  dosed  w ith  
r a d io la b e l le d  m ethim azole and th e  b i le  c o lle c te d . T h is  i s  re in fu s e d  in to  
th e  in te s t in e  o f a n o th e r  an im al from which b i le  i s  a ls o  c o lle c te d . If  
r a d io a c t iv i ty  i s  reco v ered  in  th e  b i le  from th e  second  an im al, 
e n te ro h e p a tic  c i r c u la t io n  i s  s a id  to  occur.
Agreement e x i s t s  a s  to  th e  main m e ta b o lite  o f m ethim azole being  
a m ethim azole g lucu ron ide  in  th e  b i le  (Papapetrou e t  a l.,1 9 7 2 ; S i t a r  e t  
a l.,1 9 7 3 ) . There i s  co n s id e red  to  be a m olecu lar w eigh t req u irem en t fo r  
th e  b i l i a r y  e x c re tio n  o f d ru g s. For many, a tta in m e n t o f such  a m olecu lar 
w eigh t i s  u su a lly  ach ieved  by m etabolism ; e.g . co n ju g a tio n  w ith  
g lu cu ro n ic  a c id . Such m e ta b o lite s  can th e  ap p ear in  th e  fa e c e s . However 
co n ju g a tio n  o f m ethim azole w ith  g lu cu ro n ic  a c id  g iv e s  a  m olecu lar w eight 
o f 290 which i s  n o t la rg e  enough to  a llow  such  a p ro c e s s . In s te a d  t h i s  
con juga te  would be h y d ro ly sed  in  th e  g u t by th e  g u t b a c te r ia  and e n te r  
in to  e n te ro h e p a tic  re c y c lin g . C onjugation r e a c t io n s  a re  u s u a lly  m ediated  
by h ig h  energy  in te rm e d ia te s  (PAPS,UDPGA) and o f te n  occur in  th e  
cy top lasm . Q u a lita tiv e  d if fe re n c e s  can occur from s p e c ie s  to  s p e c ie s , 
however M M I-S-glucuronide h as  been shown to  occur b o th  in  r a t s
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(M archant and A lexander,1972; S k e lle rn  e t  a l.,1 9 7 3 ) and man (A lexander e t  
a l.,1 9 6 9 ) .
1.3 .3 .3  E x c re tio n  o f M ethimazole in  B re a s t Milk
E x c re tio n  o f x e n o b io tic s  in  b r e a s t  m ilk  i s  a  r e l a t i v e ly  m inor pathw ay 
b u t im p o rta n t in  te rm s  o f th e  e f f e c t  o f in g e s t io n  by th e  s u c k lin g  
in fa n t .  M ilk i s  a  complex f lu id  w ith  h ig h  f a t  and p ro te in  le v e ls  w ith  
s ig n i f i c a n t  changes in  com position  d u rin g  th e  co u rse  o f l a c ta t io n .  A 
s e le c t iv e  b lo o d /m ilk  b a r r i e r  e x i s t s  f o r  th e  mammary d u c ts  o f m ost 
s p e c ie s  s tu d ie d . The duc t membrane i s  perm eable to  w a te r b u t m ilk  
rem ain s  iso sm o tic  to  plasm a.
S ince  human b r e a s t  m ilk  i s  an aqueous f lu id  o f h e te ro g en o u s and 
v a ry in g  co m position , th e  amount o f drug  e x c re te d  in  m ilk  w i l l  v a ry  w ith  
b o th  th e  com position  and th e  y ie ld . Fundam ental p ro c e s s e s  fo r  x e n o b io tic  
e lim in a tio n  de te rm in e  which d rugs w il l  be e x c re te d . P hysiochem ical 
p r o p e r t ie s  o f th e  drug  in flu e n ce  bo th  i t s  p a ssa g e  and 't r a p p in g ' in to  
m ilk  com ponents. A sch em atic  r e p re s e n ta t io n  o f drug  t r a n s f e r  betw een 
m ilk  and p lasm a i s  g iven  in  F igu re  (1 .6 ).
The main f a c to r s  which a f f e c t  d rug  t r a n s p o r t  in to  m ilk  a re ; m ilk  and 
p lasm a pH; m ilk  and plasm a p ro te in  b in d in g ; m ilk  f a t  p a r t i t io n in g .  Of 
th e s e  f a c to r s ,  th e  ones a f fe c te d  by changes in  m ilk  co m p o sitio n  a re  m ilk  
f a t  p a r t i t io n in g  and p ro te in  b in d in g .
The e x te n t  and a f f i n i t y  o f drug  b in d in g  to  bo th  p lasm a and m ilk 
p r o te in s  a re  a  d e te rm in a n t o f drug  c o n c e n tra tio n  in  whole m ilk .
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Plasma Milk










F ig u re  1.6 Schem atic  r e p r e s e n ta t io n  o f a model f o r  drug  t r a n s f e r  
betw een m ilk  and p lasm a.
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Johansen  e t  a l .  (1982) showed t h a t  th e r e  was only  a n e g i l ib le  amount o f 
m ethim azole bound to  p lasm a p ro te in s .  A lso, Cooper e t  a l.,(1984>  showed 
from  s tu d ie s  w ith  ^S -m eth im azole  t h a t  g r e a te r  th a n  99% o f th e  
r a d io a c t iv i t y  was rec o v e rab le  from  th e  aqueous phase  o f m ilk  a f t e r  
c e n tr i f u g a t io n  and th u s  concluded th a t  m ilk  p ro te in  b in d in g  o f 
m ethim azole was a ls o  n e g lig ib le .
Drug t r a n s f e r  in to  m ilk  i s  g e n e ra lly  c o n s id e red  to  be c h a ra c te r iz e d  
by th e  fo llo w in g  assum ptions: on ly  th e  unbound, un ion ized  form  o f th e
drug  which i s  lo c a te d  in  th e  aqueous phase  o f th e  p lasm a and m ilk  can 
d i f f u s e  a c ro s s  mammary membranes, and no c a r r i e r  m edia ted  t r a n s f e r  
o c c u rs . M ethim azole, w ith  a pKa value  o f 11.5 (S k e lle rn  e t  a l.,1 9 8 1 ) 
rem a in s  u n io n ised  in  both  p lasm a (pH6.6-6.8) and m ilk  (pH 7 .4 -7 .7 )
The c o e f f ic ie n t  o f l ip id  s o lu b i l i ty  fo r  an u n io n ised  drug  d e te rm in e s  
b o th  i t s  p e n e tra t io n  o f th e  b io lo g ic a l  membrane to  g a in  e n tra n c e  to  m ilk  
and a ls o  i t s  c o n c e n tra tio n  in  f a t .
M ethimazole h a s  a  h ig h  l ip id  s o lu b i l i ty  and th u s , c o n s id e r in g  t h i s  
f a c to r  and a ls o  t h a t  i t  i s  a n o n -p ro te in  bound drug  show ing no 
io n is a t io n  in  a  h y d ro p h il ic  env irom ent, in d ic a te s  t h a t  i t  would te n d  to  
e q u i l ib r a te  a c ro s s  th e  l ip id  b a r r i e r  o f th e  mammary g lan d . D esp ite  
th e s e  s im p le  p h y s io lo g ic a l  c o n s id e ra t io n s , i t  was th e  g e n e ra l  b e l ie f  th a t  
m ethim azole was c o n c e n tra te d  in  b r e a s t  m ilk . T h is  was based  on th e  
f in d in g s  o f W illiam s e t  a l .  (1944) who d em o n stra ted  t h a t  th e  le v e l  of 
th io u r a c i l  in  b r e a s t  m ilk  was th re e  tim es  h ig h e r  th a n  th e  le v e l  in  whole 
b lood  .These r e s u l t s  were l a t e r  found to  lac k  s e n s i t i v i t y  and s p e c i f ic i t y ,  
Schuppan e t  a l.(1973> , bu t th e  f in d in g s  had a lre a d y  been ex tended  to
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m ethim azole, However, f iv e  re c e n t s tu d ie s  have c h a llen g ed  t h i s  
assu m p tio n  ( Low e t  a l . ,  1979; T eg ler e ta l . ,  1980: Johansen  e t  a l . ,  1982; 
Cooper e t  a l . ,  1984 and N o ta rian n i e t  a l . ,  1986 ). These s tu d ie s  show a 
m ilk  : p lasm a r a t i o  o f m ethim azole from 0.58 to  1.19 and t h a t  th e  drug 
was never c o n c en tra te d  in  th e  m ilk .
1.3.4 D esign and O p tim ization  o f Dosage Regimen
Dosage d e s c r ib e s  both  th e  ro u te  and th e  r a t e  o f a d m in is t ra t io n  o f 
d rug . Some d ru g s e.g . a n a lg e s ic s , h y p n o tic s , neurom uscular b lo ck in g  
a g e n ts , b ro n c h o d ila to rs  and a n tie m e tic s  a re  used e f f e c t iv e ly  a s  a s in g le  
dose . More f re q u e n tly  d rugs a re  used on a con tinuous b a s is .  A lso m ost 
d ru g s  a re  used in  a dosage regim en th a t  r e s u l t s  in  m easureab le  and o f te n  
p h a rm a co lo g ica lly  a c tiv e  le v e ls  o f drug p e r s i s t  in  th e  body when th e  
n e x t dose i s  a d m in is te re d .
For d ru g s  a d m in is te re d  in  a f ix e d  dosage in te r v a l ,  th e  peak plasm a 
le v e l  fo llo w in g  th e  second and succeed ing  doses i s  h ig h e r  th a n  th e  peak 
le v e l  a f t e r  th e  f i r s t  dose th e re fo re  th e  drug accum ulates in  th e  body 
r e l a t i v e  to  th e  f i r s t  dose. Under such c o n d it io n s  drug accum ulation  
p ro ceed s  a t  a d e c re a s in g  r a te  w ith  in c re a s in g  number o f d o ses  u n t i l  a 
s te a d y  s t a t e  p lasm a lev e l o f drug i s  ach ieved . At s te a d y  s t a t e  th e  
p lasm a c o n c e n tra tio n  o f drug a t  any p o in t in  tim e d u rin g  any d o sin g  
in te r v a l  w i l l  be id e n t ic a l .  For th e  con tinuous m ain tenance  of
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th e ra p e u t ic  amount o f drug in  th e  body, th e  i n i t i a l  and m ain tenance 
d o se s  m ust be g iven  a t  d o sin g  in te r v a l s  t h a t  keep th e  amount above a 
minimum e f f e c t iv e  le v e l  and below a le v e l  p roducing  e x c e s s iv e  s id e  
e f f e c t s  and to x ic i ty .  The r a t e  and e x te n t o f accum ulation  o f a  drug  a re  
dependen t on th e  r e l a t iv e  m agnitudes o f th e  d o sin g  in te r v a l  and th e  
h a l f - l i f e  o f th e  drug.
In th e  t re a tm e n t of h y p e rth y ro id ism  w ith  m ethim azole v a r io u s  dosages 
a r e  recommended. Some a u th o rs  favou r a  f ix e d  dosage in  a l l  th y ro to x ic  
p a t i e n t s  < E avard , 1974; I rv in e  and T o ft, 1976), w h ile  o th e r s  recommend 
in d iv id u a liz e d  d o ses  based  on an a sse ssm e n t o f th e  s e v e r i ty  o f th e  
d is e a s e  < Braverm an, 1978; Solomon, 1978 ) . In th e  l a t t e r  c a se  i t  can 
som etim es be d i f f i c u l t  in  a g iven  p a t ie n t  to  de te rm in e  a s u i ta b le  
m ethim azole dosage regim en. However th e re  i s  a ls o  th e  problem  of 
a d v e rse  r e a c t io n  w ith  m ethim azole u su a lly  o ccu rin g  w ith in  fo u r  m onths 
from  th e  s t a r t  o f tre a tm e n t. The m ost common s id e  e f f e c t s  a re  nausea , 
h eadaches, r a s h e s  and a r th r a lg ia .  R arer r e a c t io n s  in c lu d e  a lo p e c ia , 
a g ra n u lo c y to s is  and jaund ice . Complete spon taneous r e v e r s i b i l i t y  i s  th e  
r u le  a f t e r  w ithd raw al o f th e  drug . G o itre  and h y p o th y ro id ism  a re  
u s u a lly  a  r e s u l t  o f o v e rtrea tm e n t. Occurence o f a d v e rse  r e a c t io n s ,  
e s p e c ia l ly  n e a r  th e  beg inn ing  o f tre a tm e n t where h ig h  d o se s  a re  used , 
seem s to  in d ic a te  a  dosage r e la t io n s h ip .
T h is  problem  o f amount o f dose needed f o r  e f f ic a c y  v e rs u s  s id e  e f f e c t  
was s tu d ie d  by Rom aldini e t  a l .  (1983). He com pared th e  re m is s io n  r a t e  
in  p a t i e n t s  re c e iv in g  h igh  dose th e ra p y  (60mg d a i ly  ) w ith  th o s e  in  
p a t i e n t s  re c e iv in g  a m aintenance dose (13.6mg d a i ly ) .  The group
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r e c e iv in g  h ig h -d o se  th e ra p y  had an a lm o st tw ofo ld  h ig h e r  re m iss io n  r a t e  
a f t e r  a  mean fo llow -up  p e rio d  o f fo r ty - tw o  m onths. However th e  r a t e  of
s id e  e f f e c t s  was a ls o  h ig h er .
The dosage regim en c u rre n tly  recommended fo r  m ethim azole ( B r i t is h  
N a tio n a l Form ulary  1987) i s  30-60mg d a ily  u n t i l  th e  p a t ie n t  becomes
e u th y ro id  (fou r to  e ig h t  weeks) when i t  i s  reduced to  a m ain tenance  dose
o f betw een 5 and 15mg d a ily .
The dosage regim en employed i s  a s se s s e d  u sin g  a p p ro p r ia te  chem ical 
in d ic e s  (A lexander e t  a l.,1973 ; V ise e t  a l.,1973 ; Low e t  a l.,1 9 7 9 ; D ahlberg  
e t  a l . ,  1981; R om aldini e t  a l.,1 9 8 3 ). There a re  many la b o ra to ry  
te c h n iq u e s  a v a ila b le  fo r  a s s e s s in g  th e  le v e l o f th y ro id  fu n c tio n . These 
f a l l  in to  th r e e  c a ta g o r ie s :-
(1) t o t a l  c i r c u la t in g  le v e ls  o f th y ro id  hormone
(2) c i r c u la t in g  le v e ls  of f re e  th y ro id  hormone e .g . F ree  T hyrox ine  Index 
(FTI) and
(3) dynam ic t e s t s  o f th y ro id  fu n c tio n  e.g . 132I Uptake, MmTc Uptake and 
th e  P o tassium  P e rc h lo ra te  t e s t .
Some of th e s e  c l in ic a l  in d ic e s  a re  n o t r e l i a b le  in d ic a t io n s  o f 
th y ro id  o v e ra c t iv i ty  e s p e c ia l ly  b a sa l  m etabo lic  r a t e s  o r serum  th y ro x in e  
(T4 ) le v e ls  (Wayne, 1960; L arsen , 1975; Nusynowitz and Young, 1979) 
P h arm aco k in e tic s  can se rv e  a s  a u se fu l means o f e v a lu a tin g  e x is t in g  
d osage  reg im en s. Plasm a c o n c e n tra tio n s , however, can on ly  be used  fo r  
any  c o r r e la t io n  i f  th ey  a re  a t  s te a d y  s t a t e  and th e  l i t e r a t u r e  i s  very  
s p a r s e  f o r  m u ltip le  dosage k in e t ic  s tu d ie s .  One s tu d y  by D ahlberg  e t  
a l.(1 9 8 1 )  found th a t  a lthough  mean c o n c e n tra tio n s  o f m ethim azole showed
a l in e a r  dose  re sp o n se  (80ng/ml to  35ng/m l a f t e r  dose re d u c tio n  o f from 
30 to  15mg d a ily )  th ey  d id  n o t c o r r e la te  s ig n i f ic a n t ly  w ith  th e  a c tu a l  T3 
l e v e l s .
One o f th e  m ajor q u e s tio n s  r e la t in g  to  m ethim azole th e ra p y  i s  w hether 
p a t i e n t s  re q u ire  s in g le  o r m u ltip le  d a ily  doses  o f m ed ica tio n . 
P h arm aco k in e tic  s tu d ie s  su g g e st t h a t  m ethim azole w ith  a  h a l f - l i f e  o f 
th r e e  to  s ix  h ou rs  canno t be e f f e c t iv e  when a d m in is te re d  in  s in g le  d a ily  
d o se s . Yet a  s tu d y  by V ise e t  a l.(1 9 7 3 ) showed t h a t  a f t e r  d iv id e d  dose  
th e ra p y  had blocked  th y ro id a l  horm onogenesis, t h i s  b lo ck  cou ld  be 
m ain ta in e d  w ith  an e q u iv a len t s in g le  d a ily  dose.
T h e rfo re , c le a r ly  plasm a c o n c e n tra tio n s  canno t be r e l a te d  to  
th e r a p e u t ic  e f f ic a c y . There a re  two p o s s ib le  re a s o n s  f o r  th e  a p p a re n t 
la c k  o f c o r r e la t io n .  F i r s t ly ,  th e  r a t i o  o f p lasm a m ethim azole 
c o n c e n tra t io n  to  m ethim azole a t  th e  s i t e  o f a c tio n  does n o t rem ain  
c o n s ta n t  over tim e. As d isc u sse d  e a r l i e r  ( se c tio n  1 .3 .2 .2 ), m ethim azole 
i s  a c t iv e ly  c o n c e n tra te d  by th e  th y ro id  g lan d  and th e r f o r e  th e  
in t r a th y r o id a l  m ethim azole c o n c e n tra tio n s  a re  more c le a r ly  r e la te d  to  
c l i n i c a l  e f f e c t .  Secondly, no account a s  been made o f m e ta b o li te  
a c t i v i t y .  As d isc u sse d  e a r l i e r  (se c tio n  1 .3 .3 .2 ), 3 -m e th y l-2 -  
th io h y d a n to in  h as  a p lasm a h a l f - l i f e  th re e  tim es  lo n g e r  th a n  m ethim azole 
and p ro lo n g ed  d u ra tio n  of a c tio n  may be p a r t i a l l y  a t t r ib u t a b l e  to  th e  
■thyroid a c t i v i t y  o f t h i s  m e ta b o lite . 3—m ethyl—2—th io h y d a n tio n  h a s  been 
shown to  have a n t i th y ro id  a c t i v i t y  in  th e  r a t  (S earle  e t  a l . ,  1951), b u t 
t h i s  rem a in s  to  be dem onstra ted  in  humans.
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1.3.5 P h a rm aco k in e tic s  in  H yperthyro id ism
Many pharm aco k in e tic  s tu d ie s  a re  perform ed in  norm al human s u b je c ts  
b u t l i t t l e  in fo rm a tio n  has appeared  on th e  e f f e c ts  which d is e a s e  s t a t e s  
may have on drug p h arm acok ine tics . D isease s t a t e s  by d e f in i t io n  change 
th e  norm al fu n c tio n s  o f th e  body, so  i t  i s  n o t s u p r is in g  t h a t  d ru g s 
a d m in is te re d  under th e se  c o n d itio n s  could have a l te r e d  p h a rm a co k in e tic s . 
In p a r t i c u l a r ,  u su a l dosage regim ens may need to  be s u b s ta n t ia l ly  
m od ified  in  p a t ie n ts  w ith  re n a l  fu n c tio n  im pairm ent and l i v e r  d i s o r d e r s  
( a l t e r e d  m etabolism  and e lim in a tio n ) , co n g e stiv e  h e a r t  f a i lu r e  
( p ro tra c te d  and e r r a t i c  drug a b so rp tio n , reduced l iv e r  and r e n a l  blood 
flow  g iv in g  th e  r i s k  of to x ic i ty ) ,  g a s t r o in t e s t i n a l  d i s o r d e r s  ( a l te r e d  
a b s o rp t io n )  and th y ro id  d is o rd e rs .
H yperthy ro id ism  in c re a se s  th e  g e n e ra l m etabo lic  r a t e .  E xcess th y ro id  
horm ones r e s u l t  in  in c re ase d  p ro te in  s y n th e s is  and enzym atic  a c t i v i t y .  
The h e a r t ,  d iaphragm , l iv e r  and k idneys a re  a l l  m arkedly  s tim u la te d  by 
th y ro x in e . Thus, i t  would seem lo g ic a l  to  su sp e c t t h a t  th e  
b io tra n s fo rm a tio n  o f d rugs would be enhanced in  p a t i e n ts  w ith  t h i s  
d is o rd e r .
The com parison  o f c e r ta in  pharm acok ine tic  p a ra m e te rs  betw een 
h y p e r th y ro id  and e u th y ro id  p a t ie n ts  shou ld  g ive  a r e f l e c t io n  o f th e  
p h y s io lo g ic a l  v a r ia b le s  of t h a t  d ise a s e  s t a t e  and th e  dosage reg im en can
be a d ju s te d  a c co rd in g ly .
The problem  of a l te re d  m etabolism  of m ethim azole in  h y p e rth y ro id ism  
h a s  a t t r a c t e d  many in v e s t ig a to r s .  E arly  s tu d ie s  u s in g  n o n - s p e c if ic
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m ethods su g g ested  a sh o rten ed  h a l f - l i f e  in  h y p e rth y ro id ism  and a 
p ro lo n g ed  one in  hypothyro id ism  ( B alzer e t  a l . ,  1975; Crooks e t  a l . ,
1973; V ese ll e t  a l . ,  1975). However, w ith  th e  developm ent o f th e  GC-MS 
m ethod (F loberg  e t  a l . ,  1980), th e  k in e t ic  p r o f i le s  o f o r a l  m ethim azole 
were com pared in  h y p e rth y ro id  p a t ie n ts  both  d u ring  th e  h y p e rth y ro id  and 
e u th y ro id  s t a t e s  and no s ig n i f ic a n t  d if fe re n c e s  in  Cmax, tm ax, t& o r 
AUC were found. These r e s u l t s  were confirm ed in  s im i l i a r  s tu d ie s  
in v o lv in g  o r a l  a d m in is tra t io n  of m ethim azole undertaken  by Cooper e t  a l .  
(1984) u s in g  RIA and Jansson  e t  a l .  (1985) aga in  u s in g  GC-MS. Thus i t  
ap p eared  t h a t  h y p erthy ro id ism  d id  n o t a f f e c t  th e  k in e t ic s  o f 
m ethim azole. However, c o n f l ic t in g  d a ta  was th en  p u b lish e d  by Hengstmann 
and  Hohn (1985). Using both  o ra l and in trav en o u s  d a ta  th ey  found a 
p ro lo n g ed  h a l f - l i f e ,  lower c lea ran ce  and b io a v a i la b i l i ty  in  h y p e r th y ro id  
p a t i e n ts .  These r e s u l t s  were th e  com plete re v e rs e  t h a t  would be 
ex p ec ted  i f  th e  in c re ase d  m etabo lic  r a t e  was to  a f f e c t  m ethim azole a t  
a l l .
The fo llo w in g  y ear th e  most e x te n s iv e  s tudy  to  d a te  was u n d e rtak en  
by Okamura e t  a l  (1986). T heir r e s u l t s  were com patib le  w ith  th o s e  o f 
H a llen g ren , Cooper and Jansson  and showed th a t  h y p e rth y ro id ism  does n o t 
a f f e c t  th e  k in e t ic s  o f m ethim azole.
The f in a l  s o lu tio n  to  t h i s  q u es tio n  m ust come from s tu d ie s  u s in g  b o th  
in tra v e n o u s  drug  a d m in is tra t io n  and th e  same p a t ie n ts  b e fo re  and a f t e r  
t re a tm e n t  to  c o r r e c t  th e  a l te re d  th y ro id  s t a t e .  In t h i s  way any 
f lu c tu a t io n s  caused  by v a r ia b le  g a s t r o in te s t in a l  a b s o rp tio n  and 
i n t e r  in d iv id u a l  v a r ia t io n  w ill  be m inimized.
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1.4 AIMS AMD OBJECTIVES OF THE STUDY
T h is  rev iew  h as  o u tlin ed  th e  developm ent of m ethim azole th e ra p y , 
d is c u s s e d  in  d e ta i l  th e  th e o r ie s  of i t s  mechanism of a c tio n  and 
d e s c r ib e d  what i s  known about i t s  m etabolism  and p h a rm a co k in e tic s  in  
man. There i s  a s u b s ta n t ia l  amount of in fo rm atio n  co n cern in g  th e  
a b s o rp t io n , d i s t r ib u t io n  and ex c re tio n  of m ethim azole bu t th e r e  a re  s t i l l  
some a re a s  which re q u ire  fu r th e r  in v e s t ig a t io n  in  o rd e r  to  o b ta in  a  
t r u l y  com prehensive view of th e  d is p o s i t io n  of m ethim azole. V ith  a  
g r e a te r  u n d e rs ta n d in g  of th e  k in e t ic s  involved  more a c c u ra te  p r e d ic t io n s  
f o r  s u i t a b le  dosage regim ens w ill  be made r e s u l t in g ,  u l t im a te ly , in  
im proved drug e f f ic ia c y .
The main a re a s  fo r  in v e s tig a tio n  a re  th e  frequency  and s iz e  o f dose, 
v a r i a t io n  in  drug  hand ling  w ith th y ro id  s ta tu s ,  and a d e ta i le d  
e x a m in a tio n  o f th e  le v e ls  of methimazole achieved  in  m a te rn a l b lood , 
u m b ilic a l  co rd  and in  m ilk during  pregnancy and la c ta t io n .
The p roposed  in v e s t ig a t io n  w ill  aim to  develop a s im p le  b u t s e le c t iv e  
e x t r a c t io n  and g as  chrom atography-m ass sp e c tro m e try  a s sa y  fo r  th e  
m easurem ent o f m ethim azole from a v a r ie ty  of b io lo g ic a l  m a tr ic e s . T h is  
tec h n iq u e  w il l  th en  be used fo r  some of th e  c l in ic a l  in v e s t ig a t io n s  
m entioned  above. Dose response  r e la t io n s h ip s  w ill  be s tu d ie d  in  
p a t i e n t s  a t  two doses and th e  c o n c en tra tio n  tim e cu rv es  w i l l  be 
c o r r e la te d  w ith  th e  e f f e c t  o f o rg a n if ic a tio n . The v a r ia t io n  o f 
p h a rm a c o k in e tic s  w il l  be compared in  h y p e rth y ro id  and e u th y ro id  
p a t i e n t s .  T h y ro id a l m ethim azole le v e ls  w ill  be m easured and c o r r e la te d
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t o  th e  drug  a c tio n . A study  o f m aternal blood and m ilk  and in fa n t  b lood 
w i l l  be undertaken  to  a s s e s s  th e  s a fe ty  of m ethim azole tre a tm e n t  in  
l a c t a t i n g  m others  w ith  reg a rd  to  th e  su ck lin g  in fa n t .  F in a lly , an 
a d d i t io n a l  s tu d y  w il l  be made of m ethim azole le v e ls  in  p lasm a and u r in e  
o f th e  ra c in g  greyhound. T his w ill  be used to  compare p lasm a and 
u r in a ry  le v e ls  and to  in v e s tig a te  th e  p o s s ib i l i ty  of m easuring  3 -m e th y l-  







G a s-liq u id  chrom atography (GLC) i s  a  p ro c e s s  in  w hich a m ix tu re  
o f o rg a n ic  compounds in  th e  vapour s t a t e  a re  s e p a ra te d  in to  t h e i r  
c o n s t i tu e n t  p a r t s  by p a r t i t io n  between a m obile gaseous phase  and a 
s t a t io n a r y  l iq u id  phase.T h is  techn ique was f i r s t  in tro d u c ed  to  th e  f ie ld  
o f a n a ly t ic a l  ch e m is try  by James and M artin  (1952).
Mass sp e c tro m e try  i s  a techn ique fo r  s e p a ra tin g  ch a rg ed  p a r t i c l e s  
d e r iv e d  from  th e  m olecule of in te r e s t .  The developm ent o f th e  m ass 
s p e c tro m e te r  d a te s  h i s to r ic a l ly  from 1897 when Vien showed t h a t  a  beam 
o f  p o s i t iv e  io n s  could be d e fle c te d  u sin g  e le c t r i c  and m agnetic  f i e ld s .  
The f i r s t  m ass sp e c tro m e te rs  were a v a ila b le  fo r  com m ercial use  in  1940 
(W ashburn and Hoover). The coupling  o f th e  m ass sp e c tro m e te r  to  th e  g as  
ch rom atog raph  fo r  use a s  a d e te c to r  and a n a ly se r  o f GLC e f f lu e n ts  was 
ach iev ed  by Ryhage (1964). The dynamic com bination  o f a g a s  
ch rom atog raph  and a m ass sp ec tro m e te r p e rm its  d i r e c t  id e n t i f i c a t io n  o f 
compounds. The m ass sp ec tro m e te r g iv e s  a d d it io n a l  s e le c t iv e  in fo rm a tio n  
ab o u t th e  compound, o th e r  th an  th a t  o f r e te n t io n  tim e a lo n e . F ig u re s  2.1 
and  2.2 show a  p i c to r i a l  and schem atic  diagram  o f a  g a s  chrom atograph  -  





































































































































2.2 .1  Columns
The GC column I s  th e  h e a r t  o f a GC/MS system . W ithout i t s  power of 
s e p a ra t io n  th e  m ass s p e c t r a l  d a ta  would be im p o ss ib le  to  in te r p r e t .
2 .2 .1 .1  Packed Columns
S im ple m ix tu re s  a re  b e s t  s u ite d  to  packed colum ns w hich can  g ive
r e l a t i v e ly  s h o r t  a n a ly s is  tim es.
The column tu b in g , e i th e r  g la s s  o r s ta in le s s ”  s t e e l ,  i s  f i l l e d  w ith
sm a ll s o l id  p a r t i c l e s  (so lid  su p p o rt)  each coa ted  w ith  a  l iq u id  phase .
The id e a l  f e a tu re s  o f a s o l id  su p p o rt a re  t h a t  i t  shou ld  c o n s is t  o f i n e r t
un ifo rm ly  s p h e r ic a l  p a r t i c l e s  hav ing  a la rg e  su rfa c e  a re a  p e r  u n i t  volume
and t h a t  i t  shou ld  be m echan ica lly  s tro n g  over a wide tem p e ra tu re  ran g e .
The m ost commonly used s u p p o rts  a re  d iatom aceous e a r th s ,  e i th e r
k ie s e lg u h r  o r c ru sh ed  f i r e b r ic k .
A wide v a r ie ty  of s ta t io n a r y  p h ases  a re  a v a ila b le  com m ercially . They
ran g e  from  n o n -p o la r  to  very  p o la r  m a te r ia ls .  The s ta t io n a r y  phase  i s  a
l iq u id  which i s  n o n -v o la t i le  a t  th e  o p e ra tin g  column tem p e ra tu re .
S e p a ra tio n  o f th e  sam ple i s  ach ieved  by th e  d if fe re n c e  in  th e  s o lu b i l i t i e s
o f i t s  in d iv id u a l com ponents in  th e  liq u id  phase. The l iq u id  phase  i s
on ly  lo o se ly  bound to  th e  su p p o rt and s low ly  e lu te s  a s  "column bleed" a s
th e  te m p e ra tu re  in c r e a s e s ,th u s  l im it in g  th e  maximum o p e ra tin g  tem p era tu re
(MAOT) and th e  l if e t im e  o f th e  column.
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2 .2 .1 .2  C a p illa ry  Columns
T h is  ty p e  o f  column, which i s  made from  e i th e r  g l a s s  o r fu sed  
s i l i c a ,  h a s  no pack ing  m a te r ia l. The l iq u id  phase  i s  bonded e i th e r  
d i r e c t l y  to  th e  column w a lls  <WCOT> o r  to  a su p p o rt m a te r ia l  c o a tin g  th e  
in n e r  w a ll s u r fa c e  (SCOT). There i s ,  co n seq u en tly , no peak b roaden ing  
caused  by th e  p a th s  o f th e  gas  th rough  th e  p ack ing  and so  e f f ic ie n c y  i s  
im proved. However , fo r  th e re  to  be e f f e c t iv e  in te r a c t io n  betw een th e  two 
p h a ses ; th e  in te r n a l  d iam eter needs to  be sm a ll <0.1 -  0.3mm) and g as  
flow  r a t e s  a re  th e re fo re  low (0.1 to  2m l/m in).
U n fo rtu n a te ly , c a p i l la r y  colum ns a re  lim ite d  in  t h e i r  sam ple and 
s o lv e n t  c a r ry in g  c a p a c ity . I t  i s  o f te n  n e c e s sa ry  to  s p l i t  th e  sam ple a t  
th e  in je c to r  to  p re v e n t column damage by a r e l a t i v e ly  la rg e  in je c t io n  of 
h o t s o lv e n t .  To overcome th e  problem  of sam ple lo s s  due to  s p l i t  
in je c t io n s ,  a  number o f in je c tio n  tec h n iq u es  have been developed . The 
Grob In je c to r  (F igure  2.3 ) can o p e ra te  in  bo th  s p l i t  and s p l i t l e s s  mode. 
T h is  i s  a  tech n iq u e  c a r r ie d  out w ith  a s p l i t  in je c to r  in  which th e  sam ple 
i s  in tro d u c ed  w ith  th e  s p l i t  v en t c lo se d , and w ith  th e  column a d ju s te d  to  
a  low tem p e ra tu re  in  th e  reg io n  o f th e  b o i lin g  p o in t  o f th e  sam ple 
s o lv e n t .  In t h i s  way th e  ev apo ra ted  sam ple from th e  in je c to r  l in e r  te n d s  
to  s ta y  in  th e  to p  o f th e  column. A fte r  an i n i t i a l  w a itin g  tim e, u su a lly  
in  th e  re g io n  o f 20 to  30 seconds, th e  s p l i t  v en t i s  opened to  f lu s h  out 
th e  l in e r  and th e  column oven i s  tem p era tu re  programmed to  th e  sam ple 
re q u ire m e n ts . T h is  techn ique  g iv e s  a narrow  in je c t io n  band w ith  th e  
ad v an tag e  o f low sam ple lo s s  and no s o lv e n t t a i l .  However, to  p re v e n t 
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Figure 2.3  Grob type injector for capillary column systems. (Copyright ©  1982, Finni* 
gan Corporation. All rights reserved.)
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developed . In t h i s  ca se , th e  l iq u id  sam ple i s  in tro d u c e d  th ro u g h  a 
p r e c is io n  guide and p laced  d i r e c t ly  in to  th e  p recoo led  column.
2 .2 .2  D e r iv a tiv e s
As th e  sam ple moves th rough  th e  column, a b s o rp t io n  p rob lem s can be 
m et w ith  compounds of a  more p o la r  n a tu re  c o n ta in in g  fu n c t io n a l  g roups 
such  a s  h y d ro x y ls , c a rb o x y lic  a c id s  and am ines le a d in g  to  poor peak 
sh ap e . Problem s may a ls o  be ex p erienced  w ith  compounds o f low 
v o l a t i l i t y .  In many c a se s  i t  p ro v es  p o s s ib le  to  im prove o r  c o n fe r  
s u i t a b le  GLC p r o p e r t ie s  on a m olecule by d e r iv a t i s a t io n .
On d e r iv a t i s a t io n ,  th e  c h a ra c te r  o f th e  m olecule i s  changed from 
p o la r  and a c t iv e  to  n o n -p o la r  and in e r t .  T h is  i s  g e n e ra lly  coupled w ith  
an in c re a s e  in  v o l a t i l i t y  and th erm al s t a b i l i t y  which a re  th e  p r o p e r t ie s  
m ost d e s ire d  fo r  gas chrom atography. I n te r a c t io n s  betw een th e  column 
su p p o rt  and th e  d e r iv a t is e d  form of th e  m olecule a re  reduced  to  a  
minimum and peak shape i s  s h a rp e r . A lso th e  d e r iv a t iv e  m ust s u i t  th e  
req u irem e n ts  o f th e  d e te c to r  system . The m ost im p o rta n t req u irem en t o f a 
m olecule fo r  m ass sp e c tro m e try  i s  t h a t  i t  shou ld  g iv e  abundan t and 
d i s t i n c t iv e  io n s  in  i t s  m ass spectrum . R eagents commonly used in c lu d e  
d iazom ethane f o r  m e th y la tin g  c a rb o x y lic  a c id s , th e  p e r f lu o r in a te d  
a n h y d rid e s  fo r  a c y la tin g  am ines and th e  v a r io u s  s i l y l a t i n g  re a g e n ts  which 
have u n iv e r s a l  a p p lic a t io n s .
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2.3 MASS-SPECTROMETRY
2.3.1 MS In te r fa c e s
Between th e  GLC o u t le t  and th e  ion  sou rce  o f th e  m ass sp e c tro m e te r  
a  pump o r  'm o lecu lar sep ara to r*  i s  in s e r te d .  I t  i s  n e c e s s a ry  to  remove 
th e  c a r r i e r  g a s , helium , from th e  GLC e lu a te  s in c e  th e  o p e ra tin g  p re s s u re  
a t  th e  column o u t le t  i s  incom patib le  w ith  th e  o p e ra tin g  p re s s u re  of th e  
m ass sp e c tro m e te r . As th e  sam ple moves th rough  th e  s e p a r a to r  i t  i s  
p r e f e r e n t ia l ly  en ric h ed  in  th e  o rg an ic  com ponents.
W herever p o s s ib le , d i r e c t  con n ectio n  to  th e  ion  so u rc e  i s  p re f e r r e d  
fo r  c a p i l la r y  colum ns. T h is i s  a c ce p tab le  because o f th e  low g as  flow  
r a t e s .  With th e  u l t r a f le x ib le  fused  s i l i c a  colum ns i t  i s  n o t uncommon fo r  
th e  column to  be tak en  r ig h t  in to  th e  sou rce  w ith o u t any c o n n e c tio n s  and 
a s s o c ia te d  dead volumes. T h is  i s  n o t on ly  a s im p le  and p r a c t ic a l
a rran g em en t bu t a ls o  one th a t  conveys th e  maximum am ounts o f sam ple to  
th e  m ass sp e c tro m e te r  ion source .
2 .3 .2  Io n is a tio n
There a re  s e v e ra l  m ethods fo r  p roducing  io n s  in  th e  so u rc e  o f a 
m ass sp e c tro m e te r . The m ost common mode o f io n is a t io n  i s  by e le c tro n  
bom bardm ent o f th e  gaseous sam ple. The r e s u l ta n t  p o s i t iv e ly  charged  
m o lecu la r ion  (M+) frag m en ts  in to  io n s  o f low er m ass, a s  de te rm ined  by 
th e  s t r u c tu r a l  f e a tu re s  o f th e  p a re n t m olecule.
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E le c tro n s  a re  produced in  th e  ion  so u rce  by th e rm a l em iss io n  from  a 
m eta l f ila m e n t. The e f fe c tiv e n e s s  in  io n is in g  th e  sam ple m olecule 
in c re a s e s  w ith  th e  e le c tro n  energy (5-100eV), Most re fe re n c e  s p e c t r a  a re  
r e p o r te d  a t  70eV because a t  t h i s  le v e l, changes in  e le c tro n  energy  have 
n e g lig ib le  e f f e c t  on ion p ro duction  and fra g m en ta tio n  p a t t e r n s
Many p o la r  m olecules do n o t y ie ld  m olecu lar io n s  under th e  
c o n d it io n s  o f e le c tro n  im pact io n is a tio n . I f  m olecules could  be io n ise d  
w ith o u t a  s ig n i f ic a n t  a d d it io n  o f energy , f ra g m en ta tio n  would be reduced  
and m o lecu lar io n s  would be much more abundant. In r e c e n t  y e a rs  a 
number o f s o f t  io n is a t io n  tech n iq u es  such a s  chem ical io n is a t io n ,  f i e ld  
d e s o rp t io n  and f a s t  atom bombardment have been developed  w hich y ie ld  
more abundan t m olecu lar io n s  w ithou t lo s s  o f s e n s i t iv i ty .
2 .3 .3  Mass A n a ly se rs
2 .3 .3 .1  S in g le  F ocussing  M agnetic In stru m en t
The ion  beam i s  a c c e le ra te d  th ro u g h  an e l e c t r i c  f i e ld  p r io r  to  
s e p a ra t io n . The m ost common mode o f s e p a ra tio n  i s  by m agnetic  
d e f le c t io n . The f l i g h t  o f a moving p a r t i c l e  in  a m agnetic  f i e ld  i s  g iv en  
by th e  fo llo w in g  eq u a tio n
m/e=H R / 2E  0)
H=magnetic f ie ld ,  E = a c ce le ra tin g  f ie ld ,  R =radius
Keeping th e  a c c e le ra tin g  p o te n t ia l  c o n s ta n t  and a l t e r in g  th e  
m agnetic  f ie ld ,  io n s  o f d i f f e r e n t  m/e v a lu es  a re  b ro u g h t s e q u e n t ia l ly  to  
fo cu s  on th e  d e te c to r  p la te ,  g iv in g  th e  f u l l  m ass spectrum .
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2 .3 .3 .2  Double F ocussing  Hass S p ec trom eters
Ions o f th e  same m/e value can have d i f f e r e n t  k in e t ic  e n e rg ie s . I f  
th e  ion  beam i s  passed  th rough  an e le c t r o s ta t i c  f i e ld  p r io r  to  th e  
m agnetic  s e c t o r , th e  f ie ld  w ill  a c t  a s  a  d i re c t io n  and v e lo c i ty  fo c u ss in g  
d e v ic e . Thus, th e  io n s  w ill  have a narrow er band o f k in e t ic  energy  and 
th e r e fo r e  im proved re s o lu tio n .
2 .3 .3 .3  Quadrupole Mass S pec trom eters
The s e p a ra tio n  o f io n s  by th e i r  m/e can a ls o  be ach ieved  by e l e c t r i c  
f i e l d s  a lo n e . The quadrupole s e p a ra to r  c o n s is t s  o f fo u r  p a r a l l e l  
c y l in d r ic a l  ro d s  which a re  d iag o n a lly  e le c t r i c a l ly  connected . Between 
each  p a i r  o f  o p p o s ite  and e le c t r i c a l ly  connected  ro d s  i s  a p p lie d  a d .c . 
v o lta g e  and a superim posed ra d io -fre q u e n c y  <rf) p o te n t ia l .  With th e  
r f / d c  v o lta g e  c o n s ta n t ,  th e  v o lta g e s  a re  v a rie d  to  e f f e c t  s e p a ra tio n  o f 
io n s  a c co rd in g  to  m ass.
2 .3 .4  C o lle c tin g  and Recording o f Ions
As th e  se p a ra te d  ion  beam im pinges on th e  c o l le c to r  p la te  o f th e  
d e te c to r ,  th e  p la te  e m its  an e le c t r i c a l  s ig n a l  which i s  a m p lif ie d  p r io r  to  
d is p la y  on p h o to s e n s i t iv e  paper o r , more commonly now adays, i s  com puter 
p ro c e s s e d .
S ince  H ite s  and Biemann (1970) dem o n stra ted  th e  u t i l i t y  o f a 
com puter in  p ro c e s s in g  and s to r in g  m ass s p e c t r a l  d a ta  when th e  GLC
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e f f lu e n t  i s  a n a ly se d  by au tom atic  scan n in g , new developm ents have g iven  
scope  fo r  d a ta  d is p la y , m an ipu la tion  and ou tpu t in  r e a l  tim e , i .e . ,  d u rin g  
o r  s h o r t ly  a f t e r  d a ta  a c q u is i tio n . Thus GC/MS w ith  an in te g r a l  d a ta  
sy stem  h a s  evolved in to  a pow erful a n a ly t ic a l  to o l .
C om puter-generated  d ig i t a l  s ig n a ls  a re  co n v erted  in to  ana log  le v e ls  
by a d ig i t a l - to - a n a lo g  co n v e rto r  <DAC) and a re  fed  to  th e  m ass 
s p e c tro m e te r  e le c tro n ic s  th rough  a b u ffe r  c i r c u i t .  The o u tp u t an a lo g  
s ig n a l  can th e n  be used to  c o n tro l  th e  m agnetic c u r re n t,  m agnetic  f i e ld  
and a c c e le r a t in g  v o lta g e . The main so ftw a re  e lem en ts o f a l l  GC/MS d a ta  
s y s te m s  w il l  in c lu d e  fu n c tio n s  such a s ; m ass s p e c tro m e te r  tu n in g  and 
c a l ib r a t io n ,  c o n tro l  of scann ing , d a ta  a c q u is i t io n , d is p la y  p r e s e n ta t io n , 
l ib r a r y  s e a rc h in g , su rvey  se a rc h in g  and q u a n ti ta t io n  ro u tin e s ,
The work space  s to r e  o r memory m ust be a c c e s s ib le  on demand and 
c a p ab le  o f t r a n s f e r r in g  d a ta  a t  h igh  r a t e s .  To cope w ith  t h i s  problem , 
th e  com puter h as  an in te g r a l  memory u n it ,  which i s  o f te n  r e f e r r e d  to  a s  
th e  c o re . The com puter a c q u ire s  d a ta  in  a fo reg round  o r  p r io r i t y  mode 
and a llo w s  p ro c e s s in g  and d isp la y  o f th e  d a ta  in  a background, second  
p r i o r i t y  mode. In t h i s  way d a ta  can be viewed and m an ipu la ted  in  r e a l  
tim e  im m ediately  a f t e r  a c q u is i t io n . D isk -b ased  s to ra g e  p ro v id e s  
n e c e s s a ry  e x te n s io n  to  th e  com puter memory. A fte r  i n i t i a l  p ro c e s s in g , 
d a ta  a re  w r i t te n  in to  a  d a ta  f i l e  on a m agnetic  d isk .
Having acq u ired  th e  d a ta , a  VDU and keyboard  a re  n e c e s sa ry  f o r  
ex am in a tio n  o f th e  r e s u l t s  and a  p r in t e r  o r  p l o t t e r  i s  e s s e n t ia l  f o r  
perm anen t re c o rd s .
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2.3.5 Tuning and Calibration
The purpose  o f tu n in g  i s  to  ach ieve  th e  b e s t  m ass sp e c tro m e te r  
s e n s i t i v i t y  a c ro s s  th e  mass range c o n s is te n t  w ith  peak sh ap es  t h a t  
en ab le  m ass m easurem ent and p o s s ib ly  q u a n ti ta t io n  to  th e  re q u ire d  degree  
o f p re c is io n .
Sym m etrical peak shape i s  im p o rtan t i f  a c c u ra te  m ass a ss ig n m en ts  
a r e  made. Under norm al o p e ra tin g  c o n d itio n s  th e re  a re  n e a r ly  a lw ays some 
background o r b leed  ions  th a t  se rv e  fo r  b a s ic  tu n in g  p u rp o ses .
The a ss ig n m en t of mass values to  acq u ired  m ass sp e c tro m e te r  d a ta  
r e q u i r e s  t h a t  th e  in stru m en t be c a l ib ra te d .  The d eg ree  o f accu racy  
re q u ire d  w il l  de term ine  both  th e  frequency  w ith  which c a l ib r a t io n s  m ust 
be made and th e  way in  which th ey  a re  ach ieved . In a l l  c a s e s  a 
c a l ib r a t io n  compound must be in troduced  in to  th e  m ass sp e c tro m e te r , which 
sh o u ld  g iv e  s p e c t r a  w ith  io n s  evenly  spaced  a c ro s s  th e  m ass ran g e  o f 
i n t e r e s t .  T h is  i s  u su a lly  a f lu o r in a te d  hydrocarbon , p e rf lu o ro n a te d  
k e ro sen e  (PFK) being  th e  m ost common cho ice . The fra g m e n ta tio n  p a t te r n  
f o r  PFK i s  g iven  in  f ig u re  2.4. The compound shou ld  be easy  to  in tro d u c e  
in to  th e  ion  so u rce  and cause no m ajor con tam in a tio n  prob lem s.
2 .3 .6  Q u a li ta t iv e  Mass S pectrom etry
Once th e  compound under s tu d y  has  been io n is e d  and i t s  s p e c t r a  
re c o rd e d , th e  d a ta  o b ta ined  can be used fo r  s t r u c tu r e  e lu c id a t io n . The 
m ost abundan t peak in  a  spectrum  i s  c a lle d  th e  base  peak and i s  u su a lly  
s e t  to  100% when th e  raw spectrum  i s  no rm alised . The m o lecu lar ion  (o ften
F ig u re  2 .4  Mass f ra g m e n ta tio n  p a t te rn  of p e rf lu o ro n a te d  kero sene  (PFK).
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th e  b ase  peak) i s  c a lle d  th e  p a re n t ion . In te g ra t io n  o f a l l  ion  
i n t e n s i t i e s  in  a spectrum  g iv es  th e  t o t a l  ion c u rre n t, which i s  som etim es 
used  a s  a n o rm aliz in g  value when p lo t t in g  th e  r e l a t iv e  i n t e n s i t i e s .
The p h y sico -ch em ica l p ro p e r t ie s  of th e  compound and th e  c o n d it io n s
under which i t  i s  ion ized  determ ine th e  shape o f th e  spectrum . Thus, th e
spectrum  g iv e s  s t r u c tu r a l  in fo rm atio n  and, depending on th e  io n iz a tio n
c o n d it io n s , th e  norm al m olecular w eight. The m ass spectrum  o f a  compound
c o n s t i tu te s  c o n c lu s iv e  evidence o f i t s  id e n t i ty  and a c c o rd in g ly  s e rv e s  a s  
such  fo r  p o s i t iv e  id e n t if ic a t io n ;  e .g ., by com parison w ith  l ib r a r y  s p e c t r a .
2 .3 .7  Q u a n tita tiv e  Mass Spectrom etry
Two m ethods a re  used to  q u a n tify  compounds in tro d u c ed  in to  th e  
GCMS. One i s  to  m onito r th e  in te n s i ty  o f th e  compound be ing  de te rm ined , 
by sw itc h in g  th e  m ass sp e c tro m e te r a n a ly s e r  r a p id ly  betw een two
re fe re n c e  io n s  which a re  d i f f e r e n t  only by a few m olecu lar w e ig h ts  and
in  whose ran g e  th e  chosen ion of th e  compound l i e s .  T h is  m ethod, known
a s  's e le c te d  ion  m o n ito rin g ', i s  one o f th e  f a s t e s t  grow ing a re a s  o f MS. 
The second  method i s  to  scan  th e  spectrum  r e p e t i t iv e ly ,  w ith  th e  d a ta
from  th e s e  s c a n s  being  acqu ired  by a com puter. The v a ry in g  in te n s i ty  o f 
s e le c te d  io n s  can be r e tr ie v e d  from th e  sc a n s , and th e  o u tp u t p re se n te d  
in  a  s im i la r  fa sh io n  to  th e  r e a l  tim e ou tpu t o f th e  f i r s t  method.
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2 .3 .7 .1  S e le c te d  Ion M onitoring
S e le c te d  ion  m on ito ring  (SIM) i s  th e  s im u ltaneous d e te c tio n  o f one 
o r  more fragm en t io n s , a s  opposed to  th e  scan n in g  o f th e  whole spectrum  
in  c o n v e n tio n a l m ass sp ec tro m e try . The d e te c tio n  o f subnanogram  
q u a n t i t i e s  o f n a tu ra l ly  o ccu rrin g  su b s ta n c e s  and d ru g s  in  b io lo g ic a l  
m a te r ia ls  i s  th e  m ajor a p p lic a tio n  o f t h i s  techn ique,
I n i t a l l y  developed by Sweeley e t  a l  (1966) th e  im portance  o f SIM in  
GCMS a n a ly s e s , a s  being  a h ig h ly  s p e c if ic  gas ch ro m ato g rap h ic  d e te c to r  
was d e sc r ib e d  by Brooks and M iddleditch  (1971). The m ass sp e c tro m e te r  i s  
a d ju s te d  to  d e te c t  only  th o se  s e le c te d  io n s  c h a r a c te r i s t i c  o f th e  
compound o f i n te r e s t .
As can be seen  from equation  (1), th e  m ass o f th e  ion fo cu ssed  on 
th e  c o l le c to r  i s  in v e rse ly  p ro p o rtio n a l  to  th e  a p p lie d  a c c e le r a t in g  
v o lta g e . T h erefo re  by th e  ra p id  and au tom atic  ad ju s tm en t o f th e  
a c c e le r a t in g  v o lta g e  (a t c o n s ta n t m agnetic  f ie ld )  th e  ion  c u r r e n t  a t  2 o r 
3 s e le c te d  io n s  i s  focussed  a l te r n a t iv e ly  on to  th e  d e te c to r  fo r  s h o r t  
p e r io d s  o f tim e  (50-250 m secs).
The s e le c te d  ion  c u rre n t i s  reco rded  and h as  th e  ap p earan ce  o f a 
c o n v e n tio n a l gas  chrom atograph excep t th a t  th e  t r a c in g s  a re  in  d u p lic a te  
o r  t r i p l i c a t e  depending on w hether 2 o r 3 io n s  a re  be ing  m onito red . 
Peaks in  th e  c h a r a c te r i s t i c  ion  c u rre n t  p r o f i le  a t  th e  ex pected  r e te n t io n  
i s  good ev idence  fo r  th e  p resence  o f th e  compound of i n te r e s t .
The th re e  m ost im p o rtan t a s p e c ts  of th e  method to  c o n s id e r  a re ; 
s e n s i t i v i t y ,  s p e c i f ic i t y  and th e  cho ice  o f in te r n a l  s ta n d a rd .
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S ince  th e  s e n s i t iv i ty  d e c re a ses  a s  th e  number o f io n s  m onito red  
in c re a s e s ,  because le s s  tim e i s  sp e n t m on ito ring  each ion , maximum
s e n s i t i v i t y  in  d e te c tin g  a minimum of 50 pg (Brooks and M idd led itch , 
1971) i s  ach ieved  by m onito ring  a s in g le  ion. However th e  more io n s
m on ito red , th e  more confidence  can be p laced  in  th e  r e s u l t s .
2 .3 .8  I n te r n a l  S tan d ard
With an in te r n a l  s ta n d a rd , GCMS a ssa y  r e l i a b i l i t y  b e n e f i ts  th ro u g h  
c o r r e c t io n  f o r  lo s s e s  which may occur d u rin g  e x tr a c t io n , p u r i f ic a t io n  and 
d e r iv a t iz a t io n .  F urtherm ore, v a r ia t io n s  in  sam ple in je c t io n  in to  th e  GCMS 
sy s tem , to g e th e r  w ith  unnoticed  f lu c tu a t io n s  in  in s tru m e n ta l  s e n s i t i v i t y  
a r e  a u to m a tic a lly  com pensated fo r . The id e a l  in te r n a l  s ta n d a rd  shou ld  be 
c h e m ica lly  and p h y s ic a lly  very  s im i la r  to  th e  compound o f i n t e r e s t  and 
y e t  be r e a d i ly  d is t in g u is h a b le  by GCMS. These needs a re  met e i th e r  by th e  
compound i t s e l f  la b e lle d  w ith  a s ta b le  iso to p e  o r by a s t r u c tu r a l
analogue.
G en era lly , i s o to p ic a l ly  la b e lle d  analogues a re  th e  m ost e f f e c t iv e  
in te r n a l  s ta n d a rd s  fo r  GCMS because th ey  a re  p r a c t ic a l l y  id e n t ic a l  in  
chem ica l p r o p e r t ie s  to  th e  re s p e c tiv e  u n lab e lle d  compounds w h i ls t  be ing  
r e a d i ly  d is t in g u is h a b le  by m ass sp e c tro m e try  because o f t h e i r  d i f f e re n c e  
in  m ass. S ince  p a r t i t i o n  c o e f f ic ie n ts  can be tak en  a s  id e n t ic a l ,  th e  r a t i o  
o f compound to  in te r n a l  s ta n d a rd  w ill  rem ain  c o n s ta n t  even though th e  
e x t r a c t io n  c o n d it io n s  may change in a d v e r te n t ly  from one run  to  th e  n e x t. 
L ikew ise, th e  r a t e  of d e r iv a t i s a t io n  w il l  be s im i la r  ex c ep t fo r  th o se  
c a s e s  where th e  c leavage  o f a bond to  a la b e lle d  atom i s  invo lved , o r
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w here a  seco n d ary  iso to p e  e f f e c t  i s  r a th e r  la rg e . F in a l ly ,  th e  r e te n t io n  
t im e s  on th e  g as  chrom atograph column a re  s im i la r .  I n te r n a l  s ta n d a rd s  
la b e l le d  w ith  ^C, '*0, and ^C1 a re  even more s im i la r  c h em ica lly  to  th e
c o rre sp o n d in g  u n lab e lle d  compounds th an  th o se  la b e lle d  w ith  2H (D), bu t 
th e y  a re  n o t a s  po p u lar because th ey  a re  expensive  and g e n e ra lly  l e s s  
ea sy  to  s y n th e s is e .  The is o to p ic  la b e l< s ) , e s p e c ia l ly  i f  deu terium , m ust 
be in c o rp o ra te d  a t  a  's ta b le ' p o s it io n  in  th e  m olecule, o b v ia tin g  lo s s  of 
heavy is o to p e  d u rin g  th e  a n a ly t ic a l  p rocedure. The in te r n a l  s ta n d a rd  
sh o u ld  be la b e l le d  to  a  h igh  degree o f is o to p ic  p u r i ty ,  w ith  l e s s  th a n  1% 
o f r e s id u a l  u n la b e lle d  m olecules i f  a c ce p tab le  'b la n k s ' a re  to  be ach ieved  
in  th e  a s s a y . One o th e r  d isa d v a n tag e  a p a r t  from th e  c o s t ,  i s  p o o re r  
p r e c is io n .  B esid es  th e  d isad v an tag e  o f u sin g  two c h a n n e ls  r a th e r  th a n  
one, th e r e  i s  a ls o  th e  p o in t t h a t  d r i f t  on each channel may occur a t  a 
d i f f e r e n t  r a t e  and d ire c tio n . T ogether w ith  th e  norm al m agnetic  d r i f t  o f 
th e  in s tru m e n t , t h i s  would mean a change in  th e  r a t i o  o f th e  two 
re s p o n s e s  over a  co u rse  o f s e v e ra l  hours fo r  th e  same s o lu t io n s  in je c te d . 
However th e  m ass sp e c tro m e te r  p re c is io n  i s  o f l e s s  im portance  th a n  th e  
poo r p r e c is io n  in  o th e r  s ta g e s  o f th e  a n a ly s is .
2 .3 .9  E r ro r s
W ith a  d a ta  a c q u is i t io n  system , th e  accu racy  o f m ass m easurem ent i s  
v a s t l y  more dependen t upon th e  s e t t in g  up o f th e  m ass sp e c tro m e te r  th a n
on th e  d a ta  sy stem  i t s e l f .
F a c to r s  which a f f e c t  th e  r e p ro d u c ib i l i ty  o f a  spectrum  in c lu d e  th e  
te m p e ra tu re  o f th e  sou rce  and in le t  system , th e  s t a t e  o f c le a n l in e s s  o f
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th e  so u rc e , th e  c o n d itio n  of th e  f ila m e n t, th e  e le c tro n  beam, th e  t r a p  
c u r r e n t  and th e  r e p e l le r  v o ltag e .
F in a lly , when using  s e le c te d  ion m on ito ring , m agnetic  d r i f t  can be a 
problem  and t h i s  m ust be com pensated fo r  by f re q u e n t check ing  o f th e  
m agnet tu n in g  th roughou t th e  course  o f an a n a ly s is .
CHAPTER 3
DEVELOPMENT OF AN ANALYTICAL ASSAY FOR METHIMAZOLE
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SECTION 1 : GC-MS METHOD
3 .1  SYNTHESIS OF INTERNAL STANDARD
3 . 1 . 1  I n t r o d u c t i o n
With an  i n t e r n a l  s ta n d a r d ,  GC-MS a s s a y  r e l i a b i l i t y  b e n e f i t s  th ro u g h  
c o r r e c t i o n  f o r  l o s s e s  which may occu r  d u r in g  e x t r a c t i o n ,  p u r i f i c a t i o n  
and  d e r i v a t i z a t i o n .  F u r the rm ore ,  v a r i a t i o n s  in  sam ple i n j e c t i o n  i n t o  
t h e  GC-MS sy s tem , t o g e t h e r  w i th  u n n o t ic e d  f l u c t u a t i o n s  i n  i n s t r u m e n ta l  
s e n s i t i v i t y  a r e  a u to m a t i c a l l y  com pensated f o r .  As d i s c u s s e d  i n  
C h a p te r  2 ( s e c t i o n  2 .3 .8 )  th e s e  needs  a r e  met by th e  compound i t s e l f  
l a b e l l e d  w i th  a  s t a b l e  i s o to p e .  In  t h e  c a se  o f  m eth im azo le ,  t h i s  
p h i lo s o p h y  was p roven  t o  work s a t i s f a c t o r i l y  < F lo b e rg  e t  a l . , 1 9 8 0 ) .  
These w o rk e rs  who s y n th e s i s e d  d e u te r iu m  l a b e l l e d  m eth im azo le ,  and 
a f t e r  i d e n t i c a l  e x t r a c t i v e  a l k y l a t i o n  a s  m eth im azo le , was i n t r o d u c e d  
t o  t h e  GC-MS a s  t h e  i n t e r n a l  s ta n d a r d .  D e u te r iu m - la b e l l e d  m eth im azo le  
i s  a good c a n d id a te  f o r  use  a s  an i n t e r n a l  s t a n d a r d  b e c a u se  i t  i s  
r e l a t i v e l y  cheap  and easy  t o  s y n th e s i s e  w i th  t h e  l a b e l  i n  a  s t a b l e  
p o s i t i o n .  T h is  was t h e  obv ious  c h o ic e  f o r  f u r t h e r  work.
The s y n t h e s i s  was c a r r i e d  ou t  i n  two s t a g e s .  F i r s t l y ,  t h e  
s y n t h e s i s  o f  a c e t a l y l t h i o c a r b i m i d e  (Easson and Pyman, 1932) which was 
f u r t h e r  r e a c t e d  w i th  t r id e u te ro m e th y la m in e .H C 1  u s in g  a m o d i f i c a t i o n  of  
a  p r e v i o u s  method (F lo b e rg  e t  a l . ,  1980) t o  g iv e  1-
t r i d e u t e r o m e t h y l i m i d a z o l e - 2 - t h i o l
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3.1.2 Materials
E th a n o l ,  E th y l  A c e ta te  and C hloroform  were o b t a in e d  from  R a thburn  
C h em ica ls  L td . V a lkerburn . Carbon D is u lp h id e  and Lead A c e ta te  were 
p r o d u c t s  o f  B r i t i s h  Drug House (BDH), D o rse t .  A m in o ace ta l ,  Sodium 
H ydrox ide  and T r id e u te ro m e th y lam in e .  HC1 were o b t a in e d  from  Sigma 
C h em ica ls  L td ,  P o o le ,  D orse t ,  A ll  o t h e r  c h e m ic a ls  were o b t a i n e d  a s  
f o l l o w s :  Anhydrous P o ta ss iu m  C h lo r id e  from  Hopkins and W il l ia m s  L t d . , 
E ssex ;  and S u lp h u r ic  Acid from  May and Baker L t d . , Dagenham, E ssex .
C hrom atography (PTLC) was pe rfo rm ed  on 20x 20cm g l a s s  p l a t e s  c o a te d  
w i th  s i l i c a  g e l  (K ie se l  Gel 60(2mm>), The s u p p l i e r s  were E .M erck L t d . ,  
D a rm s ta d t ,  G .F .R . .
3 . 1 . 3 .  E x p e r im e n ta l
3 . 1 . 3 . 1 . The P r e p a r a t i o n  of A c e ta ly l th io c a r b im id e
A m ix tu re  o f  aqueous sodium h yd rox ide  <45ml o f  5M), c a rb o n  
d i s u l p h i d e  <20g) and a s o l u t i o n  o f  a m in o a c e ta l  <27g) i n  w a te r  (100ml) 
was warmed and g e n t l y  shaken  u n t i l  t h e  c a rb o n  d i s u l p h i d e  had 
d i s s o l v e d .  The s o l u t i o n  was t r e a t e d  a t  0°C w i th  an  i c e - c o l d  s o l u t i o n  
o f  b a s i c  l e a d  a c e t a t e  <30g> i n  w a te r  (100ml), a r e d d i s h - y e l l o w  
p r e c i p i t a t e  fo rm ing . An i c e - c o l d  c o n c e n t r a t e d  s o l u t i o n  o f  normal l e a d  
a c e t a t e  (60g) was th e n  added g r a d u a l ly  and w ith  s h a k in g .  The m ix tu re  
was k e p t  c o ld  f o r  30 m inu tes  and th e n  g r a d u a l ly  warmed on a  s te a m  b a th  
w i th  c o n t i n u a l  s h a k in g .  The c o lo u re d  p r e c i p i t a t e  b la c k e n e d .  
A c e t a l y l t h i o c a r b im id e  was removed by s team  d i s t i l l a t i o n , i s o l a t e d  and
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d r i e d  (anhyd rous  p o ta s s iu m  c a rb o n a te )  i n  e t h e r  and d i s t i l l e d  under 
d im in is h e d  p r e s s u r e .
3 .1 .  3. 2. P r e p a r a t i o n  o f  l - t r i d e u t e r o m e t h y l i m i d a z o l e - 2 - t h i o l
A c e t a l y l t h i o c a r b im id e  (5 .45g) was mixed w ith  t r i d e u t e r o -  
m e th y la n m in e . HC1 (2 .86g) and 5ml e th a n o l  in  a s c re w -c a p p ed  tu b e .  The 
m ix tu re  was c o o le d  i n  i c e  w a te r  and sodium h y d ro x id e  (1 .6 4 g )  was 
added . The tu b e  was th e n  s lo w ly  shaken  u n t i l  i t  r e a c h e d  room 
t e m p e r a t u r e ,  where i t  was a l low ed  t o  s ta n d  f o r  two h o u rs .  The sodium  
ch loride  which formed was f i l t e r e d  o f f  and th e  s o l v e n t  was 
e v a p o r a te d .  The r e s i d u e  was h y d ro ly se d  by r e f l u x i n g  w i th  20ml o f  30% 
s u l p h u r i c  a c i d  f o r  30 m inu tes . A f te r  c o o l in g  i t  was n e u t r a l i s e d  w i th  
4M sod ium  h y d ro x id e  s o l u t i o n  and e x t r a c t e d  w ith  e t h y l  a c e t a t e  (4 x 
50m l) . E v a p o r a t io n  o f  t h e  s o lv e n t  gave a c ru d e  r e s i d u e  which was 
p u r i f i e d  by p r e p a r a t i v e  t h i n  l a y e r  chrom atography ( s o l v e n t  sy s te m  9 6 :4  
c h lo ro fo rm :  e th a n o l )
3 . 1 . 4  R e s u l t s
3 . 1 . 4 . 1  Y ie ld  and Combustion A n a ly s is
The y i e l d s  f o r  a c e t a ly l t h i o c a r b i m i d e  and d e u te r iu m  l a b e l l e d  
m eth im azo le  were 6 .9 6 g  <19.4%) and 310mg <8.8%), r e s p e c t i v e l y .  The 
c o m b u s t io n  a n a l y s i s  r e s u l t s  f o r  b o th  compounds a r e  g iv e n  i n  T ab le  3 .1
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Table 3.1 Combustion a n a ly s i s  da ta
A ce ta ly l th io ca rb im id e V i a  ■ s ° 2>
Carbon Hydrogen Nitrogen Sulphur
Found 46.7 7.25 7.6 17 0
R equires  48.0 7.5 8.0 18.3
l - t r id e u te r o m e th y l im id a z o le -2 - th io l (C.H-D-jN^ 4 3 3 2S)
Carbon Hydrogen Nitrogen Deuterium
Found 40.25 2.5 23.2 5.0
R equires  41.0 2.6 23.9 5.1
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3 . 1 . 4 . 2  I n f r a - R e d  S p e c tro s c o p y
The i n f r a  r e d  sp e c t ru m  f o r  a c e t a l y l t h i o c a r b i m i d e  was o b ta in e d  u s in g  
t h e  p u re  l i q u i d  and i s  shown i n  F ig u re  3 .1 .
D e u te ra te d  and  p u re  m eth im azo le  i n f r a - r e d  s p e c t r a  were o b t a in e d  
u s in g  p o ta s s iu m  brom ide d i s c s .  The i n f r a - r e d  e x a m in a t io n  showed 
s i m i l i a r  s p e c t r a  f o r  t h e  two compounds (F ig u r e s  3 .2  and 3 .3  ) . The 
p r i n c i p a l  f u n c t i o n a l  g roup  p eak s  f o r  b o th  compounds a r e  -CH3 (1466cm) 
-JTH (1570cm ) and  -CSNH- (1271cm ).
3 . 1 . 4 . 3  Mass S p e c t ro m e t ry
The d i r e c t  i n l e t  mass s p e c t ru m  o f  s y n t h e s i s e d  a c e t a l y l t h i o c a r b i m i d e
w i th  i t s  m/e io n  i n t e n s i t i e s  i s  shown i n  F ig u re  3 .4 .  The m o le c u la r
io n  (m/e 175 ) f r a g m e n ts  a t  t h e  c a rb o n  t o  c a rb o n  single bond t o  g iv e
+
t h e  b a se  io n  m/e 103 [C(OC2H5 >2 ] .  O th e r  im p o r ta n t  f r a g m e n ts  a r e  m/e 
+ +
74 (HCSNHCH2 ) and  m/e 130 (HCSNHCHCOQ, H j)
The mass s p e c t r a  o f  t h e  two compounds ( d e u t e r a t e d  and  p u re
m eth im azo le  ) showed th e  same p a t t e r n  o f  io n  pe a k s .  The e x p e c te d
i n c r e a s e  o f  t h r e e  mass u n i t s  f o r  t h e  m o le c u la r  io n  due t o  t h e
d e u te r iu m  atom s was c l e a r l y  v i s i b l e ;  i . e .  m/e 117 i n s t e a d  o f  114
( F ig u r e s  3 .5  and  3 .6  ) .
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F igu re  3.1 I n f r a - r e d  spec trum  f o r  a c e ta ly l th io c a r b im id e .
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F ig u re  3.2 I n f r a - r e d  spectrum  f o r  deuterium  l a b e l le d  methimazole.
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S y n t h e s i s  o f  t r i d e u t e r a t e d  m eth im azo le  v i a  a c e t a l y l t h i o c a r b i m i d e ,  
was s u c c e s s f u l l y  a c h ie v e d  w i th  th e  a p p r o p r i a t e  s p e c t r o s c o p i c  a n a l y s i s  
u se d  f o r  v e r i f i c a t i o n .
The f i n a l  y i e l d s ,  q u o ted  above, were much low er  th a n  th o s e  a c h ie v e d  
by t h e  r e s p e c t i v e  a u t h o r s  ( 60% f o r  a c e t a l y l t h i o c a r b i m i d e  and 21% f o r  
t r i d e u t e r o m e th i m a z o l e  ) . However, a l th o u g h  a c e t a l y l t h i o c a r b i m i d e  
c o n ta i n e d  some i m p u r i t i e s ,  t h e  f i n a l  c r y s t a l s  of  t r i d e u te r o m e th im a z o le  
were o f  a  p u r i t y  a c c e p t a b l e  f o r  a  GC-MS (SIM) i n t e r n a l  s t a n d a r d .  
A dequate  p u r i f i c a t i o n  was a c h ie v e d  by th e  use  o f  PTLC a s  opposed  t o  
column ch ro m a to g rap h y  which was a d v o c a te d  i n  t h e  o r i g n a l  a r t i c l e .
3 .2  DEEIVATISATION
3 . 2 . 1 .  I n t r o d u c t i o n
The u n d e r i v a t i s e d  t h i o l ,  m eth im azo le  does  n o t  c h ro m a to g rap h  w e l l  
b e c au se  o f  n o n - s p e c i f i c  a b s o r p t i o n  e f f e c t s .  However, t h e r e  a r e  a  wide 
v a r i e t y  o f  d i f f e r e n t  d e r i v a t i s a t i o n  p r o c e d u r e s  s u i t a b l e  f o r  r e a c t i o n  
w i th  t h e  t h i o l  f u n c t i o n a l  g roup , th e  most commonly u se d  b e in g  
a c y l a t i o n ,  a l k y l a t i o n  and s i l y l a t i o n .
A c y la t i o n  i s  p o p u la r  f o r  amino a c i d s ,  g iv in g  v e ry  s t a b l e  
d e r i v a t i v e s .  Thus, i t  becomes a l e s s  s u i t a b l e  d e r i v a t i s a t i o n  method 
f o r  m eth im azo le  i n  which th e  t h i o l  g roup  i s  i n  r e s o n a n c e  w i th  an  amino 
g roup . T h is  c o u ld  g iv e  r i s e  t o  a  m ix tu re  o f  p r o d u c t s  and  hence  a 
complex mass sp e c tru m .
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A l k y l a t i o n  h a s  p r e v i o u s l y  been u sed  t o  d e r i v a t i s e  m eth im azo le  f o r  
GC ( S te n la k e  e t  a l . , 1 9 7 0 ;  Bending and S t e v e n s o n ,1978) and GC-MS 
(F lo b e rg  e t  a l . , 1 9 8 0 ) .
Methyl i o d id e  was used  t o  form  t h e  S -m ethy l m eth im azo le  d e r i v a t i v e  
( S te n la k e  e t  a l . , 1970). However, r e a c t i o n  t im e  was c r i t i c a l  and th e  
i n s t a b i l i t y  o f  t h e  d e r i v a t i v e  c o u ld  l e a d  t o  t h e  r e t e n t i o n  o f  f r e e  
m eth im azo le  on t h e  column. M e th y la t io n  w i th  d iazom ethane  was a l s o  
a t t e m p te d  b u t  was found  t o  c a u se  c le a v a g e  o f  t h e  im id a z o le  r i n g .
The b e s t  a l k y l a t i o n  f o r  GC t o  d a t e  h a s  been f l a s h  m e t h y la t io n  i n  
t h e  i n j e c t i o n  p o r t  w i th  te tram ethy lam m onium  h y d ro x id e  (Bending and 
S te v e n so n ,  1978). However, m e th y la t io n  o n ly  i n c r e a s e s  t h e  m o le c u la r  
w e ig h t  o f  m eth im azo le  by 14 mass u n i t s .  For SIM, t h e  d e r i v a t i v e  n eed s  
t o  have  a s i g n i f i c a n t  i n c r e a s e  i n  w e ig h t  from  114 t o  g iv e  good 
r e s o l u t i o n .
F or GC-MS, a l k y l a t i o n  h a s  been  pe rfo rm ed  u s in g  two d e r i v a t i v e s ,  
b en zy l  c h l o r i d e  and p e n ta f lu o r o b e n z y l  bromide (F lo b e rg  e t  a l . ,  1980 ) .  
These gave  good ch rom a tog raphy  however b en zy l  c h l o r i d e  p roduced  a 
d e r i v a t i v e  w i th  a  p ro m in e n t  mass o f  207. T h is  i s  a  p ro m in e n t  peak  i n  
t h e  mass s p e c t ru m  o f  t h e  common s i l i c o n e  d e r i v a t i v e  g a s  
c h ro m a to g ra p h ic  p h a s e s .  These v a p o u rs  'co lum n b l e e d 1, a r e  a 
c o n s i d e r a b l e  s o u rc e  o f  i n t e r f e r e n c e  i n  GC-MS a n a l y s i s .  T h e i r  
f r a g m e n t a t i o n  p a t t e r n  w i l l  be p r e s e n t  i n  each  s p e c t ru m  and may o c c lu d e  
t h e  p r e s e n c e  o f  m eth im azo le  i n  b la n k  sam ples .  P e n ta f lu o r o b e n z y l  
brom ide i s  a  s t r o n g  la c h r y m a to r  and s h o u ld  be h a n d le d  w i th  ex trem e 
c a u t i o n  and  a s  su c h  i s  an u n d e s i r a b l e  o p t io n .
As y e t  no i n v e s t i g a t o r s  have a t t e m p te d  th e  f o rm a t io n  o f  a s i l y l  
d e r i v a t i v e  o f  m eth im azo le  f o r  GC o r  GC-MS a n a l y s i s .  However, t h i s
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t e c h n iq u e  i s  a p p l i c a b l e  t o  a l l  compounds c o n t a i n i n g  a c t i v e  hydrogen  
f u n c t i o n s .
S i l y l a t i o n  . t h e r e f o r e ,  was i n v e s t i g a t e d  a s  a  p o t e n t i a l  method f o r  
t h e  d e r i v a t i s a t i o n  o f  m eth im azo le  and t h e  r e s u l t a n t  f r a g m e n ta t io n  
p a t t e r n  f rom  t h e  t o t a l  io n  s c a n  s t u d i e d  t o  choose  t h e  c h a r a c t e r i s t i c  
i o n s  most s u i t a b l e  f o r  SIM. I t  was d e c id e d  t o  c o n v e r t  m eth im azo le  t o  
t h e  t - b u t y l d i m e t h y l s i l y l  d e r i v a t i v e  u s in g  t h e  s i l y l a t i o n  r e a g e n t  N- 
m ethyl N - t e r t b u t y l d i m e t h y l s i l y l t r i f 1uo ro a c e ta m id e  (MTBSTFA).
3 . 2 . 2  M a t e r i a l s  and  Methods
MTBSTFA was s u p p l i e d  by P i e r c e  C hem ica ls  L t d . , Luton , B e d f o r d s h i r e .  
Sam ples o f  m eth im azo le  and l - t r i d e u t e r o m e t h y l i m i d a z o l e - 2 - t h i o l  ( lu g )  
were d e r i v a t i s e d  u s in g  MTBSTFA r e a g e n t  ( lO u l ) .  Then t h e  d e r i v a t i s e d  
compounds were i n t r o d u c e d  i n t o  t h e  mass s p e c t r o m e te r  ( s e t  on ' s c a n  
m ode ')  th r o u g h  t h e  g a s  c h ro m a to g rap h  ( l u l  i n j e c t i o n  o f  e a ch  compound 
was u s e d  ) .  The mass s p e c t ru m  o f  e a c h  o f  t h e  above compounds was t h u s  
o b t a in e d .
3 . 2 . 3  R e s u l t s
The mass s p e c t r a  o f  t h e  TB D M S-derivatives  o f  m eth im azo le  and 
t r i d e u t e r i m e t h i m a z o l e  a r e  shown i n  F i g u r e s  3 .7  and  3 .8 ,  r e s p e c t i v e l y .  
T a b le  3 . 2  shows t h e  m ajo r  io n  p e a k s  and t h e i r  r e l a t i v e  a b u n d a n c ie s .
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3.2.4 Discussion
The s i l y l a t i o n  r e a c t i o n  i s  c o n s id e r e d  t o  in v o lv e  t h e  f o rm a t io n  o f  a 
t r a n s i t i o n  s t a t e  (F ig u re  3 .9 ) .
The p r o p e r t i e s  most d e s i r e d  o f  X, t h e  l e a v i n g  g ro u p  a r e  low 
h a s i c i t y ,  t h e  a b i l i t y  t o  s t a b i l i z e  a  n e g a t i v e  c h a rg e  i n  t h e  t r a n s i t i o n  
s t a t e  and  l i t t l e  o r  no <p— >d) b a c k -b o n d in g  betw een X and  s i l i c o n .
The b a s i c i t y  o f  t h e  l e a v i n g  g ro u p  s h o u ld  be l e s s  t h a n  t h a t  o f  Y a s  t h e  
f o r m a t io n  o f  t h e  t r a n s i t i o n  s t a t e  i s  a  r e v e r s i b l e  p r o c e s s  w hich i s  
f a v o u r e d  by X, t h e  weak b a s e .
The r e a c t i o n  mechanism f o r  t h e  d e r i v a t i s a t i o n  o f  m eth im azo le  by 
MTBSTFA i s  g iv e n  i n  F ig u re  3 .1 0 .
In  t h i s  c a s e  t h e  l e a v i n g  g roup , t r i f l u o r o a c e t a m i d e ,  c an  s t a b i l i z e  a 
p a r t i a l  n e g a t i v e  c h a rg e  th ro u g h  r e s o n a n c e ,  and th e  p r e s e n c e  o f  i t s  
c a rb o n y l  g ro u p  e n s u r e s  t h a t  i t s  b a s i c i t y  i s  l e s s  t h a n  t h e  d e p r o to n a te d  
m eth im azo le .  T h i s  d e r i v a t i v e  i s  more s t a b l e  t o  h y d r o l y s i s  th a n  
c o r r e s p o n d in g  TMS d e r i v a t i v e s  and  c o n s e q u e n t ly  s a m p le s  do n o t  need  t o  
be m e t i c u l o u s ly  d r i e d  b e f o r e  s i l y l a t i o n .
In  g e n e r a l , t h e  r e a c t i o n  t im e  i s  d e p e n d en t  on t h e  s i l y l a t i n g  
c o n d i t i o n s  and  on t h e  s t r u c t u r a l  f e a t u r e s  o f  t h e  d rug . T h is  r a t e  of  
r e a c t i o n  c a n  be i n c r e a s e d  by :
t h e  a d d i t i o n  o f  an  a c i d  o r  b a se  c a t a l y s t
t h e  c o r r e c t  c h o ic e  o f  s o l v e n t  ( p o l a r  and a b l e  t o  d i s s o l v e  b o th  
r e a g e n t  and  sam ple  w i th o u t  r e a c t i n g  w i th  e i t h e r ) . 
an  i n c r e a s e  i n  t e m p e ra tu re  
However, i n  t h e  c a s e  of  MTBSTFA w i th  m eth im azo le ,  t h e  r e a c t i o n  betw een 

























































































































































rl A O A A o>




































«H A «-• 
CVJ c\j
O CV) rH rl r-( rt
«
o
• • m • • • m
o> CO ri CM CO A




































a*° i  if5 O— CO— o
x CO |




I 5 *1 x°
0—0—o


































r e a c t i o n  was v i r t u a l l y  i n s t a n t a n e o u s  a t  room te m p e r a tu r e  w i th o u t  t h e  
h e lp  o f  a  c a t a l y s t  o r  t h e  need  f o r  a s o lv e n t
In  a d d i t i o n ,  compounds p o s s e s s i n g  a TBDMS f u n c t i o n  p roduce  s im p le r ,  
more e a s i l y  i n t e r p r e t a b l e  mass s p e c t r a .  C h a r a c t e r i s t i c a l l y ,  t h e  l o s s  
o f  a  t e r t - b u t y l  f u n c t i o n  p ro d u c e s  a p ro m in e n t  mass s p e c t ru m  f ragm en t  
o f  57 ( m o le c u la r  w e ig h t)  and M-57. The m ajor  io n  f r a g m e n ts  o f  th e  
TBDMS d e r i v a t i v e s  o f  m eth im azo le  and t r i d e u te r o m e th i m a z o l e  a p p e a re d  a t  
m/e 171 and  m/e 174 r e s p e c t i v e l y .  T h is  c o r r e s p o n d s  t o  c le a v a g e  o f  t h e  
t e r t - b u t y l  g roup . The m o le c u la r  i o n s  o f  t h e i r  TBDMS d e r i v a t i v e s  
a p p e a re d  a t  m/e 228 and m/e 231 f o r  t h e  d rug  and t h e  l a b e l l e d  d rug  
r e s p e c t i v e l y .  Thus m/e 171 and 174 were u sed  t o  m o n i to r  t h e  compounds 
i n  t h e  a p p l i c a t i o n  o f  mass f ra g m en to g ra p h y .
3 .3  GAS CHROMATOGRAPHY AMD MASS SPECTROMETRY COMDITIOMS
3 . 3 . 1  I n t r o d u c t i o n
In  t h i s  s tu d y ,  t h e  i n s t r u m e n t  u se d  was a  3B P e rk in -E lm e r  Sigma g a s  
c h ro m a to g ra p h  and  VG IGF m ag n e t ic  s e c t o r  mass s p e c t r o m e te r .  T h is  was 
c o n n e c te d  t o  a  VG2050 d a ta s y s te m .
C a p i l l a r y  GC was c h o sen  f o r  sam ple  a n a l y s i s .  The g a s  ch rom a tog raph  was 
d i r e c t l y  i n t e r f a c e d  t o  t h e  mass s p e c t r o m e te r  s o u rc e .  The g a seo u s  
sam ple  was i o n i z e d  by e l e c t r o n  im p ac t  and th e  s p e c t r a  r e c o r d e d  a t  
70eV.
The F o reg ro u n d /B ack g ro u n d  s e l e c t i v e  io n  r e c o r d i n g  d a ta s y s te m  
(F/BSIR) a l l o w s  t h e  u s e r  t o  q u a n t i t a t i v e l y  m o n ito r  and s t o r e  th e  
i n t e n s i t i e s  o f  i o n s  o f  s e l e c t i v e  mass th ro u g h o u t  a g a s  ch rom atography
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ru n .  The d a ta s y s te m  can  m o n ito r  t h e  i n t e n s i t i e s  o f  up t o  t e n  io n s  
s im u l t a n e o u s l y  and t h e  s t o r e d  d a t a  can  be p r o c e s s e d  t o  p r o v id e  
a c c u r a t e  peak  h e i g h t ,  a r e a  c o n c e n t r a t i o n  and a r e t e n t i o n  t im e  
m easurem ent.
U sing  t h i s ,  i n s t r u m e n t a l  optimum p a r a m e te r s  were a d o p te d  f o r  
s tu d y i n g  TBDMS-Methimazole by s e l e c t i v e  io n  m o n i to r in g .
3 . 3 . 2 .  Methods
( i )  GC C o n d i t io n s  f o r  TBDMS-Methimazole
Column ty p e  : VCOT Fused  S i l i c a  CP S i l 5  CB MAOT=350°C
L eng th  : 25 m
D iam ete r  : 0 .2 2  mm
F ilm  t h i c k n e s s  : 0 ,1 2  mm
The t e m p e r a t u r e  p rogram  u se d  was:
1 s t  s t a g e  : 140°C -  180°C a t  5 ° /m in  
2nd s t a g e  : 180°C -  250°C a t  15° /m in
I n j e c t o r  t e m p e r a t u r e  : 225°C
D e t e c t o r  t e m p e r a tu r e  : 225°C ( io n  s o u rc e )
( i i )  MS C o n d i t io n s  f o r  SIM o f  m/e 171 and 174 




Response 0 .003  s
E l e c t r o n  e n e rg y 70 eV
M u l t i p l i e r  s u p p ly  : 2 .5  kV
P e r f l u o r o k e r o s e n e  (PFK) f r a g m e n t a t i o n  io n s ;  C3F7 (m/e 168 .9888) and 
CjFy (m/e 180 .9888 )  were u sed  a s  r e f e r e n c e  io n s .
Channel 1 was s e t  t o  m o n i to r  m/e 171 .041
Channel 2 was s e t  t o  m o n i to r  m/e 174 .064
3 . 3 . 3  R e s u l t s  and D i s c u s s io n
C a p i l l a r y  co lum ns may be made e i t h e r  o f  g l a s s  o r  f u s e d  s i l i c a .  I t  
was d e c id e d  t h a t  a  f u s e d  s i l i c a  column would be t h e  b e s t  c h o ic e  a s  
t h e y  have  t h e  a d v a n ta g e  o f  f l e x i b i l i t y  and  s t r e n g t h .  Thus s i l i c a  
co lum ns may be t h r e a d e d  th ro u g h  complex p ipew ork  t o  emerge a t  t h e  mass 
s p e c t r o m e te r  i o n  s o u rc e .
The s t a t i o n a r y  l i q u i d  phase  may be c h e m ic a l ly  bonded t o  t h e  
c a p i l l a r y  w a l l s .  T h is  l i q u i d  s h o u ld  have low v o l a t i l i t y ,  h ig h  th e rm a l  
s t a b i l i t y  and must n o t  r e a c t  w i th  t h e  com ponents  o f  t h e  sam ple .
I t  i s  a  g e n e r a l  r u l e  t o  s e l e c t  p h a s e s  which a r e  c h e m ic a l ly  s i m i l a r  
t o  t h e  compound o f  i n t e r e s t .  T h is  means t h a t  t h e  s o l u b i l i t y  o f  t h e  
com ponents  w i l l  be h ig h  hence  g i v i n g  f a v o u r a b le  k v a lu e s .  The 
f o rm a t io n  o f  t h e  TBDMS d e r i v a t i v e  o f  m eth im azo le  h a s  r e s u l t e d  i n  
d e c r e a s e d  p o l a r i t y  t h e r e f o r e  an a p o l a r  phase  was s e l e c t e d  f o r  
a n a l y s i s .
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A medium column l e n g t h  was c h o sen  w ith  a  n a rro w  b o re  d ia m e te r  
m easurem ent t o  g iv e  b e t t e r  r e s o l u t i o n  and t o  complement t h e  i n j e c t o r  
sy s tem . A t h i n  f i l m  was used  so  t h a t  t h e  column b l e e d  would be 
m in im ised . The column ty p e  h a s  a maximum o p e r a t i n g  t e m p e r a tu r e  (MAOT) 
o f  350°C. T h i s  t e m p e r a tu r e  i s  q u o te d  assum ing  i s o th e r m a l  o p e r a t i o n  
w i th  a f lam e  i o n i s a t i o n  d e t e c t o r .  A mass s p e c t r o m e te r  w i l l  impose 
g r e a t e r  l i m i t a t i o n s  b e c au se  o f  i t s  s u s c e p t i b i l i t y  t o  column b le e d in g .  
T h e r e f o r e  t h e  column t e m p e ra tu re  was k e p t  w e l l  be low  t h i s  l i m i t .
The i n j e c t o r ,  t h e  column and t h e  d e t e c t o r  a r e  h e a te d  s e p a r a t e l y ,  
t h e  i n j e c t o r  and  d e t e c t o r  u s u a l l y  t o  a  t e m p e ra tu re  o f  50°C above th e  
column t e m p e r a t u r e .  The c h o ic e  o f  column t e m p e ra tu re  w i l l  be a 
comprom ise. I t  s h o u ld  be h ig h  enough t o  g iv e  r a p i d  a n a l y s i s  and y e t  
low enough t o  a l l o w  t h e  d e s i r e d  s e p a r a t i o n .  As h ig h  s e n s i t i v i t y  i s  
r e q u i r e d ,  a  f a i r l y  s h o r t  r e t e n t i o n  t im e  i s  f a v o u r a b le .  Thus t h e  column 
was t e m p e r a tu r e  programmed t o  r i s e  from  140°C t o  180°C a t  5 ° /m in  t o  
s e p a r a t e  t h e  com ponents  and t h e n  from  180°C t o  250°C a t  15° /m in  t o  
remove any  sam ple  c o n ta m in a t io n .
M eth im azole  and  l - t r i d e u t e r o m e t h y l i m i d a z o l e - 2 - t h i o l  t e r t i a r y  b u ty l  
d im e th y l  s i l y l  d e r i v a t i v e s  were p r e v i o u s l y  scan n ed  i n  o r d e r  t o  f i n d  
t h e  m ajo r  io n  o f  e a c h  compound. Once d e te rm in e d ,  t h e  n e c e s s a r y  
a d ju s t m e n t s  t o  t h e  a c c e l e r a t i n g  v o l t a g e  can  be made which w i l l  a l lo w  
t h e  f o c u s s i n g  o f  t h e s e  p a r t i c u l a r  i o n s  on t h e  c o l l e c t o r  p l a t e ;  i . e .  
t h e  c o n d i t i o n s  c a n  be s e t  f o r  s e l e c t i v e  io n  m o n i to r in g .
Two p e r f l u o r o k e r o s e n e  (PFK) f r a g m e n t a t i o n  i o n s  a r e  u s e d  a s  th e  
r e f e r e n c e  i o n s  t o  d e f i n e  t h e  mass window o f  i o n s  a l lo w e d  t o  r e a c h  th e  
c o l l e c t o r  p l a t e .  O b v io u s ly  t h e  two i o n s  s e l e c t e d  f o r  t h e  m eth im azole  
a n a l y s i s  a r e  w i t h i n  t h i s  mass ra n g e .
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The mass s p e c t r o m e te r  i s  e q u ip p e d  w i th  a 10 c h a n n e l  m u l t i p l e  io n  
d e t e c t i o n  u n i t  which s e l e c t s  i o n s  by programming t h e  a c c e l e r a t i n g  
v o l t a g e .  Channel 1 was s e t  t o  m o n i to r  t h e  m ajo r  io n  o f  m/e 171.041 f o r  
TBDMS-methimazole and  c h a n n e l  2 was s e t  on m/e 174 .064  f o r  t h e  
i n t e r n a l  s t a n d a r d  T B D M S -tr ideu terom eth im azo le .
3 .4  SUMMARY
A good a n a l y t i c a l  method f o r  t h e  q u a n t i t a t i o n  o f  m eth im azo le  h a s  
been  d e v e lo p e d  u s in g  GC-MS. An i n t e r n a l  s t a n d a r d ,  
t r i d e u t e r o m e t h y l i m i d a z o l e ,  h a s  been s u c c e s s f u l l y  s y n t h e s i s e d  and 
c h ro m a to g ra p h s  i n  an  i d e n t i c a l  manner t o  m eth im azo le  w h i l s t  b e in g  
c l e a r l y  d i s t i n g u i s h a b l e  by mass s p e c t r o m e t r y .  F i n a l l y ,  a d e r i v a t i v e  
h a s  been  c h o sen  w hich n o t  o n ly  c h ro m a to g ra p h s  w e l l  on t h e  ch o sen  
column, b u t  a l s o  g i v e s  a  l u c i d  f r a g m e n ta t io n  p a t t e r n  c o n t a i n i n g  
d i s t i n c t  m ajo r  i o n s  f o r  m eth im azo le  and  t h e  i n t e r n a l  s t a n d a r d  which 
a r e  a p p r o p r i a t e  f o r  SIM GC-MS.
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SECTION 2 : EXTRACTION FROM BIOLOGICAL SAMPLES
3 .5  EXTRACTION
3 . 5 . 1  I n t r o d u c t i o n
In  g e n e r a l ,  b i o l o g i c a l  f l u i d s  a r e  n o t  u sed  f o r  d i r e c t  i n j e c t i o n  
o n to  t h e  a n a l y t i c a l  sys tem , b u t  r a t h e r  an  e x t r a c t  i s  u sed . T h is  i s  
b e c au se  t h e  d ru g  i s  u s u a l l y  p r e s e n t  i n  v e ry  low c o n c e n t r a t i o n s  and 
t h e r e f o r e  a  c o n c e n t r a t i o n  s t e p  i s  needed . A lso  t h e  sam ple w i l l  c o n t a i n  
numerous endogenous compounds t h a t  a r e  o f t e n  p r e s e n t  i n  much h i g h e r  
c o n c e n t r a t i o n  t h a n  th e  d rug  and t h e s e  may c o - e l u t e  p r e v e n t in g  a c c u r a t e  
q u a n t i t a t i o n  o r  s im p ly  c o n ta m in a te  t h e  column, s h o r t e n i n g  i t s  
e f f e c t i v e  l i f e t i m e .
E x t r a c t i o n  can  be b ased  on l i q u i d - l i q u i d  o r  l i q u i d - s o l i d  
d i s t r i b u t i o n .  In  l i q u i d - s o l i d  e x t r a c t i o n  th e  s o l i d  phase  h a s  a  g r e a t e r  
a t t r a c t i o n  f o r  t h e  i s o l a t e  th a n  t h e  s o l v e n t  i n  which th e  i s o l a t e  i s  
d i s s o l v e d .  As t h e  sam ple s o l u t i o n  p a s s e s  th ro u g h  th e  s o r b e n t  bed, t h e  
i s o l a t e  c o n c e n t r a t e s  on t h i s  s u r f a c e  w h ile  o t h e r  sa m p le s  p a s s  th ro u g h  
t h e  bed. The sam ple  i s  th e n  e l u t e d  w i th  a  s o l v e n t  t h a t  w i l l  d i s p l a c e  
i t  from  t h e  a b s o r b e n t .
Some exam ples  o f  a b s o r b e n t s  a r e  XAD-2 (A m b e r l i t e ) ,  a  p o l y s t y r e n e  
d i v i n y l  c o -p o ly m er ,  Alumina(AI2 0 3 ) , E x t r e l u t  (d ia to m a c eo u s  e a r t h )  and 
io n  e x c h a n g e rs .  In  r e c e n t  y e a r s  t h e r e  h a s  been t h e  deve lopm en t of  
bonded s i l i c a  a b s o r b e n t s .  The s p e c i f i c  p r o p e r t i e s  o f  a g iv e n  bonded 
s i l i c a  s o r b e n t  a r e  a r e s u l t  o f  t h e  f u n c t i o n a l  g roup  c o v a l e n t l y  bonded 
t o  t h e  s i l i c a  s u b s t r a t e .  A v a r i e t y  o f  d i f f e r e n t  bonded s i l i c a s  a r e
co m m e rc ia l ly  a v a i l a b l e ,  o f f e r i n g  a wide ran g e  o f  s e l e c t i v e  p r o p e r t i e s  
f o r  e x t r a c t i o n .  However l i q u i d - l i q u i d  e x t r a c t i o n  i s  s t i l l  u s u a l l y  
p r e f e r r e d  when r e s u l t s  of h ig h  a c c u ra c y  and p r e c i s i o n  a r e  r e q u i r e d ,  
f o r m a l l y  p u re  s o l v e n t s  o r  m ix tu re s  o f  s o l v e n t s  a r e  u sed . Commonly u sed  
s o l v e n t s  i n c l u d e  d i e t h y l  e t h e r ,  c h lo ro fo rm ,  d ic h lo ro m e th a n e ,  
d i c h l o r o e t h a n e ,  e t h y l  a c e t a t e  and b u ta n o l .  P r e c o n d i t i o n s  f o r  th e  
c h o ic e  o f  a  s u i t a b l e  s o l v e n t  a r e  t h a t  t h e  two p h a s e s  s h o u ld b e  
im m is c ib le ,  i n e r t  to w a rd s  t h e  s o l u t e ,  e a s i l y  s e p a r a t e d  by low sp e ed  
c e n t r i f u g a t i o n  and alow  b o i l i n g  p o i n t  f o r  sample c o n c e n t r a t i o n .
M eth im azole  i s  f a i r l y  s o l u b l e  i n  a  number o f  o r g a n ic  s o l v e n t s .
These i n c l u d e  c h lo ro fo rm ,  e t h y l  a c e t a t e ,  a c e t o n i t r i l e  and d i e t h y l  
e t h e r .  Compared w i th  t h e  s o l v e n t s  m en tioned , c h lo ro fo rm  h a s  t h e  
g r e a t e s t  s o l u b i l i t y  f o r  m eth im azo le  and h a s  t h e  w eakes t  p o l a r i t y .
In  o r d e r  f o r  t h e  d ru g  t o  p r e f e r e n t i a l l y  d i s s o l v e  i n  t h e  o r g a n ic  
p h a se ,  i t  must have  no n e t  c h a rg e ;  i . e .  i t s  i o n i s a t i o n  must be 
s u p p r e s s e d .  The pH o f  t h e  en v iro n m en t w i l l  t h e r e f o r e  p l a y  an  im p o r ta n t  
r o l e  i n  d e te r m in in g  t h e  l e v e l  o f  u n - io n i s e d  d rug  a v a i l a b l e  t o  
p a r t i t i o n  i n t o  t h e  o r g a n ic  s o l v e n t .
The r e v e r s i b l e  b in d in g  o f  d ru g s  t o  normal body m acrom olecu le  i s  one 
o f  t h e  most im p o r ta n t  m a t r ix  e f f e c t s  o f  t h e  b i o l o g i c a l  m a t e r i a l  i n  
d ru g  a n a l y s i s .  Complex f o rm a t io n  betw een a d ru g  and a m acrom olecule  
i n  t h e  b i o l o g i c a l  m a t e r i a l  w i l l ,  i n  p r i n c i p l e ,  d e c r e a s e  t h e  d e g re e  o f  
e x t r a c t i o n .  T h i s  p rob lem  i s  more p ronounced  i n  c e l l - r i c h  m a t e r i a l s  and 
e s p e c i a l l y  i n  t i s s u e s  w i th  a  h ig h  f a t  c o n te n t .  P ro c e d u r e s  f o r  
d e n a t u r a t i o n  o f  p r o t e i n s  can  be o f  a d v a n ta g e .  However, e v e ry  form  of  
p r e c i p i t a t i o n  o f  p r o t e i n s  can  g iv e  s e r i o u s  d i s t u r b a n c e s  i n  low 
c o n c e n t r a t i o n  a n a l y s i s .
M ethim azole  was r e p o r t e d  t o  be 40% p r o t e i n  bound i n  p lasm a 
( S k e l l e r n  e t  a l . , 1974) b u t  t h e s e  f i n d i n g s  were l a t e r  rev o k e d
( S k e l l e r n  e t  a l ; 1 9 8 0 ( a ) ) .  R ecen t s t u d i e s  showed t h a t  no serum  p r o t e i n
b in d in g  o f  m eth im azo le  c o u ld  be d e m o n s t ra te d  by t h e  u se  o f  
u l t r a f i l t r a t i o n  ( B a lz e r  e t  a l .  , 1975; Jo h a n se n  e t  a l . ,  1982) , 
t h e r e f o r e  a  p r o t e i n  d e n a t u r a t i o n  s t e p  s h o u ld  n o t  be r e q u i r e d  f o r  t h e  
p lasm a a s s a y .
In  u r i n e  a n a l y s i s  t h e  h ig h  c o n c e n t r a t i o n  o f  i n o r g a n i c  s a l t s  and 
u r i n a r y  p ig m e n ts  can  p r e s e n t  p ro b lem s.  A lso  u r i n e  i s  h i g h ly  i n f l u e n c e d  
by i n t a k e  o f  fo o d  and o t h e r  s u b s t a n c e s .  I t  i s  t h e r e f o r e  a good i d e a  t o
f i r s t  d i l u t e  t h e  u r i n e  w i th  a t  l e a s t  an  e q u a l  volume o f  w a te r  o r
a p p r o p r i a t e  b u f f e r  b e f o r e  e x t r a c t i n g  t h e  sam ple .
T i s s u e  s a m p le s  a r e  u s u a l l y  hom ogenized a s  t h e  f i r s t  s t e p  o f  
t r e a t m e n t .  T h y ro id  t i s s u e  i s  s t r i c t l y  more p r o t e i n a c e o u s  t h a n  f a t t y ,  
t h e r e f o r e  i t  would be b e t t e r  t o  homogenize u n d e r  p o l a r  c o n d i t i o n s .  
A f t e r  h o m o g e n iz a t io n  th e  r e m a in in g  s o l i d s  can  be s e p a r a t e d  by 
c e n t r i f u g a t i o n .  A lthough  m eth im azo le  i s  n o t  p r o t e i n  bound i n  p lasm a, 
i t  c o u ld  be a t t a c h e d  t o  endogenous m ac rom olecu le s  i n  t h y r o i d  t i s s u e .  
T h e r e f o r e ,  r e c o v e r y  c o u ld  p o s s i b l y  be i n c r e a s e d  by t h e  a d d i t i o n  o f  a 
p r o t e i n  d e g r a d a t i o n  a g e n t .
The a n a l y s i s  o f  b r e a s t  m ilk  can  be r e a d i l y  a c c o m p lis h e d  u s in g  
s t a n d a r d  a n a l y t i c a l  p r o c e d u r e s .  The p r im a ry  d i f f e r e n c e  betw een  b r e a s t  
m ilk  and o t h e r  body f l u i d s  n o rm a l ly  a n a ly s e d  i s  t h a t  b r e a s t  m ilk  
c o n t a i n s  a  r e l a t i v e l y  h ig h  c o n c e n t r a t i o n  o f  f a t t y  a c i d s  and  r e l a t e d  
l i p i d s .  These l i p i d  m a t e r i a l s  can  r e d u c e  e x t r a c t i o n  e f f i c i e n c y  and 
a l s o  i n t e r f e r e  w i th  a n a l y s i s ,  p a r t i c u l a r l y  g a s - l i q u i d  ch rom atog raphy . 
A c c o rd in g ly ,  m u l t i p l e  s o l v e n t  e x t r a c t i o n s  a r e  n e c e s s a r y  f o r  t h e
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co m p le te  e x t r a c t i o n  o f  compounds w i th  h ig h  l i p i d  s o l u b i l i t y .
T e c h n iq u e s  f o r  t h e  rem oval o f  l i p i d s  in c lu d e  w ash ing  w i th  a  low 
p o l a r i t y  s o l v e n t  such  a s  hexane, column ch rom atog raphy , p r o t e i n  
p r e c i p i t a t i o n  p r i o r  t o  e x t r a c t i o n ,  s te a m  d i s t i l l a t i o n  and 
l y o p h i l i s a t i o n .
However, s t u d i e s  w i th  [ 35S3 MMI i n d i c a t e d  t h a t  g r e a t e r  t h a n  99% of 
t h e  r a d i o a c t i v i t y  was r e c o v e r a b l e  from  t h e  aqueous  phase  o f  m ilk  a f t e r  
c e n t r i f u g a t i o n  a t  3000xg (Cooper e t  a l . , 1984). T h e r e f o r e  t h e  t o p  
l i p i d  l a y e r  o b t a i n e d  by c e n t r i f u g a t i o n  can  be d i s c a r d e d .
3 . 5 . 2  M a t e r i a l s
C h lo ro fo rm  was o b ta in e d  from  R a thbu rn  C hem ica ls  L t d . , P e e b l e s h i r e .  
M eth im azole  was k i n d l y  d o n a te d  by N ic h o la s  L a b o r a t o r i e s ,  S lough. 
E x t r e l u t  was o b t a i n e d  from  E. Merck L t d . ,  D a rm stad t,  G.F.R.
( E x t r e l u t  co lum ns were p r e p a r e d  by p a c k in g  0 .7 g  o f  c h lo ro fo rm  washed 
e x t r e l u t  i n t o  a  p a s t e u r  p i p e t t e  c o n t a i n i n g  a g l a s s  wool f r i t )
B u f f e r  s o l u t i o n  was c h lo r id e -b o ra te /N a O H  0.05M pH 9 (Meulemans e t  
a l . ,1980)
3 . 5 . 3  Methods
3 . 5 . 3 . 1 .  P lasm a E x t r a c t i o n
Plasm a (1 ml) c o n ta i n in g  m e th im a z o le (aq )  (1 u g /m l) ,  pH9 c h l o r i d e -  
b o r a t e  b u f f e r  (0 .05M ,lm l)  and i n t e r n a l  s t a n d a r d  
( t r i d e u t e r o m e t h i m a z o le ,2 0 u l  o f  lOug/ml aqueous  s o l u t i o n  g i v in g
0 .2 u g /m l)  were mixed on a v o r t e x  f o r  30 se c o n d s .  C h lo ro fo rm  <5ml) was 
added and t h e  sam ple  was r o l l e r m ix e d  f o r  15 min t h e n  c e n t r i f u g e d  a t  
3000 r .p .m .  f o r  10 min. The o r g a n ic  phase  was removed u s in g  a p a s t e u r  
p i p e t t e  and e v a p o r a te d  undr o x y g e n - f r e e  n i t r o g e n .  The e x t r a c t  was 
d e r i v a t i s e d  a s  d e s c r i b e d  i n  s e c t i o n  2 .3 .
3 . 5 . 3 . 2 . U r in e  e x t r a c t i o n
A l i q u o t s  o f  u r i n e  (0 .5  ml) were p l a c e d  i n  s c re w -c a p p ed  t e s t - t u b e s  
(10 m l) .  I n t e r n a l  s t a n d a r d  ( t r id e u te r o m e th im a z o le  40 u l  o f  lOug/ml 
aqueous  s o l u t i o n  g iv in g  0 .4 u g /m l)  was added and th e  t u b e s  v o r t e x  mixed 
f o r  t e n  se c o n d s .  C h lo r id e -b o ra te /N a O H  b u f f e r  (pH9 0.05M, 2ml) and 
c h lo r o f o rm  (8ml) was added t o  t h e  s p ik e d  u r in e .  The t e s t  t u b e s  were 
capped , r o l l e r m i x e d  f o r  15 m in u te s  and th e n  c e n t r i f u g e d  a t  3000 r .p .m .  
f o r  10 m in u te s .  A f t e r  rem oval o f  th e  upper  aqueous  l a y e r  t h e  o r g a n ic  
e x t r a c t s  were t r a n s f e r r e d  t o  t a p e r e d  t e s t - t u b e s  and e v a p o r a te d  u n d e r  a 
s t r e a m  o f  o x y g e n - f r e e  n i t r o g e n  a t  30°C. The sam p les  were r e c o n s t i t u t e d  
i n  pH9 c h lo r id e - b o ra te / f la O H  b u f f e r  ( 0 . 05M,200ul) and s o n i c a t e d  f o r  
f i v e  m in u te s .  The e x t r a c t s  were t h e n  a p p l i e d  t o  e x t r e l u t  colum ns and 
a f t e r  t e n  minutes were e l u t e d  w i th  c h lo ro fo rm  (2ml) i n t o  dram v i a l s  
and  c o m p le te ly  e v a p o ra te d .  The e x t r a c t  was d e r i v a t i s e d  a s  d e s c r i b e d  i n  
s e c t i o n  2 .3 .
3 . 5 . 3 . 3 . T h y ro id  T i s s u e  E x t r a c t i o n
T h y ro id  t i s s u e  ( Ig )  was c u t  i n t o  s m a l l  p i e c e s  and pH9 c h l o r i d e -  
borate/f iaO H  b u f f e r  (0.05m, 10ml) was added t o g e t h e r  w i th  i n t e r n a l
117
s t a n d a r d  (lOug/m l t r i d e u te r o m e th im a z o le  (lOOul) )• The m ix tu re
was hom ogenized and th e n  c e n t r i f u g e d  a t  3000 rpm f o r  10 m in u te s .  The 
s u p e r n a t a n t  was d e c a n te d  t o  a  s e p a r a t e  t e s t - t u b e  where i t  was v o r te x e d  
f o r  10 s e c o n d s  and  a 1ml a l i q u o t  removed t o  a 10ml sc re w -c a p p e d  tu b e .  
C h lo ro fo rm  <5ml) was added t o  t h e  s p ik e d  s u p e r n a t a n t .  The t e s t  tu b e  
was capped , r o l l e r m i x e d  f o r  15 m in u te s  and th e n  c e n t r i f u g e d  a t  3000 
r .p .m .  f o r  10 m in u te s .  A f t e r  rem oval o f  t h e  uppe r  aqueous  l a y e r ,  t h e  
o r g a n ic  e x t r a c t  was t r a n s f e r r e d  t o  a  t a p e r e d  t e s t - t u b e  and e v a p o r a te d  
un d e r  a  s t r e a m  o f  o x y g e n - f r e e  n i t r o g e n  a t  30°C. The sam ple  was th e n  
m a n ip u la te d  a s  f o r  u r in e .
3 . 5 . 3 . 4 . M ilk  E x t r a c t i o n
A l i q u o t s  o f  m ilk  (1ml) were c e n t r i f u g e d  f o r  10 m in u te s  a t  3000 
r .p .m .  A f t e r  rem oval o f  t h e  u p p e r  l a y e r ,  t h e  sam p les  were p l a c e d  i n  a 
10ml s c re w -c a p p e d  t e s t - t u b e .  I n t e r n a l  s t a n d a r d  ( t r id e u te r o m e th im a z o le  
40u l o f  lOug/ml aqueous  s o l u t i o n  g iv in g  0 .4  ug /m l)  and  pH9 c h l o r i d e -  
borate/NaOH b u f f e r  (0.05M, 1ml) was added  and th e  t u b e s  v o r t e x  mixed 
f o r  10 s e c o n d s .  The sam p les  were t h e n  e x t r a c t e d  a s  f o r  u r in e .
3 . 5 . 4  R e s u l t s  and  D is c u s s io n
M ethim azole  i s  a  v e ry  weak a c i d  w i th  a  pKa v a lu e  o f  11 .5  ( S k e l l e r n  
e t  a l . ,  1981). T h e re fo re  any d e c re a s e  i n  pH from  11 .5  w i l l  i n c r e a s e  
t h e  l e v e l  o f  d ru g  which i s  u n - io n i z e d .  Tab le  3 .3  shows t h e  p e rc e n ta g e  
r e c o v e r y  o f  m eth im azo le  i n  p lasm a e x t r a c t s  o v e r  t h e  pH ra n g e  5 - 1 0  i n  
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a t  t h e  same c o n c e n t r a t i o n .  Over t h i s  pH ran g e  t h e r e  was l i t t l e  
d i f f e r e n c e  i n  r e c o v e r y .  However t h e  chrom atogram  a t  pH9 showed th e  
l e a s t  i n t e r f e r e n c e  and t h e r e f o r e  t h i s  was t h e  b u f f e r  sy s te m  chosen ,
A p rob lem  w i th  c h lo ro fo rm  e x t r a c t i o n s  i s  t h e  f o rm a t io n  of  
e m u ls io n s .  To p r e v e n t  t h i s ,  t h e  s o l v e n t  volume was much l a r g e r  th a n  
t h e  sam ple  volume. A lso  c e n t r i f u g a t i o n  w i l l  b re a k  up any e m u ls io n s  
which may s t i l l  o c c u r .
A f t e r  l i q u i d - l i q u i d  e x t r a c t i o n  a lo n e ,  u r in e ,  t h y r o i d  and m ilk  
e x t r a c t s  a l l  s t i l l  c o n ta in e d  endogenous compounds which c o - e l u t e d  o f f  
t h e  GC column w i th  m eth im azo le .  T h e re fo re  an e x t r e l u t  column was u sed  
a s  a c l e a n - u p  s t e p .  I t  would have been  much s im p le r  i f  t h i s  c o u ld  have 
been  u se d  a s  a s i n g l e  e x t r a c t i o n  s t e p ;  i . e .  i f  t h e  sam ple  was lo a d e d  
d i r e c t l y  o n to  t h e  column and th e  e l u a n t  e v a p o ra te d  and d e r i v a t i s e d .  
However, a s  e x t r e l u t  i s  an a b s o rb e n t  medium, t h e  sam ple volum es a t  
t h i s  s t a g e  would be su ch  a s  t o  o v e r lo a d  th e  column.
As was m en t io n ed  i n  t h e  i n t r o d u c t i o n ,  m eth im azole  c o u ld  be bound t o  
endogenous m ac ro m o lecu le s  i n  t h y r o i d  t i s s u e .  T ab le  3 .4  shows th e  
r e c o v e r i e s  o f  m eth im azo le  i n  s p ik e d  and p a t i e n t  sam p les ,  t h r e e  w i th  
and t h r e e  w i th o u t  S u b t i l i s i n  A <0.1 mg/ml), a p r o t e o l y t i c  enzyme.
A ll  t h e  s a m p le s  were p u t  i n t o  a w a te r  b a th  w i th  a s h a k in g  d e v ic e  
and were i n c u b a te d  f o r l h r a t 5 0 ° C  b e f o r e  e x t r a c t i o n .  A s p ik e d  c o n t r o l  
sam ple  was e x t r a c t e d  i n  t h e  normal way t o  check  t h a t  t h e  t e m p e ra tu re  
d i d  n o t  have  any a d v e rs e  e f f e c t  on m eth im azo le  r e c o v e r y .  The r e s u l t s  
from  T ab le  3 .4  show t h a t  t h e r e  was no improvement i n  r e c o v e r y  by 
em ploy ing  S u b t i l i s i n  A, and t h e r e f o r e  i t  can  be assumed t h a t  
m eth im azo le  i s  n o t  s i g n i f i c a n t l y  bound t o  p r o t e i n s  i n  t h e  t h y r o i d  
g la n d .
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Table 3.4  Peak height, recovery o f methimazole from thyroid, t is s u e  both 
with and without pretreatment with s u b t i l is in  A.
Sample S u t i l i s l n  A Peak Height










Thus, s u f f i c i e n t  e x t r a c t i o n  methods have been  d e v e lo p e d  f o r  a l l  o f  
t h e  m a t r ix e s  t o  be a n a ly s e d .  T y p ic a l  chrom atogram s f o r  m eth im azo le  
e x t r a c t e d  from  p lasm a, u r in e ,  m ilk  and t h y r o i d  t i s s u e  a r e  shown i n  
F i g u r e s  3 .1 1  t o  3 .1 4
3 .6  METHOD VALIDATION
3 . 6 . 1  I n t r o d u c t i o n
B e fo re  a  new a s s a y  i s  u sed  t o  d e te rm in e  th e  q u a n t i t y  o f  a  d rug  i n  
p a t i e n t  s a m p le s ,  i t  must be shown t o  be p r e c i s e ,  a c c u r a t e ,  s e n s i t i v e  
and s p e c i f i c .  The p r e s e n c e  o f  an  i n t e r n a l  s t a n d a r d  i s  u se d  t o  
com pensa te  f o r  l o s s e s  d u r in g  sam ple p r e p a r a t i o n  and s h o u ld  h e lp  t o  
i n c r e a s e  a c c u r a c y  and p r e c i s i o n .  However, t h e r e  must be some k in d  of  
v a l i d a t i o n  by t h e  r e p e a t e d  a n a l y s i s  o f  s p ik e d  sam p les  t o  d e te rm in e  
e x a c t l y  t h e  a c c u r a c y  and p r e c i s i o n  o f  t h e  method.
The mean r e c o v e r i e s  w i th  t h e i r  s t a n d a r d  d e v i a t i o n s  g iv e  a measure 
o f  t h e  a c c u r a c y  o f  t h e  method, w h i le  t h e  c o e f f i c i e n t  o f  v a r i a t i o n  
g i v e s  a  m easure  o f  t h e  p r e c i s i o n  o f  t h e  method. The c a l i b r a t i o n  c u rv e  
g i v e s  an i d e a  o f  t h e  l i n e a r  r a n g e  o f  t h e  method.
B i o l o g i c a l  m a t e r i a l s  f o r  a n a l y s i s  o f  d ru g s  a r e  a lm o s t  e x c l u s i v e l y  
s t o r e d  a t  -20°C . T h is  i s  u s u a l l y  s u f f i c i e n t  t o  p r e v e n t  s i g n i f i c a n t  
c h a n g es  o f  t h e  b i o l o g i c a l  m a t e r i a l  i n c l u d in g  m ic r o b io l o g ic a l  
d e g r a d a t i o n .  At t h i s  t e m p e ra tu re  most d ru g s  a r e  n o t  decomposed t o  any 
g r e a t  e x t e n t  even  d u r in g  p ro lo n g e d  s to r a g e ;  e .g .  f o r  s e v e r a l  months. 
However, r e p e a t e d  f r e e z i n g  and th aw in g  o f  a b i o l o g i c a l  m a t e r i a l  may
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g iv e  r i s e  t o  d e c o m p o s i t io n  and t h e r e f o r e  t h e  s t a b i l i t y  o f  a  d ru g  i n  a 
c e r t a i n  b i o l o g i c a l  m a t e r i a l  must a lw ays  be s tu d i e d
3 . 6 . 2  Methods
3 . 6 . 2 . 1 a  P r e p a r a t i o n  of  C a l i b r a t i o n  S ta n d a r d s
A l i q u o t s  o f  c o n t r o l  plasm a and u r i n e  were s p ik e d  w i th  a p p r o p r i a t e  
am ounts o f  an  a q ueous  s t a n d a r d  s o l u t i o n  o f  m eth im azo le  ( c o n s t i t u t i n g  < 
10% o f  t h e  t o t a l  m ix tu re  ) t o  p roduce  a t  l e a s t  s i x  s t a n d a r d s  o v e r  t h e
r e q u i r e d  c o n c e n t r a t i o n  ra n g e .  The sam p les  were a n a ly s e d  a c c o r d in g  t o
t h e  d e s c r i b e d  m ethods. The r a t i o  o f  t h e  peak  a r e a s  (Y) r e s u l t i n g  from  
t h e  m o le c u la r  i o n s  171 and 174 o f  t h e  s i l y l  d e r i v a t i v e s  were p l o t t e d  
a g a i n s t  t h e  c o n c e n t r a t i o n  o f  m eth im azo le  (X) e x p re s s e d  i n  u n i t s  o f  
ug /m l.
3 . 6 . 2 . 1 b  F i t t i n g  o f  t h e  c a l i b r a t i o n  d a t a
The s t a n d a r d  d e v i a t i o n  o f  e x p e r i m e n t a l l y  d e te rm in e d  r a t i o s  from  t h e  
f i t t e d  line is expressed in concentration units as 
x= s / b  where:
s  = s t a n d a r d  d e v i a t i o n  i n  peak  a r e a  r a t i o  u n i t s .
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the ' dj ' being the d ev ia tio n  of experim ental peak area r a t io s  from the  
l in e  and 'n' the number of p o in ts .
b = s lo p e  o f the l in e  in  u n its  o f peak area r a tio /c o n c e n tr a tio n s .
S ( X - x ) . ( Y - y )
2 ( X - x ) 2
- i S X ) . ( S Y )
2XY -  n
2X 2 -  ( 2 X ) 2 
—
where the X and Y are th e co n cen tra tion s and th e ir  a s so c ia te d  area  
r a t io s .
A l im it  o f r e l ia b le  determ ination  (LRD) fo r  each c a lib r a t io n  l in e  i s  
estim ated  a s  fo llo w s:
LRD = 2X fo r  in te r c e p t  a > 0,
= -a /b  + 2X fo r  in te r c e p t a < 0.
The r e la t iv e  standard d ev ia tio n  (RSD) o f each c a lib r a t io n  i s  estim ated  
by exp ressin g  th e con cen tration  standard d e v ia t io n ,X  , a s  a percentage  
o f the mean sp iked  con cen tration , x, th a t is :
RSD = 1 0 0 X /x  
where x = 2X^ 
n
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t h e  X| b e in g  t h e  s p ik e d  c o n c e n t r a t i o n s  a s sa y e d  t o  c o n s t r u c t  t h e  
c a l i b r a t i o n  l i n e .
3 . 6 . 2 . 2 . R e p r o d u c i b i l i t y
The r e p r o d u c i b i l i t y  o f  t h e  method was e v a lu a t e d  by p e r fo rm in g  t h r e e  
r e p l i c a t e  a s s a y s  on s p ik e d  p lasm a, u r i n e ,  m ilk  and t h y r o i d  t i s s u e  a t  
t h r e e  d i f f e r e n t  c o n c e n t r a t i o n s  o f  m eth im azo le . These a l i q u o t s  were 
t h e n  a n a ly s e d  a s  p r e v i o u s l y  d e s c r i b e d .  The v a r i a b i l i t y  o f  t h e  peak  
a r e a  r a t i o s  a t  e a ch  c o n c e n t r a t i o n  were e x p re s s e d  a s  c o e f f i c i e n t s  o f  
v a r i a t i o n  Ccv).
3 . 6 . 2 .  3 . E x t r a c t i o n  E f f i c i e n c y
The e x t r a c t i o n  e f f i c i e n c y  o f  m eth im azo le  and t h e  i n t e r n a l  s t a n d a r d  
from  p lasm a, u r i n e ,  m ilk  and t h y r o i d  t i s s u e  was c a l c u l a t e d  by 
com paring  peak  h e i g h t s  from  t h e  e x t r a c t s  w i th  t h o s e  o f  s t a n d a r d  
c h lo r o f o rm  s o l u t i o n s .
3 , 6 , 2 . 4 . S t a b i l i t y  S tudy
6 ml a l i q u o t s  o f  e a ch  plasm a (0 .5  and l .O u g /m l)  and u r i n e  sam p les  
(1 .0  and 2 .0 u g /m l)  were s t o r e d  a t  -20°C f o r  p e r i o d s  o f  1 day, 3days ,  7 
d ays ,  14 d a y s ,  1 month, 3 months and 6 months
The sa m p le s  were a s s a y e d  f o r  m eth im azo le  a g a i n s t  f r e s h l y  p r e p a r e d  
c a l i b r a t i o n  s t a n d a r d s  i n  t h e  a p p r o p r i a t e  b i o l o g i c a l  f l u i d .  S t a b i l i t y  
o f  m eth im azo le  was a s s e s s e d  by com paring  th e  r e s u l t s  o f  s u c c e s s iv e  
a s s a y s  w i th  t h e  c o n c e n t r a t i o n  d e te rm in e d  i n i t i a l l y .
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1171S B171S
RETN.TJME HEJGHT RRER UNCRLJBRRTED.
0-.00-.27 1 0 0 1 1 .5 3  1 3 8 1 8 .1 2
TBDMS Methimazole
HRS 0 HJNS 10 SECS 0 HRS 10 HJNS 25 SECS
B171S I1 7 1 S
RETN.TJME HEJGHT flRER UNCRLJBRRTED.
2 :0 6 :2 6  1 6 1 8 7 .1 1  9 7 8 7 1 .2 3
TBDMS Do Methimazole
0 HRS 10 HJNS 25 SECS- 0 HRS 0 HJNS 10 SECS
Figure 3.11 Typical chromatogram of methimazole in plasma
■171S B174S 
REDi.TlME HEIGHT
8 : 8 6 : 2 2  1 5 7 5 7 .5 8  9 9 T S 1 .8 3
TBDMS Methimazole
8  HRS 10 11 INS 25  SECS8 H R ?  B MINS 18 SEES
B171S I174S
BETN.T1ME IE1SHT fSZEfr UNCRLlBRffTHJ.
8 :8 6 :1 9  5 8 9 9 .8 2  3TfiB*.2e
TBDMS D, Methimazole
8  HRS 18 MINS 25  SECS8  HRS 8  MINS 18 SECS
Figure 3.12 Typical chromatogram of methimazole in urine
1171S B171S 
RETN.TJME HEJGHT AREA UNCAL.
TBDMS Methimazole
fe-HR9— B O O jE L j  SECS" B HRS 10 HJNS 15 SECS
R171S I1 7 4 S
RETN.TJME HEJGHT AREA UNCRLIBRATED.
8 :0 7 :0 1  i i 8 3 . 5 0  3 3 5 i3 .1 1
TBDMS D, Methimazole
B HRS 10 HJNS 15 SECS_0 HRS B HJNS B SECS
Figure 3.13 Typical chromatogram of methimazole in milk
 »171S B17-iS
RETN.TJME HEIGHT fiREH UNCflLIBRHIEB.
8 :8 5 :3 5  83+.S7 38 5 2 ,9 8
TBDMS Methimazole
8 W 5  8 MINS 8 SEES
H171S 1174S  
EETN.T1HE HEIGHT FREE*
8 :0 6 :3 +  B70+.+1 3 7 5 8 2 .5Z
8 HRS 18 MINS 1 5  SECS
UNCflLlBRfflEB-
TBDMS D, Methimazole 
4 3
V, .
0 HRS 10 MINS 15  SECS8  HRS 8 MINS 8  SEES • _  .............. ..................
Figure 3.14 Typical chromatogram of methimazole in thyroid tissue.
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Table 3.5 Linear regression  a n a ly sis  of ca lib ration  curves 
for methimazole in human plasma, milk and thyroid  
t is su e  and from greyhound urine.
C a lib ra tio n  Curve 
Range <ug/nl)
R e la tive  S tandard 
D eviation  (X)




0 -.05 4.47 0.003
.0 5 - .5 5.31 0.027
Hunan K llk
.025-1 .0 3.75 0.020
Hunan Thyroid
.1 0 -5 .0 6.10 0.004
Greyhound Urine
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Table  3.10 E x t r a c t io n  r e c o v e r ie s  o f  m ethim azole  from human p lasm a, 
m ilk  and th y ro id  t i s s u e  and from greyhound u r in e .
K ethlnazole 
C oncentrat i  on 
(ug /n l) E x trac tio n  E ffic ien cy  (X>
<1> 0.05 80
a)Hunan Plasma <2> 0.1 71
<3> 0 .5 86.5
Xean= 75.8 + /-  4 .5
<1> 0 .1 59
b)Hunan Xilk <2> 0 .5 67
<3> 1 .0 69
lean  * 65 + /-  4 .3
<1> 0.1 65
c)Greyhound Urine <2> 0 .5 72
<3) 1 .0 60
lean  *65.7 + /-  4 .9
<1> 0.1 60 .0
d)Hunan Thyroid (2) 1 .0 81.7
(3) 2 .0 74.4 
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F ig u re  3.15 C a l ib r a t io n  curve  f a r  m ethim azole  in  p lasm a 
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F igu re  3.16 C a l ib ra t io n  cu rve  f o r  methimazole in  p lasm a 
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Figure 3.18 Calibration curve for methimazole in urine.
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3.6.3 Results and Discussion
F a c to r s  le a d in g  t o  compound lo s s e s  d u r in g  sam ple p r e p a r a t io n  a re  
c r i t i c a l  a t  low c o n c e n t r a t io n s  and can a d v e rs e ly  a f f e c t  th e  r e l i a b i l i t y  of 
t h e  a s s a y .  In t h i s  s e c t io n ,  from th e  s tu d y  o f  th e  o v e ra l l  reco v e ry  
( Table  3.10 ), th e  p r e c i s io n  ( Table 3.6 t o  3.9) and accu racy  ( Table 
3.5 ), i t  can  be seen  t h a t  th e  sam ple p r e p a r a t io n  h as  been op tim ized  to  
enab le  th e  developm ent of a r e l i a b l e  and v a l id a te d  method f o r  methimazole 
which i s  s u i t a b l e  f o r  use  in  c l i n i c a l  th e r a p e u t i c  m on ito ring .
The o v e r a l l  e x t r a c t i o n  e f f i c i e n c i e s  ranged  from 65 t o  76%. Plasma 
e x t r a c t i o n  gave th e  b e s t  rec o v e ry  p robab ly  because  i t  invo lved  l e s s  
s t a g e s .  E x t r a c t io n  from m ilk  had th e  low es t  recovery  p e rh a p s  s u g g e s t in g  a 
l o s s  o f  compound a t  th e  s e p a r a t io n  o f  th e  aqueous and l i p i d  l a y e r s .
The r e p r o d u c ib i l i t y  o f  th e  a s s a y  i s  h igh  a s  shown by th e
c o e f f i c i e n t s  o f  v a r i a t i o n  which were a l l  below 10%.
The c a l i b r a t i o n  cu rv es  were shown t o  be l i n e a r  over th e  r a n g e s
s tu d ie d  ( f ig u re s  3.15 t o  3 .18) w ith  r e l a t i v e  s ta n d a r d  d e v ia t io n s  which 
were a l l  below 8% ( Table 3.5 ). The sam ples  showed good s t a b i l i t y  a f t e r  
s to r a g e  a t  -2 0 °C  f o r  up t o  s i x  m onths. The s t a b i l i t y  sample r e s u l t s  a re  
g iven  in  Table  3.11 and a re  g r a p h ic a l ly  p re s e n te d  in  F igu re  3 .20&21JDespite a 
wide variation, the mean value was very close to the actual value. Thus, it was
concluded that there was no significant sample loss and the stability of methimazole
over six months was satisfactory. However, from figures 3.20 and 3.21, the graphs
appear to show a positive trend which may ref lec t  a change in the sample matrix
with time (Appendix I, p. 286 ).
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CHAPTER 4
URINARY ELIMINATION OF METHIMAZOLE AND 
3-METHYL-2-THI0HYDANT0IN IN THE RACING GREYHOUND
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4.1 INTRODUCTION
4.1.1. Doping in Greyhound Racing
The ra c in g  o f greyhounds i s  an in te r n a t io n a l  in d u s try  w orth  £3000 
m illio n , w ith  i t s  p o p u la r i ty  in  B r i ta in  second  on ly  to  f o o tb a l l .  The
huge sums o f money a s s o c ia te d  w ith  th e  s p o r t ,  make i t  im p o rta n t to  have
a  dop ing  c o n tro l  programme. At p re s e n t  r a c e - t r a c k s  r e g i s te r e d  by th e  
N a tio n a l Greyhound Racing Club (NGRC) have a p re - r a c e  t e s t in g  
la b o ra to ry .  Here, each  d o g 's  u r in e  i s  t e s t e d  by th in  la y e r  
ch rom atography  fo llo w in g  s o lv e n t /s o lv e n t  e x tr a c t io n  f o r  th e  p re se n c e  o f 
b a r b i tu r a te s  and common n e u tr a l  d ru g s  and a lk a lo id s  (Bogan and 
S m ith ,1968). The F u jiw ara  t e s t  i s  used to  d e te c t  c h lo ra l  d ru g s, I f  any of 
th e s e  p ro ce d u re s  p rove  p o s i t iv e  o r i f  th e re  i s  any o th e r  re a so n  fo r  
s u s p ic io n  ( e .g . a l t e r e d  perfo rm ance ), t r a c k  o f f i c i a l s  send  a sam ple to  
th e  D epartm ent o f F o re n s ic  M edicine and Science  a t  Glasgow U n iv e rs i ty  
where a ran g e  o f a n a ly t ic a l  te c h n iq u e s  a re  c a r r ie d  ou t.
Drugs w hich b lo ck  p a in  can make an in ju re d  dog run  f a s t e r  and
d e p re s s a n ts  can  a ls o  som etim es im prove th e  perfo rm ance o f nerv o u s o r 
s t r e s s e d  g reyhounds. However, a s  th e  d o se -re sp o n se  r e l a t io n s h ip  o f 
d ru g s  in  th e  r a c in g  greyhound a re  n o t w idely  known, i t  i s  l ik e ly  t h a t  
th e  a d m in is t r a t io n  o f any drug  could  be c o u n te rp ro d u c tiv e  to  a good 
p erfo rm ance. V ith  t h i s  aim , an opponent may d e l ib e ra te ly  dope th e  
g reyhound. A l te rn a tiv e ly ,  because dogs a re  u su a lly  ru n  in  g rad ed  ra c e s , 
on th e  b a s i s  o f  t h e i r  p a s t  perfo rm ance, th e  owner can  use  t h i s  p loy  in
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o rd e r  to  mask th e  d o g 's  p o te n t ia l .  Then, i t s  odds w il l  be im proved in  
sub seq u en t r a c e s  where a dope t e s t  w i l l  re v e a l  n o th in g . In r e a l i t y ,  t h i s  
s o p h is t ic a te d  p la n  i s  ve ry  d i f f i c u l t  to  ach iev e  w ith  th e  l im ite d  body of 
knowledge a v a i la b le  on greyhound drug r e a c t io n s .
Drugs w hich a re  m ost commonly a d m in is te re d  a re  oxyphenylbutazone, 
pheny lbu tazone , c a f f e in e  and p ro c a in e  (A sso c ia tio n  o f O f f ic ia l  Racing 
C hem ists , 1985) b u t o f te n , e s p e c ia l ly  when a tte m p tin g  to  slow  a dog, 
t r a i n e r s  u se  a l l  s o r t s  o f d ru g s  which cou ld  r e s u l t  in  any m anner of 
e f f e c t s .
4 .1 .2 . P o s s ib le  P h y s io lo g ic a l  E f fe c ts  o f M ethimazole in  th e  R acing 
G reyhound.
Hormones have a  c e n t r a l  m odulato ry  e f f e c t  on th e  v e ry  fundam ental 
m o lecu lar p ro c e s s e s  which govern  v a r io u s  m etab o lic  a c t i v i t i e s  a t  b o th  
b a s ic  c e l l u la r  and o rgan  le v e l . An e x c e ss  o r d e f ic ie n c y  o f a  s p e c i f ic  
hormone may th e r e fo r e  produce profound  and w idesp read  p h y s io lo g ic a l  
e f f e c ts .
As d isc u s s e d  in  th e  in tro d u c tio n  (se c tio n  1 .1 .2 ), th y ro id  fu n c tio n  i s  
r e g u la te d  by th e  s p e c i f ic  hormone, th y ro tro p in  (TSH). The r a t e  o f 
s e c r e t io n  o f  th y ro t ro p in  i s  d e l ic a te ly  c o n tro l le d  by th e  q u a n ti ty  o f 
th y ro id  hormone in  th e  c i r c u la t io n .  I f  e x tr a  hormone i s  g iv en , th e  
s e c r e t io n  o f th y ro t ro p in  i s  su p p re sse d  and th e  th y ro id  becomes in a c t iv e  
and r e g r e s s e s ,  w hereas any d e c re a se  in  th e  norm al r a t e  o f  s e c r e t io n  of
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th e  th y ro id  evokes an enhanced s e c r e t io n  o f th y ro t ro p in  and th e  th y ro id  
i s  s t im u la te d  to  in c re a s e d  grow th and fu n c tio n .
Thus, i t  can  be seen  t h a t  th e  a d m in is t ra t io n  o f m ethim azole w il l  have 
two e f f e c t s  w ith  tim e . I n i t i a l l y ,  a s  i t  i n h ib i t s  p ro d u c tio n  o f th y ro id  
horm ones i t  w i l l  p roduce th e  symptom s o f h y p o th y ro id ism . However, 
n e g a tiv e -fe e d b a c k  a c tio n  o f th y ro id  hormone w il l  r e v e r s e  th e  s i tu a t io n  
i .e .  th e r e  w i l l  be an in c re a s e  in  th y ro id  hormone p ro d u c tio n  r e s u l t in g  in  
h y p e r th y ro id is m .
In th e  h y p o th y ro id  s t a t e ,  th e  a p p e t i te  i s  poor, g a s t r o in t e s t i n a l  
a c t i v i t y  i s  d im in ish e d  and abdom inal d i s te n t io n  and c o n s t ip a t io n  a re  
common ( B ell e t  a l . ,  1977; F o r fa r  e t  a l . ,  1980 ). The v o lu n ta ry  m uscles 
a re  weak and f la b b y  and deep -ten d o n  r e f le x e s  a re  slow ed. The h e a r t  i s  
o f te n  d i la te d  and c a rd ia c  o u tp u t i s  d im in ish ed .
In th e  h y p e r th y ro id  s t a t e ,  th e  m uscles a re  weak and trem u lous; th e  
h e a r t  r a t e  i s  r a p id  and th e  h e a r t  b e a t  i s  fo rc e fu l ,  th e  a r t e r i a l  p u lse s  
a re  p rom inen t and bounding b u t th e  c a rd ia c  o u tp u t i s  d e c re a sed  on 
e x e rc is e  < F o r fa r  e t  a l . ,  1982; Sobel and Braunwald, 1971 ).
O bviously , th e  e x te n t  o f e i t h e r  o f th e s e  c o n d it io n s  w i l l  depend very  
much on th e  s iz e  o f th e  dose  and how o f te n  and r e g u la r ly  i t  i s  
a d m in is te re d .
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4.1 .3  Com parison o f U rin ary  E x c re tio n  o f M ethim azole and M e ta b o lite s  in  
D if fe re n t S p ec ie s .
4 .1 .3 .1  M etabolism  o f M ethim azole in  R ats
M etabolic  s tu d ie s  u s in g  35S m ethim azole (M archant and A lexander,1972) 
and 2 - ^ C  m ethim azole (S k e lle rn  e t  a l.,1 9 7 3 ) in  r a t s  have shown th e  
p re se n c e  o f in o rg a n ic  s u lp h a te  and a t  l e a s t  s ix  o th e r  m e ta b o li te s  in  
u r in e . There i s  a ls o  ev idence  fo r  th e  p rese n c e  o f a  g lu cu ro n id e  o f 
m ethim aozle in  th e  u r in e  o f r a t s  r e c e iv in g  m ethim azole ( S i ta r  e t  
a l.,1 9 7 3 ) . The n a tu re  o f th e  compounds e x c re te d  in  r a t  u r in e  a f t e r  
m ethim azole a d m in is t r a t io n  i s  sum m arised in  Table 4 .1 .
4 .1 .3 .2 . M etabolism  o f M ethim azole in  Man
The m etabo lism  o f m ethim azole in  man h as  been d isc u s s e d  e a r l i e r  
( s e c tio n  1 .3 .3 .2 ). Com paring human m etabolism  s tu d ie s  w ith  th o se  in  th e  
r a t  th e r e  a re  some d if f e re n c e s  in  r e s u l t s .  A h igh  p e rc e n ta g e  o f 
m eth im azo le -g lu cu ro n id e  was found to  be e x c re te d  in  r a t  u r in e  ( S i ta r  e t  
a l . ,  1973) b u t, a lth o u g h  a m ethim azole -g lu c u ro n id e  h as  been shown in  
human b i le ,  none was d e te c te d  in  u r in e  (M archant e t  a l . ,  1979). The 
u r in a ry  m e ta b o li te s  found in  th e  r a d io a c t iv e  s tu d ie s  (A lexander e t  a l . ,  
1969; M archant e t  a l . ,  1979) have n o t been f u r th e r  c h a ra c te r is e d ,  bu t a 
m inor m e ta b o li te , 3 -m e th y l-2 - th io h y d a n to in , was l a t e r  id e n t i f ie d  










































Phase I m etabo lism  re a c tio n  i .e . in tro d u c tio n  o f a new chem ical group 
on a m olecule, in  t h i s  ca se  by th e  h y d ro ly s is  o f m ethim azole. T h is ty p e  
o f r e a c t io n  i s  p ro b ab ly  common to  a l l  s p e c ie s , v a ry in g  on ly  in  degree, 
a s  h y d ro ly t ic  enzymes a re  w idely  d i s t r ib u te d  to  d ea l w ith  endogenous 
compounds p r e s e n t  in  th e  d ie t .
However, a  Phase II  m etabolism  i .e . a d d it io n  o f an endogenous m olecule 
t o  a  compound such  a s  g lu c u ro n id a tio n , may n o t be common to  a l l  s p e c ie s . 
I t  i s ,  f o r  exam ple, a lre a d y  known t h a t  th e  c a t  i s  v i r t u a l ly  in c a p a b le  of 
m e tab o lic  c o n ju g a tio n  w ith  g lu cu ro n ic  a c id .
4 .1 .3 .3 . M etabolism  o f M ethim azole in  Greyhound
Ve can n o t p r e d ic t  what a d rug , w ell s tu d ie d  in  man, w i l l  do in  
a n o th e r  s p e c ie s  o r  how i t  w i l l  be m etab o lised . Even th e  p h y s io lo g ic  
d if f e re n c e s  betw een th e  ra c in g  greyhound and th e  d om estic  dog a re  q u ite  
la rg e .
The ra c in g  greyhound h as  a v e ry  la rg e  a e ro b ic  c a p a c i ty  p a r t ly  
because o f th e  q u a l i ty  o f i t ' s  b lood which h as  a v e ry  h igh  c o n c e n tra tio n  
o f th e  o x y g e n -c a rry in g  red  blood  c e l l s .  The in c re a se d  v i s c o s i ty  o f 
t h e i r  b lood  m eans t h a t  in  o rd e r  t o  pump e f f i c i e n t ly ,  t h e i r  h e a r t  i s  huge 
com pared w ith  th e  r e s t  o f t h e i r  body. Most o f th e  greyhound m ass, some 
60%, i s  devo ted  to  m uscle which has been found to  have only  low s to r e s  
o f g lycogen .
From t h i s  l im ite d  p h y s io lo g ic a l  in fo rm a tio n , i t  seem s t h a t  th e  
greyhound h a s  q u i te  unique energy  s to r e s  and i t  i s  re a so n a b le  to  assum e
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t h a t  th e  enzymes in te rm e d ia tin g  in  th e s e  p ro c e s s e s  m igh t be 
q u a n t i ta t iv e ly  o r q u a l i ta t iv e ly  d i f f e r e n t  from o th e r  s p e c ie s .
T h e re fo re , i t  i s  im p o ss ib le  to  say  much abou t th e  m etabolism  of 
m ethim azole, e x c ep t t h a t  by th e  n a tu re  o f i t s  common r e a c t io n  pathw ay 
th e r e  i s  a  p o s s ib i l t y  t h a t  3 -m e th y l-2 - th io h y d a n to in  could  be form ed.
4 .1 .4 . Aim o f S tudy
The aim o f t h i s  s tu d y  i s  to  d e te rm in e  th e  p lasm a c o n c e n tra tio n  
v e rs u s  tim e  p r o f i le  and u r in a ry  e x c re tio n  o f m ethim azole in  th e  
greyhound fo llo w in g  a  s in g le  o r a l  dose . A lso an a tte m p t w i l l  be made to  
id e n t i f y  m eth im azole  m e ta b o li te s  in  greyhound u r in e .
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4.2 MATERIALS AMD METHODS
M TH-glycine was o b ta in ed  from Sigma C hem icals L td . M ethanol was 
o b ta in e d  from  R athburn  C hem icals L td ., W alker burn . Ammonium- H ydroxide 
was a p ro d u c t o f B r i t i s h  Drug House <BDH>, D orse t. Thin la y e r  
ch rom atography  (TLC) was perfo rm ed  on 5 x 20 cm g la s s  p la te s  coa ted  
w ith  s i l i c a  g e l ( K ie se lg e l 60, (0.25mm)). The s u p p lie r  was E.Merck, 
D arm stad t, G.F.R. Chromogenic s p ra y s  were su p p lie d  by Shandon, C h esh ire , 
England. A ll o th e r  re a g e n ts  a re  a s  l i s t e d  in  3 .5 .2 .
A s in g le  o r a l  dose s tu d y  in  g reyhounds was conducted by The Wellcome 
S u rg ic a l I n s t i t u t e ,  Glasgow U n iv e rs i ty , G arscube E s ta te , Glasgow. Two
h e a lth y  g reyhounds were a d m in is te re d  m ethim azole. The m ale dog was
g iv en  5mg w h ile  th e  fem ale dog was g iven  lOmg of m ethim azole. The dose 
was g iv en  in  a  c e l lu lo s e  ca p su le  w ith o u t e x c ip ie n ts .  The dogs were 
housed in d iv id u a l ly  in  m etabolism  c ag es  fo r  48 h o u rs  under c o n d it io n s  of 
c o n tro l le d  te m p e ra tu re  and h um id ity . They were fed  tw ice  a day a t  
10.30am and 4.00pm w ith  meal and t in n e d  dog food.
Blood sam p les  (10ml) were tak e n  from  th e  ju g u la r  v e in  p red o se  and a t  
f re q u e n t tim e  in te r v a l s  up to  6 h o u rs  fo llo w in g  drug  a d m in is t ra t io n .
The sam ples were c o lle c te d  in to  h e p a r in is e d  tu b es  and a f t e r  
c e n tr if u g a t io n , th e  r e s u l ta n t  p lasm a was s to re d  a t  -20°C . U rine was 
a ls o  c o lle c te d  a t  r e g u la r  tim e  in te r v a l s  up to  48 h o u rs  fo llo w in g  drug
a d m in is t r a t io n  and was s to re d  a t  -20°C .
At th e  end o f th e  s tu d y , th e  sam ples were im m edia te ly  tak e n  to  The 
D epartm ent o f F o re n s ic  M edicine and S c ience . U rine sam p les  were thawed
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f o r  volume m easurem ent th en , l ik e  th e  p lasm a sam p les, s to r e d  a t  -20°C  
u n t i l  a ssa y e d .
E ig h t sam ples o f u r in e  from W althamstow Stadium  were s e n t  fo r  
a n a ly s i s  over a  p e rio d  o f n in e  weeks. The i n i t i a l  sam ple w a s 's e n t  
because o f im proved perfo rm ance; w ith  th e  p r e - r a c e  r o u tin e  t e s t s  p rov ing  
n e g a tiv e . A fte r  d e te c tio n  o f m ethim azole ,f u r th e r  sam ples where s e n t  
each  tim e  th e  dog com peted a t  t h i s  s tad ium . The sam ples were s e n t  by 
p o s t  and on a r r i v a l  im m ediately  fro z e n  a t  -20°C  u n t i l  a ssa y e d .
The sam p les  were a ssa y e d  fo r  m ethim azole a s  d e sc r ib e d  in  3 .5 .3 .2 .
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4.3. RESULTS
4.3.1. Methimazole Plasma and Urine Concentrations
The p lasm a c o n c e n tra t io n - t im e  d a ta  o f m ethim azole fo r  th e  two 
greyhounds a re  l i s t e d  in  Table 4.2 and d e p ic te d  in  F ig u re  4 .1 . A 
ty p ic a l  chrom atogram  o f m ethim azole from  greyhound u r in e  i s  shown in  
f ig u re  4.2.
Fo llow ing  d o s in g , maximum p lasm a c o n c e n tra t io n s  (Cmax) were 306 and 
546ng/m l f o r  th e  5 and lOmg d o se s , r e s p e c t iv e ly .  They o ccu rred  betw een 
1 and 2 h o u rs  p o s t-d o s in g . The a re a s  under th e  cu rve  to  th e  l a s t  d a ta  
p o in t  were 973 and 2002 fo r  th e  5 and lOmg d o se s , r e s p e c t iv e ly .
D oubling th e  dose  r e s u l te d  in  app rox im ate  tw o -fo ld  in c re a s e s  in  AUC 
(2.06) and Cmax v a lu e s  (1.8) in d ic a t in g  a l in e a r  dose re sp o n se .
U rin a ry  e x c re tio n  o f m ethim azole (T ab les 4.3 and 4 .4) was low, w ith
5 .5  and 8.2% o f th e  dose be ing  rec o v e red  in  48 h o u rs  a f t e r  
a d m in is t r a t io n  o f th e  5 and lOmg d o se s , r e s p e c t iv e ly .  The e x c re tio n  was 
r a p id  s in c e  th e  m a jo r ity  o f th e  e lim in a te d  m a te r ia l  (47.3 and 57,3%) 











Figure 4.1 Plasma concentration versus time curve for  the two 
greyhounds follow ing oral adm inistration  o f 5mg or 
lOmg o f methimazole.
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4.3 .2 . 3 -M e th y l-2 -T h io h y d an to in
4 .3 .2 .1 . T o ta l Ion M onito ring
A t o t a l  ion  m ass spectrum  o f a u th e n tic  3 -m e th y l-2 - th io h y d a n to in  was 
o b ta in e d  u s in g  a s to c k  s o lu t io n  (O .lm g/m l). I t ' s  m ass spectrum  shows 
an in te n s e  m o lecu lar ion  a t  m/e 130 and a p rom inen t ion  a t  102 
c o rre sp o n d in g  to  th e  e x p u ls io n  o f carbon  monoxide ( f ig u re  4 .3 ). The 
m ass spectrum  o f 3 -m e th y l-2 - th io h y d a n to in  i s  shown in  f ig u re  4.4 . Table
4.5 show s th e  m ajor peaks and t h e i r  r e l a t i v e  abundancies.
Greyhound u r in e  (20ml) was e x tr a c te d  by th e  m ethim azole u r in e  a s sa y  
(se c tio n  3 .5 .3 .2 ) w ith  th e  same r a t i o  o f sam ple to  s o lv e n t. I f  th e  
m e ta b o li te  3 -m e th y l-2 - th io h y d a n to in  was p re s e n t  i t  was hoped t h a t  by 
com paring th e  i n t e n s i t i e s  o f th e  m o lecu lar io n s  o f m ethim azole (m/e 114) 
and 3 -m e th y l-2 - th io h y d a n tio n  (m/e 130), a  r a t i o  v e rs u s  tim e  cu rve  could  
be o b ta in e d . However, 3 -m e th y l-2 - th io h y d a n to in  was only  id e n t i f i e d  from  
th e  t o t a l  io n  sc an  o f one sam ple, th e  6 -24hou r c o l le c t io n  a f t e r  th e  lOmg 
dose a d m in is t r a t io n . I t ' s  spectrum  i s  shown in  f ig u re  4.5.
4 .3 .2 .2  S e le c te d  Ion M onito ring
A s to c k  s o lu t io n  o f 3 -m e th y l-2 - th io h y d a n to in  was d e r iv a t i s e d  u sin g  
MTBSTFA re a g e n t  fo llo w in g  th e  same p ro ced u re  a s  g iven  f o r  m ethim azole 
(s e c tio n  3 .2 .2 ) . The m ass spectrum  o f th e  TBDM S-derivative o f 3 - 
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B* TIC fi! M-114 C^H-102 
CBU25MBB 2 5 9
T o ta l ion  sc a n  o f  u r in e  sam ple 
c o n ta in in g  m ethim azole and 
3 -m e th y l-2 - th io h y d a n to in
Scan number 103 show ing th e  
g r e a te s t  i n te n s i t y  o f 114 io n s  
i .e .  m ethim azole
Scan n u m b e r  87 show ing th e  
g r e a t e s t  i n te n s i t y  o f 102 io n s
i .e .  • peak fo r  




F ig u re  4 .5  T o ta l ion  s c a n  o f  th e  6 -2 4  ho u r u r in e  c o l le c t io n  a f t e r  o r a l  












































































































m ajor ion  peaks and th e i r  r e l a t i v e  ad u ndancies. The m ajor ion  fragm en t 
a p p e a rs  a t  m/e 187. T h is  c o rre sp o n d s  to  c leavage  o f th e  t e r t - b u t y l  
group and can be used  in  th e  a p p lic a t io n  o f s e le c te d  ion  m o n ito rin g  
( f ig u re  4 .7 ).
In o rd e r  to  have th e  a b i l i t y  o f m o n ito rin g  th e  TBDMS d e r iv a t iv e s  of 
m ethim azole, t r id e u te r a te d  m ethim azole and 3-m ethy 1 -2 - th io h y d a n to in  
s im u lta n e o u s ly ; P e rflu o ro k e ro sen e  (PFK) fra g m e n ta tio n  io n s  C3F7 (m/e 
168.9888 and C^F7 (m/e 192.9888) were used  a s  re fe re n c e  io n s
C hannel 1 was s e t  to  m on ito r m/e 171.041
Channel 2 was s e t  to  m on ito r m/e 174.064
Channel 3 was s e t  to  m on ito r m/e 187,036
The r e s t  o f th e  GC-MS c o n d it io n s  were a s  d e s c r ib e d  fo r  TBDMS- 
m ethim azole ( s e c tio n  3 .2 .2 ).
A chrom atogram  f o r  3-m ethy  1 -2 - th io h y d a n to in  in  u r in e  i s  shown in  
F ig u re  4 .8 .
The l im i t  o f d e te c tio n  f o r  s to c k  s o lu t io n s  d e r iv a t i s e d  to  TBDMS-3- 
m e th y 1 -2 -th io h y d a n to in  was 50ng/m l.
However, when e x tr a c t io n  o f 3 -m ethy  1 -2 - th io h y d a n to in  was a ttem p ted  
from  u r in e  sam p les  fo llo w in g  th e  same p ro ced u re  a s  fo r  m ethim azole, 
rec o v e ry  was v e ry  poor w ith  a l im i t  o f d e te c tio n  o f 0.5ug/m l. 3 -m ethy 1-
2 - th io h y d a n to in  h as  a  low er pKa va lu e  th a n  m ethim azole because o f th e  
p re se n c e  o f a ca rb o x y l group. Thus, a t  pH9, i t s  io n is a t io n  may n o t be 
com p le te ly  s u p p re s se d  r e s u l t i n g  in  apoor e x tr a c t io n  in to  o rg a n ic  
s o lv e n t .  C onsequen tly , a lth o u g h  ch ro m ato g rap h ic  c o n d it io n s  s u i ta b le  fo r  
th e  a n a ly s e s  o f 3 -m ethy  1 -2 -th io h y d a n to in  had been developed , th e  lack  o f
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Figure 4.8 Typical chromatogram of 3-methy 1-2-thiohydantoin  
in  greyhound urine.
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s u f f i c i e n t  e x tr a c t io n  rec o v e ry  m eant t h a t  th e  method was n o t of 
s u f f i c i e n t  s e n s i t i v i t y  to  d e te c t  th e  le v e ls  p re s e n t  in  one m i l l i l i t r e  of 
u r in e . T h e re fo re , th e  e x tr a c t io n  was c a r r ie d  ou t u s in g  20ml o f u rin e , a s  
was done f o r  t o t a l  ion  m o n ito rin g . However, i t  was found in  t h i s  ca se  
t h a t  3 -m ethy  1 -2 - th io h y d a n to in  was n o t f u l ly  re so lv e d  from  endogenous 
u r in a ry  com ponents and could  n o t be a c c u ra te ly  de te rm ined .
4 .3 .3 . M ethim azole Doping in  th e  R acing Greyhound
4.3.3.1 .R outine E x tra c tio n  P rocedure
D ilu te  ammonium h y d ro x id e  was added to  u r in e  (20ml) u n t i l  th e  sam ple 
became a lk a l in e .  E th y l a c e ta te  (40m ls) was added to  th e  sam ple. A fte r  
sh a k in g , th e  e th y l  a c e ta te  la y e r  was removed and d r ie d  w ith  sodium 
s u lp h a te . A fte r  f i l t r a t i o n  in to  an e v a p o ra tin g  b a s in , th e  sam ple was 
p laced  on a s team  b a th  and ev a p o ra te d  to  d ry n e ss . The re s id u e  was 
r e c o n s t i tu te d  in  a  few d ro p s  o f ch lo ro fo rm  and s p o tte d  on two th in  
la y e r  ch rom atography  (TLC) p la te s .  The p la te s  were developed  u s in g  th e  
a scen d in g  tec h n iq u e  in  a g la s s  cham ber (Shandon TLC Chrom otank) 
s a tu r a te d  w ith  th e  s o lv e n t  sy stem  ,ch lo ro fo rm :m ethano l (3 :1 ). The 
s o lv e n t  was run  to  a  h e ig h t  o f 15cm. The p la te s  were allow ed  to  a i r  
d ry . V arious chrom ogenic r e a g e n ts  were used  to  v i s u a l i s e  th e  TLC 
p la te s .  Both p la te s  were exposed  to  h y d ro c h lo r ic  a c id  fumes and th en  
th e  f i r s t  p l a t e  was sp ra y e d  w ith  io d o p la t in a te  s o lu t io n  to  lo c a te  th e
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a lk a lo id s  and th e  second p la te  was sp ra y e d  w ith  fu rfu ra ld e h y d e  to  lo c a te  
th e  c a rb am a tes .
A b row nish  s p o t  on was d e te c te d  th e  f i r s t  p la te  w ith  an Rf x 100 
va lue  o f 74. As th e  TLC p la te  showed a p o s i t iv e  r e s u l t ,  th e  u r in e  
r e s id u e  was tak e n  f o r  f u r th e r  id e n t i f i c a t io n  by t o t a l  ion  m o n ito rin g  
where i t  showed enhanced ion in te n s i ty  a t  m/e 114, th e  m olecu lar ion  of 
m ethim azole.
In o rd e r  to  d e te rm in e  i f  t h i s  p o s i t iv e  s p o t  was m ethim azole th e  TLC 
system  was re p e a te d  b u t t h i s  tim e  th e  p la te  was s p o tte d  w ith  th e  
e x tr a c te d  u r in e  sam ple and a sam ple o f m ethim azole in  ch lo ro fo rm . A fte r  
s p ra y in g , th e  s p o t  c o rre sp o n d in g  to  m ethim azole had th e  same RfxlOO 
va lue  a s  th e  unknown s p o t  from  th e  u r in e  sam ple.
4 .3 .3 .2 . S e le c te d  Ion M onito ring
The i n i t i a l  u r in e  sam ple was e x tr a c te d  and d e r iv a t i s e d  a s  d e sc r ib e d  
in  s e c t io n  3 .5 .3 .2 . The sam ple gave a  va lu e  o f 2ug/m l.
Any su b seq u en t sam p les  from  th e  same dog were th e n  a n a ly se d  by t h i s  
method f o r  m ethim azole. The a n a ly s i s  r e s u l t s  f o r  th e  sam p les a re  g iven  
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4.4 DISCUSSION
The amount o f m ethim azole e x c re te d  unchanged in  th e  u r in e  o f 
g reyhounds confirm ed  t h a t  r e n a l  e x c re tio n  i s  a  m inor pathw ay f o r  th e  
e lim in a tio n  o f  unchanged drug . In f a c t ,  th e  p e rc e n ta g e  le v e ls  a re  very  
s im i l i a r  t o  th o s e  a lre a d y  found in  man (M archant 1979; P ittm a n  e t  a l . ,  
1971; Okamura e t  a l . ,  1986). M etabolism  i s  th e  m ajor ro u te  o f 
e lim in a tio n  and one o f th e  m e ta b o li te s  o f m ethim azole a lre a d y  id e n t i f ie d  
in  r a t  and man, 3 -m ethy  1 -2 - th io h y d a n to in , was id e n t i f ie d  in  greyhound 
u r in e  in  t h i s  s tu d y .
3 -m e th y l-2 - th io h y d a n to in  i s  more p o la r  and l e s s  l ip o p h i l ic  th a n  
m ethim azole and th e r e fo r e  would be expected  to  show v e ry  l i t t l e  
r e a b s o rp tio n  a lo n g  th e  d i s t a l  tu b u le  o f th e  k idney . However, th e  
q u a n t i t i e s  o f t h i s  m e ta b o lite  were so  sm a ll t h a t  i t  was on ly  
id e n t i f i a b le  in  one sam ple. Thus, i t  would ap p ear t h a t  3 -m e th y l-2 -  
th io h y d a n to in  i s ,  a s  w ith  r a t  and man, on ly  a m inor m e ta b o li te  p e rh a p s  
because  o f f u r th e r  m etabolism  w ith in  th e  l iv e r .  The u r in e  f r a c t io n  in  
w hich 3 -m e th y l-2 - th io h y d a n to in  was id e n t i f ie d  was 6 -24  h o u rs  a f t e r  a 
lOmg dose  s u g g e s tin g  a lo n g e r  h a l f  l i f e  th a n  m ethim azole. In one human 
s tu d y , th e  h a l f - l i f e  o f 3 -m e th y l-2 - th io h y d a n to in  was c a lc u la te d  to  be
13.5 h o u rs  < S k e lle rn  e t  a l . ,  1980a) i .e .  abou t 2 to  3 t im e s  lo n g e r  th an  
m ethim azole. 3 -m ethy  1 -2 - th io h y d a n to in  h as  been shown to  have 
a n t i th y r o id  a c t i v i t y  in  th e  r a t  (S earle  e t  a l . ,  1951), b u t t h i s  rem ains 
t o  be d e m o n s tra ted  in  o th e r  s p e c ie s . However, t h i s  p o t e n t i a l i t y  makes 
th e  m e ta b o li te  w orthy  o f k in e t ic  s tu d ie s .  A p lasm a c o n c e n tra tio n  tim e
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curve fo r  3 -m e th y 1 -2 - th io h y d a n to in  h as  been m easured over 24 h o u rs  by 
HPLC (S k e lle rn  e t  a l . ,  1980a). However, t h i s  m ethod s u ffe re d  
in te r fe re n c e  from  c a f fe in e  and th e o p h y llin e  and endogenous plasm a 
m a te r ia l .  The s e le c te d  ion m o n ito rin g  m ethod d e sc r ib e d  in  t h i s  c h a p te r  
a llo w s  ch ro m a to g rap h ic  a n a ly s is  o f m ethim azole and 3 -m e th y l-2 -  
th io h y d a n to in  s im u lta n e o u sly  w ith o u t in te r fe re n c e .  Thus, fo llo w in g  
re f in em e n t o f th e  e x tr a c t io n  p ro ced u re , t h i s  method could  be used fo r  
k in e t ic  s tu d ie s  on 3 -m e th y 1 -2 - th io h y d a n to in .
O bviously , th e r e  a re  f u r th e r  m e ta b o li te s  o f m ethim azole p re s e n t  in  
th e  greyhound which have n o t been id e n t i f ie d .  C onjugation  a t  th e  t h io l  
fu n c t io n a l  group o f m ethim azole i s  a  s tro n g  p o s s ib i l i ty  e i t h e r  by 
g lu c u ro n id a tio n  c a ta ly s e d  by U D P -g lu cu ro n y ltran sfe ra se  o r  by 
g ly c o s id a tio n  in v o lv in g  U D P -g ly c o sy ltran s fe ra se .
The m ass s p e c t r a l  c h a r a c t e r i s t i c s  o f g lu cu ro n id e  co n ju g a te s  have been 
s tu d ie d  (Feug e t  a l . ,  1983; B i l le t s  e t  a l . ,  1973; and Feuselau and Johnson 
(1980). The g lu c u ro n id e s  u su a lly  have to  be d e r iv a t i s e d  i f  m o lecu lar 
io n s  a re  to  be d e te c te d  in  t h e i r  m ass s p e c t r a ,  and th e s e  a re  u s u a lly  
found in  low abundance. C onsequently  th e  id e n t i ty  o f th e  m o lecu lar ion 
in  an  unknown spectrum  may n o t be im m ediately  a p p a re n t. Thus, 
i d e n t i f i c a t io n  o f g lu cu ro n id es  would be more e a s i ly  u n d ertak en  by HPLC 
w hich o f f e r s  many a d v a n ta g e s  when d e a lin g  w ith  such  p o la r  compounds.
The amount o f m ethim azole e x c re te d  in  th e  u r in e  sam p les s e n t  from 
th e  r a c e tr a c k  was c o n s id e ra b ly  h ig h e r  th a n  th e  le v e ls  found in  th e  s tu d y  
conducted  a t  The Wellcome S u rg ic a l  I n s t i tu t e  and th e r e fo r e  s u g g e s t  th a t
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a dose g r e a te r  th a n  lOmg had been a d m in is te re d  to  th e  greyhound b efo re  
ra c in g .
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5.1.1 M ethim azole P h a rm aco k in e tic s  in  D if fe re n t  Dosage Regimens
The c l i n i c a l  use  o f a n t i th y r o id  d ru g s  h a s  la rg e ly  been governed  by 
u n c o n tro lle d  c l i n i c a l  o b se rv a tio n . Doses a t  th e  h ig h e r  end o f th e  range 
p roduce an u n a c ce p tab le  in c id e n ce  of h y p o th y ro id ism  when used w ithou t 
th y ro id  hormone su p p le m e n ta tio n . Doses a t  th e  low er end o f th e  ran g e  in  
use  a re  e f f e c t iv e  in  a  m a jo r ity  o f, bu t by no means a l l ,  p a t i e n ts .
One c l i n i c a l  t e s t  which h as  been used to  e s tim a te  th e  d u ra tio n  o f 
a n t i th y r o id  e f f e c t  o f m ethim azole in  p a t i e n ts  th ro u g h o u t a  dose i s  th e  
p e rc h lo ra te  d isc h a rg e  t e s t  (McCruden e t  a l . ,  1987).
P o tassium  p e rc h lo ra te  i n te r f e r e s  w ith  th e  u p tak e ' o f io d id e .
The a d m in is t r a t io n  of t h i s  su b s ta n c e  to  a norm al s u b je c t , th e re fo re , 
i n t e r f e r e s  w ith  th e  in c o rp o ra t io n  o f f u r th e r  io d id e  in to  th e  th y ro id  bu t 
does n o t lea d  to  s ig n i f i c a n t  d isc h a rg e  o f io d id e  from  th e  g lan d , s in c e  
tra p p e d  io d id e  i s  o rg a n if ie d  v e ry  r a p id ly .  M ethim azole i n h ib i t s  io d id e  
o r g a n i f ic a t io n  b u t n o t up take , th e re fo re ,  p a t i e n ts  undergo ing  m ethim azole 
t re a tm e n t  w i l l  show a s ig n i f i c a n t  d isc h a rg e  o f io d id e  a f t e r  th e  
a d m in is t r a t io n  o f po tass iu m  p e rc h lo ra te  and th e  e x te n t  o f d isc h a rg e  i s  
r e l a te d  t o  th e  d eg ree  o f in h ib i t io n  o f o rg a n i f ic a t io n  .
O ral d o se s  o f m ethim azole above 20mg d a i ly  reduce th e  o rg a n if ic a t io n  
o f th y ro id a l  io d id e  to  v e ry  sm a ll le v e ls  f iv e  h ou rs  a f t e r  one o f two 
d iv id e d  d a i ly  d o se s  ( McCruden e t  a l . ,  1981 ). The re sp o n se  below th i s  
dose i s  more v a r ia b le .  I t  i s  n o t c le a r  w hether t h i s  v a r i a b i l i t y  i s  due
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to  d if f e re n c e s  betw een p a t i e n ts  in  th e  le v e ls  of p lasm a m ethim azole 
a t ta in e d .  In a n im a ls  th e  r e la t io n s h ip  between dose o f a n t i th y r o id  drug 
and plasm a le v e ls  i s  n o n - lin e a r  ( M archant e t  a l . ,  1978 ).
The b a s ic  goal of th e ra p y  w ith  many d ru g s  , i s  to  ach iev e  s te a d y  
s t a t e  b lood and t i s s u e  le v e ls  o f th e  drug  t h a t  a re  bo th  e f f ic a c io u s  and 
n o n - to x ic
S te a d y - s ta te  le v e ls  a re  c h a ra c te r is e d  by th e  c o n c e n tra tio n - t im e  
p r o f i le  rep ro d u c in g  i t s e l f  betw een any g iven  two d o ses . When equal 
m ain tenance  d o se s  a re  g iven  a t  uniform  tim e  in te r v a l s ,  th en  s te a d y - s ta te  
le v e ls  would be c h a ra c te r is e d  by th e  c o n c e n tra tio n - t im e  p r o f i le  fo r  th e  
e n t i r e  0 to  24 hour p e rio d  rep ro d u c in g  i t s e l f  each day. Thus, fo r  a one 
com partm ent model t o t a l  a re a  under cu rve  i s  g iven  by
AUC = F.D/V.k (p.o. dose)
i .e . AUC i s  d i r e c t l y  p ro p o r t io n a l  to  dose, p ro v id ed  V and k do n o t 
change. Hence, f r a c t io n  o f AUC n o t seen  in  th e  in te r v a l  i s  d i r e c t ly  
p ro p o r t io n a l  to  th e  f r a c t io n  o f dose  c a r r ie d  over, f ;  i .e .  AUC d u rin g  a 
dose in te r v a l  a t  s te a d y  s t a t e  i s  th e  same a s  th e  t o t a l  a re a  under cu rve  
e x tra p o la te d  to  i n f i n i t y  fo r  a  s in g le  dose.
G en era lly , in c re a s in g  th e  dose  o f a drug  p roduces a  p ro p o r t io n a l  
in c re a s e  in  th e  p lasm a c o n c e n tra tio n  a t  a l l  tim es . Hence, th e  tim e fo r  
th e  peak c o n c e n tra tio n  rem ains  unchanged but i t s  m agnitude in c re a s e s  
p r o p o r t io n a l ly  w ith  dose . The e x p la n a tio n  i s  r e a d i ly  a p p a re n t. I f  th e  
dose i s  doubled ; th e n , a t  any g iven  tim e  th e  amount a b so rb ed  i s  doubled
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and w ith  tw ice  a s  much e n te r in g  th e  body, tw ice  a s  much i s  e lim in a te d . 
Being th e  d if fe re n c e  betw een th e  amount ab so rb ed  and t h a t  e lim in a te d , 
th e  amount o f drug  in  th e  body a t  any tim e  i s ,  th e re fo re ,  a ls o  doubled 
and so  to o  i s  th e  a re a  under th e  cu rve .
T h is  dosage l i n e a r i t y  has  been i l l u s t r a t e d  f o r  m ethim azole in  two 
s tu d ie s  (Jan sso n  e t  a l.,1 9 8 3 a  and Okamura e t  a l . ,  1986 ). Ja n sso n  showed 
t h a t  a  1.5 fo ld  in c re a s e  in  dose from  lOmg to  15mg produced a 1.5 fo ld  
in c re a s e  in  th e  mean a re a  under th e  cu rve  (AUC) from  1611 + /-  
322ng.h /m l to  2454 + /-  495 ng .h /m l in  h e a lth y  s u b je c ts .  The l a t e r  s tu d y  
by Okamura exam ined th re e  dose  le v e ls  10, 15 and 30mg in  h y p e r th y ro id  
p a t i e n ts .  S im ila r ly  to  Ja n sso n , th e  dose change from  lOmg to  15mg gave 
a 1.48 fo ld  in c re a s e  in  th e  mean AUC v a lu e s
( 3228 + /-  1064ng.h/m l to  4773 + /-  1299ng.h/m l ). However, a lth o u g h  th e
30mg dose  gave a f u r th e r  in c re a s e  in  mean AUC ( 7136 + /-  718ng.h/m l ) 
t h i s  o n ly  co rre sp o n d ed  to  a 1.5 and a 2.2  fo ld  in c re a s e  from  th e  15mg 
and lOmg mean AUC v a lu e s , r e s p e c t iv e ly .  In f a c t ,  th e  peak p lasm a 
c o n c e n tra t io n  v a lu e s  ( Cmax ) which would no rm ally  be more p rone to  
d e v ia t io n s  showed a b e t t e r  c o r r e la t io n  to  dose in c re a s e s .  The mean Cmax 
v a lu e s  f o r  th e  10, 15 and 30mg d o ses  were 299 + / -  92 ng /m l, 380 + /-  64 
ng/m l and 803 + /-  147 ng/m l r e s p e c t iv e ly .  These v a lu e s  c o rre sp o n d  to  a
1.3, 2.1 and 2 .69 fo ld  in c re a s e  from th e  lOmg to  th e  15mg d o se , and th e  
15mg and lOmg d o se s  to  th e  30mg dose  r e s p e c t iv e ly .
F requency o f d o s in g  i s  a s  im p o rta n t a s  le v e l  o f d o s in g . F or a drug
o f s h o r t  to  in te rm e d ia te  h a l f - l i f e  ( 20 min -  8 h o u rs  ) , th e  m ajor
c o n s id e ra t io n s  a re  th e ra p e u t ic  index  and conven ience  o f d o s in g . A drug
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w ith  a h ig h  th e ra p e u t ic  index  need on ly  be a d m in is te re d  once every  one 
to  th re e  h a l f - l i v e s .  A drug w ith  a low th e ra p e u tic  index  m ust be g iven  
ap p ro x im ate ly  ev ery  h a l f - l i f e .  Again, by s tu d y in g  th e  s te a d y - s t a te  
c o n c e n tra t io n - t im e  p r o f i le  one can o p tim ise  th e  frequency  o f d o s in g .
B efore p h a rm a c o k in e tic a lly  i n te r p r e t in g  a c o n c e n tra t io n - t im e  p r o f i le ,  
th e  d a ta  i s  o f te n  f i r s t  f i t t e d  to  a 'com partm ent m odel'
P h arm aco k in e tic  m odels assum e t h a t  r e s u l t s  a re  decided  by p r io r  
c a u se s  which may be in h e r i te d  o r en v iro n m en ta l. D e v ia tio n s  and 
f lu c tu a t io n s  a re  u su a lly  a t t r ib u te d  to  ex p e rim e n ta l e r r o r .  P a ram e te rs  
such  a s  volum es and r a t e  c o n s ta n ts ,  a re  assum ed to  rem ain  c o n s ta n t  over 
th e  e n t i r e  o b s e rv a tio n  p e rio d .
The sc h em a tic  d iag ram s of l in e a r  p h arm aco k in e tic  m odels a l l  have 
e i t h e r  f i r s t  o rd e r  o r ze ro  o rd e r  in p u t r a t e  c o n s ta n ts ,  and f i r s t  o rd e r  
d i s t r ib u t io n  and e lim in a tio n  r a t e  c o n s ta n ts .  The s o lu t io n  d iag ram s of 
th e  d i f f e r e n t i a l  e q u a tio n s  o f such  l in e a r  com partm en ta l sy s te m s  can  be 
d e s c r ib e d  by p o ly -e x p o n e n tia l  e q u a tio n s , th e  number o f te rm s  o f which 
a re  id e n t ic a l  to  th e  number o f p h a se s , th u s
nC = 2  Ci exi* C = c o n c e n tra tio n  a t  tim e  t
W
Cj = th e  i t h  c o e f f ic ie n t  
Xj= exponen t o f th e  i t h  e x p o n e n tia l term
The 'm ethod o f r e s id u a ls ' i s  used  to  d e te rm in e  w hether th e  d a ta  may 
be ad e q u a te ly  d e s c r ib e d  by a p o ly e x p o n e n tia l eq u a tio n . The d if fe re n c e  
betw een an observed  and a c a lc u la te d  va lue  i s  c a lle d  a r e s id u a l .  T his
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d if f e re n c e  when d iv id e d  by an e s tim a te  o f i t s  e r r o r  i s  term ed  a 
s ta n d a rd is e d  r e s id u a l ,  r
i .e . r  = y - f / s
A d i g i t a l  com puter may be programmed to  perfo rm  n o n - l in e a r  l e a s t  
s q u a re s  a n a ly s i s  o f th e  d a ta . A good c r i t e r io n  o f how w ell th e  
tec h n iq u e  h a s  been a p p lie d  to  a  g iven  s e t  o f d a ta  i s  t o  c o n s id e r  th e  sum 
o f sq u a red  d e v ia t io n s  and th e  e r r o r s  on th e  f i t t e d  p a ra m e te rs  ( shou ld  
be a p p ro x im a te ly  30% o r l e s s  based  on a  S tu d e n ts  t -v a lu e  a t  th e  5% 
p r o b a b i l i ty  le v e l .)
P rev io u s  in v e s t ig a to r s  o f th e  p h a rm a co k in e tic s  o f m ethim azole a f t e r  
o r a l  a d m in is t r a t io n  have found t h a t  th e  d a ta  i s  a d eq u a te ly  d e sc r ib e d  by 
a  one com partm ent model ( S k e lle rn  e t  a l.,1 9 8 0 a ; Ja n sso n  e t  a l . ,  1985 )
A one-com partm en t model d e p ic ts  th e  body a s  a  s in g le ,  k in e t ic a l ly  
homogenous u n i t .  I t  i s  assum ed t h a t  th e  r a t e  o f  change in  drug  
c o n c e n tra t io n  in  th e  p lasm a r e f l e c t s  q u a n t i ta t iv e ly  th e  change o f drug 
c o n c e n tra t io n  th ro u g h o u t th e  body.
5 .1 .2  M ethim azole P h a rm a c o k in e tic s  in  th e  E u thy ro id  and H yp erth y ro id  
S ta te
The d i s p o s i t io n  o f many d ru g s  may be a l te r e d  in  th e  h y p e r th y ro id  
p a t i e n t .  Such a l t e r a t i o n s  a re  o f g r e a t e s t  im portance  f o r  d ru g s  w ith  a
l i t
low th e ra p e u t ic  r a t i o ,  o r in  c a se s  where a drug i s  be ing  used to  c o n tro l  
th e  h y p e r th y ro id  c o n d itio n  i t s e l f  o r one o f i t s  m a n ife s ta t io n s .
Hormones have a c e n tr a l  m odulatory  e f f e c t  on th e  v e ry  fundam ental 
m o lecu lar p ro c e s s e s  which govern  v a rio u s  m etab o lic  a c t i v i t i e s  a t  bo th  
b a s ic  c e l lu la r  and o rgan  le v e l . An e x c ess  o f th y ro id  horm ones may 
th e r e fo r e  p roduce p rofound and w idesp read  p h y s io lo g ic a l  e f f e c t s  (Table 
5 .1 ) .
The in flu e n c e  o f h y p e rth y ro id ism  on drug  k in e t ic s  h as  been review ed 
< S h e n fie ld  e t  a l . ,  1981 ) and i s  sum m arised in  Table 5 .2 .
In v e s t ig a t io n s  in to  th e  e f f e c t  o f h y p e rth y ro id ism  on m ethim azole 
p h a rm a c o k in e tic s  was d isc u s s e d  e a r l i e r  ( s e c t io n  1.3.5 ) and in  g e n e ra l 
ap p ear to  in d ic a te  t h a t  th e re  i s  no a l t e r a t io n  in  m ethim azole 
d i s p o s i t io n  in  t h i s  d is e a s e  s t a t e  a lth o u g h  one re c e n t  s tu d y  has  
in d ic a te d  o th e rw ise  (Hengstmann and Hohn, 1985).
By a n a ly s in g  th e  known p h y s io lo g ic a l  e f f e c t s  o f h y p e rth y ro id ism  
p re s e n te d  in  Table 5 .1 , we can id e n t i f y  th e  p h arm aco k in e tic  p a ra m e te rs  
w hich would r e f l e c t  th e  changes, i f  any, in  m ethim azole d i s p o s i t io n .
In c re a se d  g a s t r o in t e s t i n a l  fu n c tio n  may r e s u l t  in  an in c re a s e d  r a t e  
o f a b s o rp t io n  which would be r e f le c te d  by a d ec reased  tm ax and 
in c re a s e d  Cmax va lue .
The in c re a s e  in  b lood  flow , r e n a l  and, e s p e c ia l ly  in  th e  c a se  of 
m ethim azole, l iv e r  fu n c tio n  cou ld  a l l  have an e f f e c t  o f an in c re a se d  r a te  
o f e l im in a tio n . T h is  would be shown by a low ering  in  th e  peak plasm a 
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Table 5.2 The influence of hyperthyroidism on drug pharmacokinetics.
Parameter Change Drug* Reference
Absorption
Rate r Paracetamol Forfar et al (1900)
t Prooranolol Beit et al (1977)
« Riboflavin Levy et at (1972)
Amount a ’  Digosm Lawrence ot at. (1977)
Watters 8 Tomkm (1975)
Otatnbution ♦ Prooranolol t?5*'»l Wens et at (1983)
* Ogoim (variable results) ShenfieiO (1977. 1981)
*► Phenyloin Hansen et al. (1978)
Moisbotiem
Oticsat've ♦ Amtpynne i33*i») Shenhew (1981)
t Protxanoioi (SO*wi Feefy et al (1981b)
♦ Metoproiol (SOU.) Haaengren et al. (1982)
t ToKU/Umde Kampman 8 S aon led  (1975)
♦ Theopnytune (20**) voton et al (1904)
e Wei‘arm n ,  • smg e Cosef Mctrtoeh et al. (1970)
** Wariarm (t„ • long term therapy)* Schrogw 8 Solomon (1967)
** Phenyl om Hansen et al (1978)
** P'onvttruourac.i Ksmrwnen A SkOvSMd (1975)
« r Carorniaioie Cooper (1904)
O atepam wrens et al (1981)
GUiCuron.aai.on ♦ Paracetamor (?«*■•) Forfar et al (1980)
♦ O iatepam  (6S*u) Scon et ai (1984)
Hormonal ♦ Comsoi (t„ 4 S5NI* Galagher et al (1972)
♦ Thyroime t u  . 3a*s)» tngoer 8 Fnrttef (1909)
♦ TreodOfhyronme (118V) B—nct* m el (1979)
+ InstAn (45V) OviMbtatte et a t  (1995)
Konst clearance t D^oim Lawrence et al (1977)
&go*m Bone* et al. (1978)
•> Atenoioi Doherty 8 PeHuna (1990)
r r Sotaiot Snenfwia et m. (1977)
♦ r Naodoi Haaengren et al (1992)
Aro et ai (1982)
MMhmson 0 Burr (1904)
SmdmQ a Propranolol Feety ot ai (1981c)
4 Warfarin Feety et ai (1981c)
a  Percentage change rotates to clearance unless speohea
b A ssessed by measurement ot hat-ate u-,1
Key ♦ ■ mcreasai e r n o  cttange 4 * decrease
S h e n fie ld  e t  a l . ,  1981
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e lim in a tio n  r a t e  c o n s ta n t ,  ke and co n seq u en tly  a s m a lle r  a re a  under th e  
p lasm a c o n c e n tra tio n  curve from ze ro  to  i n f i n i t y  (AUCq.^0 0 ^
A lte r a t io n s  in  th e  c o n c e n tra tio n  o f th e  m ajor b in d in g  p r o te in s  a re  
o f te n  a s s o c ia te d  w ith  a l t e r a t io n s  in  th e  volume o f d i s t r ib u t io n  o f a 
number o f d ru g s . However, m ethim azole i s  n o t h ig h ly  p ro te in  bound and 
th u s  an in c re a s e  in  th e  volume of d i s t r ib u t io n  would n o t be ex pected  in  
t h i s  p a r t i c u l a r  c a se .
5 .1 .3  Aim Of S tudy
The aim o f t h i s  s tu d y  i s  to  exam ine th e  d o se -re sp o n se  r e l a t io n s h ip s  
f o r  m ethim azole and any v a r ia t io n  in  drug  h an d lin g  w ith  th y ro id  s ta tu s .
Twelve p a t i e n ts  were d iv id e d  in to  fo u r g roups d e s ig n a te d  a s  group 1 
( p a t ie n ts  1,2,3 and 4 ) , group 2 ( p a t ie n ts  5 and 6 ) , group 3 ( p a t ie n ts  7, 
8 and 9) and group 4 ( p a t ie n ts  10,11 and 12). Groups 1 and 2 were 
a d m in is te re d  5mg d.b . o f m ethim azole o r a l ly  and g roups 3 and 4 were 
a d m in is te re d  20mg d.b . o f m ethim azole o ra l ly .  P a t ie n ts  in  g roups 1 and 
3 had reach ed  chem ica l eu th y ro id ism  w hereas p a t i e n ts  in  g roups 2 and 4 
had rem ained  h y p e r th y ro id . O rg a n if ic a tio n  o f th y ro id a l  io d id e  was 
e s tim a te d  a t  v a r io u s  t im e p o in ts  and p lasm a sam ples were ta k e n  r e g u la r ly  
a f t e r  o r a l  a d m in is t r a t io n . From a s tu d y  o f th e  r e s u l t s  i t  i s  hoped to  
answ er th e  fo llo w in g  q u e s tio n s
i )  I s  th e r e  a  c o r r e la t io n  betw een p lasm a c o n c e n tra tio n  and e x te n t  of 
o r g a n i f ic a t io n  o f io d in e?
i i )  Can m ethim azole be g iven  a s  a  s in g le  d a ily  dose which would
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encourage g r e a te r  p a t ie n t  com pliance?
i ii)D o e s  m ethim azole d i s p o s i t io n  v a ry  w ith  th y ro id  s t a t u s  which m ight 
c a l l  f o r  th e  dosage to  be r e a s s e s s e d  a s  th e  p a t i e n t  re a c h e s  
ch em ica lly  induced  e u th y ro id ism ?
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5.2 . EXPERIMENTAL
5.2 .1 . M ethods
Twelve fem ale p a t i e n ts ,  a l l  w ith in  th e  f i r s t  th r e e  m onths o f 
t re a tm e n t, gave w r i t te n  inform ed c o n sen t to  th e  s tu d y  which had been 
approved  by th e  e th ic a l  com m ittee o f th e  W estern In firm a ry , Glasgow.
M ethim azole (Tapazole) was o b ta in e d  from  E li  L i l ly ,  In d ia n a p o lis , USA 
th ro u g h  th e  h o s p i ta l  pharm acy and was g iven  in  one o f two o ra l  
reg im ens: 5mg o r 20mg tw ice  d a i ly .  The d ie ta ry  reg im e was f a s t in g  a t  
th e  tim e  o f th e  p lasm a p r o f i le s  u n t i l  a f t e r  th e  th re e  hour sam ple. 
Sam ples f o r  m ethim azole and p e rc h lo ra te  d isc h a rg e  m easurem ents were 
tak e n  a f t e r  one o f th e  tw ice  d a i ly  d o se s . These d o ses  were n o t changed 
in  in d iv id u a l  p a t i e n ts .  P re sam ple c o l le c t io n  c l i n ic a l  and b iochem ica l 
c h a r a c t e r i s t i c s  o f  th e  p a t i e n ts  a re  shown in  T able 5 .3 . T4 
su p p le m e n ta tio n  was added a s  re q u ire d  to  avo id  sym ptom atic  
h y p o th y ro id ism .
Serum F ree  T3, F ree  T4 and TSH were e s tim a te d  u s in g  Amerlex RIA k i t s  
(Amersham U.K.). Some TSH le v e ls ,  shown in  b ra c k e ts ,  were e s tim a te d  
u s in g  an im m unoradiom etric  a s sa y  (IRMA).
A gam m a-cam era/data a n a ly s is  sy stem  was used to  m o n ito r th e  th y ro id  
123u p tak e  o f I - io d id e  f o r  30 m inu tes fo llo w in g  in tra v e n o u s  a d m in s tra tio n  
o f th e  t r a c e r .  Sodium p e rc h lo ra te  (300mg) was th en  a d m in is te re d  
in tra v e n o u s ly . The d isc h a rg e  o f t r a c e r  was fo llow ed  f o r  a  f u r th e r  30 
m inu tes and th e  p e rc e n ta g e  d isc h a rg e  was c a lc u la te d .
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1 30 BU 5 1.29 51
2 32 EU 5
3 31 EU 5 1.59 60 (10.7)
4 21 EU 5 1.30 150 (0.83)
5 52 HT 5 3.15 106 1.1
6 33 HT 5 2.58 162 1.0
7 34 EU 20 2.80 60 (0.17)
e EU 20 1.47 153 (0.28)
9 24 EU 20 2.20 95 (0.08)
10 29 HT 20 2.75 121 1.0
11 19 HT 20 2.89 197 0.5
12 50 HT 20 3.59 162 0.9
S o raal range 0.69-2.46 54-142
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Blood sam p les  were c o lle c te d  in to  EDTA tu b e s  p re -d o s e  and a t  
f re q u e n t tim e  in te r v a l s  up to  12 h ou rs  fo llo w in g  drug  a d m in is t ra t io n . 
A fte r  c e n tr i f u g a t io n ,  th e  r e s u l t a n t  p lasm a was s to r e d  in  th e  G ard iner 
I n s t i tu t e ,  D epartm ent of M edicine, The W estern In firm a ry  a t  -20°C . A fte r 
t r a n s p o r ta t io n  to  th e  D epartm ent o f F o re n s ic  S c ience  and M edicine, 
Glasgow U n iv e rs i ty ;  th e  sam ples rem ained  s to re d  a t  -20°C  u n t i l  a ssa y e d . 
The p lasm a sam p les  were a ssa y e d  f o r  m ethim azole u s in g  th e  method 
d e s c r ib e d  in  s e c t io n  3 .5 .3 .1 .
5.2 .2  A ssessm en t o f P h a rm aco k in e tic  P a ram e te rs
T erm inal lo g - l in e a r  p o in ts  from fo u r h ou rs  a f t e r  a d m in is t r a t io n  were 
used  to  c a lc u la te  th e  e lim in a tio n  r a t e  c o n s ta n t ,  Xz and th e  e lim in a tio n  
h a l f - l i f e ,  tte; u s in g  th e  * MODFIT program . The a re a  under th e  plasm a 
c o n c e n tra t io n - t im e  c u rv e s  to  th e  l a s t  d a ta  p o in t  (AUC ) and th e  a re a  
under th e  f i r s t  s t a t i s t i c a l  moment cu rve  (AUMC), were d e te rm ined  by a 
com bined l in e a r - lo g a r i th m ic  t r a p e z o id a l  method u s in g  th e  *AUCDAT 
program . The a re a  under th e  f i r s t  moment cu rve  (AUMC) i s  th e  a re a  
under th e  cu rve  o f a p lo t  o f th e  p ro d u c t o f c o n c e n tra tio n  and tim e  
v e rs u s  tim e  from  ze ro  to  th e  l a s t  d a ta  p o in t. The mean re s id e n c e  tim e 
(MET) and th e  a p p a re n t o r a l  c le a ra n c e s  (C l/F) were c a lc u la te d  by model 
in dependen t m ethods a s  fo llo w s :-
AUMCo-vt+
MRT = --------------   - — ; C l/F  = Dose/AUC
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where T = d o s in g  in te r v a l
CT= c o n c e n tra tio n  a t  th e  end o f th e  d o s in g  in te r v a l
The mean re s id e n c e  tim e  in  th e  body based  on p lasm a c o n c e n tra t io n s  i s  
d e fin e d  a s  th e  expected  in te r v a l  o f tim e  t h a t  a drug  in tro d u c e d  in to  th e  
p lasm a o r  c e n t r a l  com partm ent sp en d s  in  th e  c e n t r a l  and p e r ip h e ra l  
com partm ents b e fo re  i r r e v e r s ib ly  le a v in g  th e  c e n t r a l  com partm ent.
Peak c o n c e n tra t io n  ( Cmax ) was d e fin e d  a s  th e  h ig h e s t  va lu e  a c tu a l ly  
rec o rd e d , and th e  tim e  to  rea c h  peak c o n c e n tra t io n  < tm ax ) was o b ta in ed  
a c c o rd in g ly .
5 .2 .3 . S t a t i s t i c a l  A n a ly s is
The s t a t i s t i c a l  s ig n i f ic a n c e  o f  d if f e re n c e  was a s s e s s e d  by th e  
a n a ly s i s  o f v a r ia n c e  u s in g  th e  *ANOVA d i g i t a l  com puter program .
* MODFIT, AUCDAT and AKOVA a re  p h a rm aco k in e tic  p rogram s developed a t  
Beechams P h a rm a c e u tic a ls , Harlow and a re  n o t a v a i la b le  f o r  u se  o u ts id e  
th e  company.
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5.3 RESULTS
The p lasm a c o n c e n tra t io n - t im e  p r o f i le s  o f m ethim azole a t  th e  two 
dose le v e ls  <5mg and 20mg b .d .) and betw een th e  two p a t i e n t  c a ta g o r ie s  
(eu th y ro id  and h y p e r th y ro id )  a re  p re se n te d  in  T ab les 5.4 to  5.7 and in  
l in e a r  and lo g - l in e a r  g ra p h ic  form in  F ig u re s  5.1 to  5 .4 , r e s p e c t iv e ly .
T y p ica l chrom atogram s fo r  th e  two dose le v e ls  a re  g iven  in  F ig u re s  
5.5 and 5 .6 , r e s p e c t iv e ly .
The in d iv id u a l p h a rm aco k in e tic  p a ra m e te rs  o f m ethim azole fo r  th e  
tw elve  p a t i e n ts  a re  g iven  in  T ab les 5.8 to  5 .11, r e s p e c t iv e ly .
The Cmax v a lu e s  fo r  m ethim azole in c re a se d  w ith  in c re a s in g  dose 
le v e ls  in  b o th  th y ro id  s t a t u s  g roups. The mean Cmax v a lu e s  o f 
m ethim azole fo llo w in g  th e  5mg dose were 198 and 194.5ng/m l in  e u th y ro id  
and h y p e r th y ro id  p a t i e n ts  r e s p e c t iv e ly .  The mean Cmax v a lu e s  o f 
m ethim azole fo llo w in g  th e  20mg dose were 627 and 311ng/m l in  e u th y ro id  
and h y p e r th y ro id  p a t i e n ts  r e s p e c t iv e ly .
The a re a  under th e  p lasm a c o n c e n tra t io n - t im e  curve  to  in f in ty  
(AUCj^ oq) f o r  m ethim azole in c re a se d  w ith  in c re a s in g  dose le v e ls  in  bo th  
th y ro id  s t a t u s  g roups. The mean AUC v a lu e s  of m ethim azole fo llo w in g  th e  
5mg dose were 501 and 564ng.h/m l in  e u th y ro id  and h y p e r th y ro id  p a t i e n ts  
r e s p e c t iv e ly .  The mean AUC v a lu e s  o f m ethim azole fo llo w in g  th e  20mg 
dose were 3395 and 1283ng.h/m l in  e u th y ro id  and h y p e r th y ro id  p a t ie n ts  
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Table 5.5 The plasma concentrations following oral administration of



















Table 5.6 The plasma concentrations following oral administration of









0.0 33 97 112
0.5 438 583 580
1.0 672 617 332
1.5 575 629 300
2.0 545 587 164
3.0 377 495 305
4.0 414 458 278
5.0 338 409 164
6.0 243 265 171
7.0 209 261 128
6.0 92 245 115
13.5 I.S . 79 I.S .
24.0 V.S. S.S. 52
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Table 5.7 The plasma concentrations following oral administration of









0.0 18 110 22
0.5 H.S. U.S. 102
1.0 190 I  .S. 157
1.5 289 488 136
2.0 187 442 V.S.
2.5 H.S. 366 H.S.
3.0 I.S . 257 H.S.
3.5 H.S. 361 N.S.
4.0 113 262 U.S.
4.5 H.S. 254 V.S.
5.0 58 U.S. 66
5.5 I  .S. 243 I.S .
6.0 36 I.S . 72
6.5 I.S . 226 H.S.
7.0 24 ff.S. 56
7.5 H.S. 176 H.S.
8.0 20 148 47
0.0 H.S. S.S. 30
12.0 15 S.S. V.S.
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1171S B171S
RETN.TJME HEIGHT RREfl UNCRLIBRflTED.
2 86 22 2117 .01  12812 .51
TBDMS M ethim azole
0 HRS 10 MJNS 25 SECS 0 HRS B MJNS 1B SECS
R171S I1 71S
RETN.TJME HEIGHT RREfl UNCflLJBRflTED.
B -8 6 -2 2  1511 0 .1 1  1B 1669 .10
TBDMS D3 M ethim azole
B HRS 1B MINS 25 SECS,3_flRS B MINS 1B SECS
F ig u re  5 .5  T y p ica l chrom atogram  o f m ethim azole in  human p lasm a 
fo llo w in g  o r a l  a d m in is t r a t io n  o f 5mg o f m eth im azole .
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F ig u re  5 .6  T y p ica l chrom atogram  o f m ethim azole in  human p lasm a
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d if fe re n c e  betw een dose le v e ls  < 0.958, P= 0.05 ) o r betw een eu th y ro id  
and h y p e rth y ro id  p a t i e n ts  ( 0.184, P = 0 .05).
There were no c o n s is te n t  changes in  th e  te rm in a l h a l f - l i v e s  (t&) of
m ethim azole fo r  e i th e r  group a t  e i th e r  dose le v e l. The mean v a lu es  of 
tte o f m ethim azole fo llo w in g  th e  5mg dose were 3.76h (range 1.43 -  6.39h) 
and 5.34h (range 2.61 -  8.06h ) in  e u th y ro id  and h y p e r th y ro id  p a t ie n ts  
r e s p e c t iv e ly .  The mean v a lu es  o f tte o f m ethim azole fo llo w in g  th e  20mg 
dose  were 4.76h ( ran g e  2.12 -  8.45 ) and 3.78h ( ran g e  1.58 -  5 .85h ) 
in  e u th y ro id  and h y p e rth y ro id  p a t i e n ts  r e s p e c t iv e ly .
There were no c o n s is te n t  changes in  th e  o ra l  c le a ra n c e  (C l/F) o f
m ethim azole fo r  e i th e r  p a t ie n t  group a t  e i th e r  dose le v e l. The mean C l/F
v a lu e s  o f m ethim azole fo llo w in g  th e  5mg dose were 252 m l/m in (range 88 
-  524 m l/m in ) and 148 m l/m in (range 139 -  158 m l/m in ) fo r  e u th y ro id  
and h y p e rth y ro id  p a t i e n ts ,  r e s p e c t iv e ly .  The mean C l/F  v a lu e s  o f 
m ethim azole fo llo w in g  th e  20mg dose were 101 m l/m in (range 80 -  116 
m l/m in ) and 328 m l/m in ( ran g e  149 -  377 m l/m in ) f o r  e u th y ro id  and 
h y p e rth y ro id  p a t i e n ts  r e s p e c tiv e ly .
The tm ax v a lu e s  o f m ethim azole rem ain  v e ry  s im i la r  betw een a l l  
c a te g o r ie s . The mean tm ax v a lu es  o f m ethim azole fo llo w in g  th e  o ra l  
a d m in is t r a t io n  o f 5mg were 0.875h (range 0.5 -  l.Oh ) and 1.25h (range
1.0 -  1.5 h ) fo r  e u th y ro id  and h y p e r th y ro id  p a t i e n ts  r e s p e c t iv e ly .  The 
mean tm ax v a lu e s  o f m ethim azole fo llo w in g  th e  o ra l  a d m in is t ra t io n  o f 
20mg were lh  (range 0.5 -  1.5h ) and 1.33h (range 0.5 -  1.5h ) fo r  
e u th y ro id  and h y p e r th y ro id  p a t i e n ts  r e s p e c t iv e ly .
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The sodium p e rc h lo ra te  d isc h a rg e  r e s u l t s  a long  w ith  m ethim azole 
c o n c e n tra tio n  found a t  th e  tim e of d isc h a rg e  a re  p re se n te d  in  Table 5.12 
F ig u re  5.7 and r e p re s e n t  th e  change in  p e rc e n ta g e  p e rc h lo ra te  d isc h a rg e  
w ith  tim e  and th e  r e la t io n s h ip  betw een p e rc e n ta g e  p e rc h lo ra te  d isc h a rg e  
and p lasm a c o n c e n tra tio n  re s p e c t iv e ly .
. and
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T ab le  5 .12 C om parison o f  th e  p e rc h lo ra te  d is c h a rg e  r e s u l t s  and th e  p lasm a 
c o n c e n tra t io n  a t  th e  n e a re s t  e q u iv a le n t  t im e p o in t fo llo w in g  
o r a l  a d m in is t r a t io n  o f m eth im azole
P atien t Doee
(ag>
Thyroid
s ta tu e
CIO4 Discharge 
<%>
In terval fro a  
XKI dose <h>
Cp a t  the nearest 
tla ep o in t (ng/al)
1 5 EU 75.5 5.0 60
2 5 EU 27.0 24.5 0 <12h>
3 5 EU 0.0 25.0 0 (12h)
4 5 EU 79.7 13.0 0 <12h>
5 5 HT 60.1 3.1 76
6 5 HT 61.8 2.5 64
7 20 EU 7.5 24.0 I.S .
e 20 EU 85.4 23.0 79
0 20 EU 30.9 25.0 52 <24h>
10 20 HT 69.2 5.0 58
11 20 HT 76.8 13.0 110 <12h>
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F ig u re  5 .7  Plasm a c o n c e n tra tio n  v e rsu s  p e rc e n ta g e  io d id e  d isc h a rg e .
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5.4 DISCUSSION
A ll p a t i e n ts  had been re c e iv in g  th e  m ethim azole tre a tm e n t  fo r  more 
th an  one month when th e  sam ples were c o lle c te d . Thus, a t  t h i s  s ta g e  in  
th e  tre a tm e n t, w ith  such  a dosage reg im en, a l l  p a t i e n ts  were expected  to  
be a c h ie v in g  s te a d y - s t a te  p lasm a le v e ls .
As m entioned in  s e c t io n  5.1. th e  p lasm a c o n c e n tra tio n - t im e  cu rve  of 
m ethim azole a f t e r  o r a l  a d m in is t ra t io n  i s  no rm ally  ad e q u a te ly  d e sc r ib e d  
by a one com partm ent model. Thus, th e  m ethim azole c o n c e n tra t io n s  a f t e r  
th e  o r a l  d o ses  were a n a ly se d  by le a s t - s q u a re  n o n - lin e a r  r e g re s s io n . 
However, th e  one com partm ent model gave u n accep tab ly  h igh  sum of 
squ ared  d e v ia t io n s  < >30% ) fo r  th e  g e n e ra te d  p a ra m e te rs  , th e re fo re ,  th e  
p h arm aco k in e tic  p a ra m e te rs  were d e riv e d  from th e  p o s t-p e a k  lo g - l in e a r  
p o in ts  and th e  a p p ro p r ia te  e q u a tio n s  a s  d e sc r ib e d  in  s e c t io n  5 .2 .2 .
From s tu d y in g  th e  p lo ts  of log  C v s  tim e , th e  te rm in a l e lim in a tio n  phase 
was m easured from  fo u r h ou rs  and t h i s  t im e p o in t s e le c t io n  i s  in  
agreem ent w ith  p rev io u s  s tu d ie s  (Jansson  e t  a l . ,  1985). To g a in  an 
adequate  e s tim a te  o f th e  s lo p e  o f th e  te rm in a l  phase  o f a p lasm a 
c o n c e n tra t io n - t im e  cu rve , i t  i s  n e c e s sa ry  to  fo llow  i t s  co u rse  fo r  a t  
l e a s t  th re e  h a l f - l i v e s .  As th e  p a t i e n ts  a re  being  dosed  tw ice  d a ily ,  th e  
sam p ling  fo r  each dose ends a t  e ig h t  h o u rs. However th e  ze ro  hour tim e  
p o in t  i s  e q u iv a le n t to  th e  tw elve  hour tim e p o in t from th e  p rev io u s  dose. 
At s te a d y  s t a t e ,  f o r  ev ery  dose , th e  c o n c e n tra tio n  a t  each  tim e p o in t 
shou ld  rem ain  th e  same. T h is  th e o ry  can be i l l u s t r a t e d  by s u b je c t  te n  
who was sam pled a t  two c o n sec u tiv e  tw elve  hour tim e p o in ts  and gave
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le v e ls  o f 18 and 15ng/m l re s p e c t iv e ly  (the  d if fe re n c e  in  le v e ls  being  
e q u iv a le n t to  th e  s ta n d a rd  d e v ia tio n  o f th e  a s sa y  ).
As no in tra v e n o u s  a d m in is tra t io n  d a ta  was o b ta in ed  f o r  t h i s  s tu d y , 
th e  b io a v a i la b i l i ty  o f m ethim azole could  n o t be c a lc u la te d . T h erefo re , 
c a lc u la t io n  o f a b s o rp tio n  and d i s t r ib u t io n  k in e t ic s  was n o t j u s t i f i e d .
P harm acok ine tic  p a ra m e te rs  o f m ethim azole fo llo w in g  o r a l  
a d m in is t ra t io n  have been d e sc r ib e d  in  s e v e ra l  p a p e rs  and th e  r e s u l t s  fo r  
te rm in a l h a l f - l i f e  (t& ), o ra l  c le a ra n c e  (Cl) and a re a  under th e  curve  
(AUC) a re  sum m arised in  Table 5.13. In th e  p re s e n t  s tu d y , th e re  i s  a 
h igh  degree  o f in te r in d iv id u a l  v a r ia t io n  w ith in  each group f o r  a l l  th e  
m easured p a ra m e te rs  excep t tmax which would be u n lik e ly  to  change a s  
m ethim azole i s  known to  be r a p id ly  ab so rb ed . These v a r ia t io n s  could  be 
caused  by s e v e ra l  f a c to r s  e.g. th e  wide age ran g e  w ith in  th e  p a t ie n ts  
and p e rh a p s  d if f e re n c e s  in  l iv e r  fu n c tio n  ( d ia g n o s t ic  enzymolgy r e s u l t s  
such  a s  serum  b i l i r u b in  and tra n s a m in a s e s  le v e ls  were n o t d e ta i le d  bu t 
none o f th e  p a t i e n ts  were re p o r te d  to  have abnorm al l iv e r  c o n d it io n s ) .  
Such p a t ie n t  v a r ia t io n s  would p a r t i c u la r ly  a f f e c t  p lasm a h a l f - l i f e  and 
sy s te m ic  c le a ra n c e . However, th e  mean v a lu es  show a good agreem ent w ith  
th e  s tu d ie s  sum m arised in  ta b le  5.13.
Peak p lasm a m ethim azole le v e ls  occu rred  a f t e r  abou t 0 .5 -1 .5 h , w ith  a 
second sm a lle r  peak o c c u rr in g  in  50 % of th e  s u b je c ts  a f t e r  3 h.
S im il ia r  o b s e rv a tio n s  have been made w ith  carb im azo le  (S k e lle rn  e t  a l . ,  
1976) where i t  was p o s tu la te d  t h a t  th e  second peak was due to  slow  
carb im azo le  h y d ro ly s is  to  m ethim azole in  th e  sm a ll i n te s t i n e ,  w ith  









co n v e rs io n  o f carb im azo le  to  m ethim azole occu rs  v e ry  r a p id ly  (Nakashima 
e t  a l . ,  1979; S k e lle rn  e t  a l.,1 9 8 0 a  and Ja n sso n  e t  a l . ,  1 9 8 3 a). A lso, t h i s  
phenomenon was n o ted  a f t e r  m ethim azole a d m in is t ra t io n  ( Cooper e t  a l . ,
1984) whch c a s t  doub t on t h i s  h y p o th e s is  a lth o u g h  no a l t e r n a t iv e  
su g g e s tio n  was o f fe re d . A p o s s ib le  e x p la n a tio n  f o r  th e  second  peak i s  
t h a t  i t  i s  be ing  caused  by e n te ro h e p a tic  r e c i r c u la t io n  o f m ethim azole. 
Once e x c re te d  in to  th e  b i le ,  a drug may be rea b so rb ed  from th e  
i n t e s t i n a l  t r a c t .  As d isc u s s e d  in  s e c t io n  1 .3 .3 .2 ., i t  seem s l ik e ly  from 
ra d io a c t iv e  s tu d ie s  t h a t  e n te ro h e p a tic  c i r c u la t io n  o ccu rs  f o r  m ethim azole 
a n d /o r  i t s  m e ta b o li te s . Norm ally th e  le v e ls  rea b so rb ed  by t h i s  c y c le  
would n o t s ig n i f i c a n t ly  a f f e c t  th e  p lasm a c o n c e n tra t io n - t im e  p r o f i le .  
However, th e  g a l l - b la d d e r  can s to r e  up to  60m ls o f b i le .  A fte r  th e  
in ta k e  o f food , t h i s  b i le  i s  r e le a s e d  under th e  in f lu e n c e  o f vagus nerve  
s t im u la tio n  and th e  compound c h o le c y s to k in in  re le a s e d  by th e  duodenum. 
Thus, th e  p lasm a c o n c e n tra tio n  cou ld  be r a i s e d  s h o r t ly  a f t e r  m eals and 
th e  second  peak cou ld  be a r e s u l t  o f t h i s  phenomenon. As d isc u s s e d  in  
s e c t io n  1 .3 .3 .2 ., e n te ro h e p a tic  r e c i r c u la t io n  can  be t e s t e d  by b i le  
c a n n u la tio n , b u t o b v io u sly  t h i s  tech n iq u e  i s  on ly  s u i ta b le  f o r  an im al 
s tu d ie s .  V arious m ethods have been su g g e s te d  f o r  human s tu d ie s .  The 
b i le  can  be removed from th e  body by a t - tu b e  s e t- u p  and any  a l t e r a t io n  
in  th e  p lasm a c o n c e n tra tio n  p r o f i le  n o ted . However t h i s  tec h n iq u e  
in tro d u c e s  a  new com partm ent and th u s  can i t s e l f  a l t e r  th e  
p h a rm a co k in e tic s . A n t ib io t ic s  such  a s  neom icin and o x y te t ra c y c lin e  can 
be c o -a d m in is te re d  w ith  th e  drug  under in v e s t ig a t io n . They k i l l  th e  gu t 
f lo r a  th u s  th e  con juga ted  drug  i s  n o t broken  down to  th e  d rug  and
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rea b so rb ed  and th e re fo re  th e  second peak i s  no lo n g er p re s e n t .  However, 
an u n p le a sa n t s id e - e f f e c t  o f k i l l in g  g u t f lo r a  i s  to  cause  d ia r rh o e a  in  
th e  su b je c t . A c tiv a ted  c h a rc o a l can be c o -a d m in s te re d  w ith  th e  drug . I t  
a c t s  l ik e  a sponge fo r  th e  drug which i s  co n seq u en tly  n o t a v a ila b le  fo r  
b i l i a r y  e x c re tio n . F in a lly , i t  h a s  been su g g e s te d  t h a t  th e  n a tu ra l  b i le  
s e c r e t io n  s t im u la to r ,  c h o le c y s to k in in , be a d m in is te re d  a t  c e r ta in  
in te r v a l s  d u rin g  th e  plasm a c o n c e n tra tio n  tim e p r o f i le .  I f  a seco n d ary  
peak c o rre sp o n d s  to  th e  c h o le c y s to k in in  a d m in is t ra t io n  th en  
e n te ro h e p a tic  r e c i r c u la t io n  can be s a id  to  be o c c u rr in g . T h is  t e s t  would 
be th e  m ost d e f in i t iv e ,  however, i t  i s  d i f f i c u l t  to  judge a t  w hat dosage 
le v e l  th e  c h o le c y s to k in in  shou ld  be g iven  and, a s  i t  h a s  shown some 
to x ic i t y  t h i s  method i s  n o t favoured .
In o rd e r  to  s tu d y  th e  l in e a r i ty  o f c o n c e n tra tio n  betw een a low and 
h ig h  dose , mean Cmax and AUC fo r  g roups 1 and 2 were com pared w ith  
th o se  f o r  g roups 3 and 4. For e u th y ro id  p a t i e n ts  th e r e  was a 3.2 fo ld  
in c re a s e  in  Cmax and a 5.0 fo ld  in c re a s e  in  AUC betw een d o ses  and fo r  
h y p e rth y ro id  p a t i e n ts ,  th e  same p a ra m e te rs  showed a 1.6 fo ld  and a 1.5 
fo ld  in c re a s e  , r e s p e c t iv e ly .
A lthough a l l  com parisons gave a d e f in i t iv e  in c re a s e , none gave th e  4 
fo ld  in c re a s e  which shou ld  be expected . However, a s  shown in  th e  
r e s u l t s  s e c t io n , th e r e  was no s ig n i f i c a n t  d if f e re n c e  a f t e r  dose 
n o rm a lis a tio n  s u g g e s tin g  l i n e a r i ty  and a s  m entioned in  th e  s e c t io n  5 .1 .1 , 
th e  p o s tu la te d  and c a lc u la te d  v a lu e s  have f a i le d  to  a g ree  in  a  s im i la r  
s tu d y  (Okamura e t  a l . ,  1986). A lso, a more a c c u ra te  in s ig h t  would have 
been ga ined  in  t h i s  s tu d y  i f  th e  same p a t i e n ts  had re c e iv e d  th e  two
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do ses  th e re b y  e lim in a tin g  in te r in d iv id u a l  v a r ia t io n s .  However, th e  
s u b je c ts  were p a t i e n ts  undergo ing  n e c e s s a ry  m edical tre a tm e n t  d e fin ed  by 
t h e i r  c o n d it io n  and n o t th e  d i c t a te s  o f t h i s  s tu d y .
No s ig n i f ic a n t  d i f f e re n c e s  betw een p h arm aco k in e tic  p a ra m e te rs  a f t e r  
o r a l  a d m in is t r a t io n  to  eu th y ro id  and h y p e rth y ro id  p a t i e n ts  were 
o bserved . The r e s u l t s  can be seen  in  ta b le s  5.8 to  5.11. Cmax decreased  
in  h y p e rth y ro id  p a t i e n ts  a s  would be expected  i f  th e re  was an in c re a se d  
r a t e  o f e lim in a tio n , however th e  d e c re a se  was n o t s ig n i f ic a n t .  C o n tra ry  
to  p re d ic t io n , tm ax was in c re a se d  in  h y p e rth y ro id  p a t i e n ts  b u t, ag a in , 
th e  in c re a s e  was n o t s u b s ta n t ia l .  I f  th e re  was an in c re a s e  in  th e  r a t e  
of a b s o rp t io n , tm ax would be expected  to  d e c re a se . However, th e  r a t e  of 
a b s o rp t io n  o f m ethim azole i s  n o t l ik e ly  to  show a m arked in c re a s e  a s , in  
norm al p a t i e n ts ,  i t  h a s  been shown to  be ra p id  (Jansson  e t  a l . ,  1985).
The v a lu e s  f o r  c le a ra n c e , e lm in a tio n  r a t e  c o n s ta n ts  and a re a s  under th e  
cu rve  a l l  had a la rg e  deg ree  o f v a r ia t io n  and showed no p a r t i c u la r  t re n d  
when a l l  th e  g roups were com pared. A lso c le a ra n c e  v a lu e s  r e ly  on th e  
b io a v a i la b i l ty  o f m ethim azole which v a r ie s  from in d iv id u a l to  in d iv id u a l 
r a g a r d le s s  o f d is e a s e  s t a t e .  T h is  i s  i l l u s t r a t e d  by th e  ran g e  o f F 
v a lu e s  quoted in  th e  l i t e r a t u r e  and p re v io u s ly  d isc u s s e d  in  s e c t io n  
1.3.1. As m entioned a lre a d y  in  t h i s  d ic u s s io n  b i o a v a i l i b i l i ty  v a lu e s  
were n o t w ith in  th e  scope o f t h i s  s tu d y  th e re fo re  th e  mean value  d e riv ed  
from th e  m ost d e ta i le d  s tu d y  in  th e  l i t e r a t u r e  was used ( Ja n sso n  e t  a l . ,
1985). However t h i s  mean v a lu es  does n o t ta k e  in to  accoun t th e  
f lu c tu a t io n s  in  b io a v a i la b i l i ty  betw een in d iv id u a ls .  O bviously , a s  was 
th e  c a se  o f th e  dosage com parison , a  more r e p r e s e n ta t iv e  p ic tu r e  o f th e
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changes in  d i s p o s i t io n  between th y ro id  s t a t e s  would have been a v a ila b le  
i f  th e  same p a t i e n ts  had been compared f i r s t  in  th e  h y p e rth y ro id  s t a t e  
and th en  a g a in  when th ey  had reached  chem ical eu th y ro id ism . However, 
t h i s  was n o t p o s s ib le  w ith in  th e  c o n fin es  of t h i s  s tu d y . T h is  s tu d y  does 
however s u g g e s ts  t h a t  th y ro id  hormones do n o t d e p re ss  o r in c re a s e  th e  
m etabo lism  o f m ethim azole.
The q u e s tio n  th u s  rem ains a s  to  why th y ro id  hormones a f f e c t  th e  
d ip o s i t io n  o f s e v e ra l  d rugs but n o t m ethim azole. A p o s s ib le  e x p la n a tio n  
< H a llen g ren  e t  a l . ,  1982 ) could be th a t  th e  in flu en ce  of 
h y p e rth y ro id ism  on drug o x id a tio n  becomes ap p aren t m ainly  fo r  d rugs 
t h a t  a r e  s u b je c t  to  e x te n s iv e  p resy s tem ic  c lea ran ce  e.g . p ro p ra n o lo l and 
m e to p ro lo l (John and Regardh, 1976). Methimazole o x id a tio n  i s  
u n a ffe c te d  because  i t  h a s  a h igh  b io a v a i la b i l i ty  and th e re fo re  undergoes 
l i t t l e  o r  no f i r s t - p a s s  m etabolism  a ls o  H allengren p o s tu la te d  t h a t  . 
m eth im azole  cou ld  be m etabolized  by d i f f e re n t  o x id a tiv e  sy s tem s.
The d a ta  on peak plasm a m ethim azole c o n c e n tra tio n s  and m ethim azole 
p lasm a c le a ra n c e  in  eu th y ro id  and hyper th y ro id  p a t ie n ts  a re  c o n s is te n t  
w ith  th o s e  in  p re v io u s ly  p u b lished  r e p o r ts .  ( see ta b le  5.14 ). Thus, in  
agreem ent w ith  m ost in v e s t ig a to r s ,  th e re  a re  no pharm acok ine tic  re a so n s  
to  a d ju s t  th e  dose  o f m ethim azole during  tre a tm e n t o f th y ro to x ic o s is .
The p e rc h lo ra te  d isc h a rg e  t e s t  was used to  e s tim a te  th e  d u ra tio n  of 
a n t i th y r o id  e f f e c t  o f th e  two doses o f m ethim azole. Although th e re  was 
some d e v ia t io n  in  re sp o n se  around th i r te e n  hours, in  g e n e ra l, d isc h a rg e  
o f r a d io io d in e  from  th e  th y ro id  by p e rc h lo ra te  d im in ished  in  bo th  groups 
w ith  tim e  a f t e r  m ethim azole a d m in is tra tio n .
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The p lo t  o f th e  p e rc e n ta g e  d isc h a rg e  o f r a d io io d in e  from  th e  th y ro id  
by p e rc h lo ra te  a g a in s t  th e  p lasm a c o n c e n tra tio n  a t  th e  tim e  o f d isc h a rg e  
t e s t  ( f ig u re  5.7 ) gave an in te r e s t in g  r e s u l t .  A part from  a wide 
v a r ia t io n  in  p e rc e n ta g e  d isc h a rg e  a t  ze ro  p lasm a c o n c e n tra tio n , in  
g e n e ra l, a t  th e  s e le c te d  t im e p o in ts , th e  com parison  showed a l in e a r  
re sp o n se . Thus, i t  a p p e a rs  from th e s e  r e s u l t s  t h a t  th e  p lasm a 
c o n c e n tra t io n s  o f m ethim azole can be c o r r e la te d  w ith  i t s  e f f e c t  on th e  
in h ib i t io n  o f th e  o rg a n i f ic a t io n  of io d in e . Yet, a s  d isc u s s e d  in  s e c t io n  
1.3.4, th e  p lasm a c o n c e n tra t io n s  of m ethim azole have shown no 
c o r r e la t io n s  w ith  c l i n ic a l  in d ic e s . C onsequen tly , th e  g r e a t  d iv erg en ce  
in  th e  th e ra p e u t ic  re sp o n se  to  th e  d rug  in  th y ro to x ic o s is  i s  ob v io u sly  
n o t due to  d i f f e re n c e s  in  p lasm a p h a rm a co k in e tic s  o r th e  e x te n t  o f 
in h ib i t io n  o f o r g a n i f ic a t io n  o f io d in e .
In co n c lu s io n , p lasm a p h a rm a co k in e tic s  o f m ethim azole have shown 
q u ite  la rg e  in te r in d iv id u a l  v a r ia t io n  which could  be expected  a s  th e  
s tu d y  invo lved  p a t i e n ts  r a th e r  th an  h e a lth y  v o lu n te e rs . The 
c o n c e n tra tio n /t im e  p r o f i le  o f te n  had a second, s m a lle r  peak which may 
p o s s ib ly  be due to  e n te ro h e p a tic  r e c y c lin g . T h is  s tu d y  gave r e s u l t s  
which in d ic a te  dosage l in e a r i ty  and th e  m ethim azole p lasm a 
c o n c e n tra t io n s  seem to  c o r r e la te  w ith  i t s  e f f e c t  on th e  in h ib i t io n  of 
th e  o r g a n i f ic a t io n  o f io d in e . The p h arm aco k in e tic  p a ra m e te rs  g en e ra ted  
f o r  h y p e r th y ro id  and eu th y ro id  p a t i e n ts  gave no ev idence  o f  any 
v a r ia t io n  o f drug  h an d lin g  w ith  th y ro id  s t a tu s .
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CHAPTEF 6  
INTRATHYROIDAL METHIMAZOLE LEVELS
6,1 INTRODUCTION
An im p o rta n t a s p e c t  o f th e  pharm acology of a n t i th y r o id  d ru g s  i s  
t h e i r  c o n c e n tra tio n  by th e  th y ro id  g lan d . The accum ulation  o f 
m ethim azole by i t s  t a r g e t  o rgan  e n a b le s  m ain tenance o f an e f f e c t iv e  
c o n c e n tra tio n  a t  th e  s i t e  o f a c tio n  w ith  a minimum e x tr a th y r o id a l  
e f f e c t .
Some endogenous s u b s ta n c e s  a re  t r a n s p o r te d  a c ro s s  membranes a g a in s t  
t h e i r  c o n c e n tra tio n  g ra d ie n ts  o r a g a in s t  a g r a d ie n t  o f e l e c t r i c a l  
p o te n t ia l .  M etabo lic  energy  i s  n e c e s s a ry  to  d r iv e  such movements and 
th e  p ro c e s s  i s  known a s  a c t iv e  t r a n s p o r t .  A ctive  t r a n s p o r t  m echanism s 
a ls o  make use o f c a r r i e r  m olecu les. Exam ples o f a c t iv e  t r a n s p o r t  
m echanism s in c lu d e  th o se  invo lved  in  th e  s e c re t io n  o f H+ in to  g a s t r i c  
ju ic e  and u r in e  o f th e  k idney  tu b u le s , and th e  s e q u e s tra t io n  o f io d in e  by 
c e l l s  o f th e  th y ro id  g land .
A few d ru g s  t h a t  a re  ch em ica lly  r e la te d  to  n u t r i e n ts  a re  ab so rb ed  by 
a c t iv e  t r a n s p o r t  m echanism s e.g . m ethyldopa and « -a m in o p e n ic i l l in s  a re  
a c t iv e ly  ab so rb ed  from  th e  g a s t r o in t e s t i n a l  t r a c t ,  ch lo rp rom az ine  i s  
c o n c e n tra te d  in  th e  b ra in  and some p e n ic i l l in s  a re  a c t iv e ly  s e c re te d  
a c ro s s  th e  p rox im al tu b u le  o f th e  k idney .
The th y ro id a l  accum ulation  o f r a d io a c t iv e  m ethim azole h a s  been 
s tu d ie d  fo llo w in g  o r a l  d o se s  o f 35S-m eth im azole and ca rb im azo le  
( M archant e t  a l . ,  1972; L azarus e t  a l . ,  1975 ) and a ls o  by a g as  
c h ro m a to g rap h ic -m ass  s p e c tro m e tr ic  method ( Ja n sso n  e t  a l . ,  1983 ) 
fo llo w in g  ca rb im azo le  a d m in is t ra t io n . The r e s u l t s  o f th e s e  s tu d ie s  in
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te rm s  o f th e  th y ro id /p la sm a  c o n c e n tra tio n  r a t i o s ,  a re  sum m arised in  
Table 6 .1 .
The two r a d io a c t iv i ty  s tu d ie s  showed c o n s id e ra b le  agreem ent w ith , in  
m ost c a se s , a low th y ro id /p la sm a  r a t i o  be in g  found. However th e  GC-MS 
m ethod, which shou ld  g ive  a more a c c u ra te  a sse ssm e n t o f m ethim azole 
le v e ls ,  showed more pronounced in t r a th y r o id a l  accum ulation . A lso, th e  
r a t i o  in c re a se d  w ith  in c re a s in g  tim e in te r v a l  from th e  l a s t  dose. The 
GC-MS method g iv e s  th e  f i r s t  d a ta  on d i r e c t  m easurem ent o f 
i n t r a th y r o id a l  c o n c e n tra t io n s  o f m ethim azole and th e s e , a long  w ith  th e  
co rre sp o n d in g  p lasm a c o n c e n tra t io n s , a re  g iven  in  T able 6 .2 . The mean 
in t r a th y r o id a l  drug  c o n c e n tra t io n s  d id  n o t d i f f e r  betw een th e  group 
re c e iv in g  th e  f in a l  dose 3 -6  h o u rs  p re o p e ra tiv e ly  and th e  group ta k in g  
th e  f in a l  dose 17-20 hou rs b e fo re  e x c is io n . T h is  in d ic a te s  t h a t  th e  
e lim in a tio n  tim e  f o r  m ethim azole in  th e  th y ro id  g lan d  i s  much lo n g er 
th a n  in  b lood .
The e s tim a tio n  o f th y ro id  b in d in g  o f io d id e  from  th e  up take  o f 
r a d io io d in e  and i t s  d isc h a rg e  by p e rc h lo ra te  o r  o th e r  io n s  p ro v id e s  a 
m easure o f th e  th y ro id a l  e f f e c t  o f m ethim azole. I t  h a s  been shown 
( W artosky and In g b ar, 1971; B arnes and B ledsoe, 1972 ) t h a t ,  depending 
on dose, m ethim azole i s  e f f e c t iv e  f o r  12 h ou rs  o r more a s  an in h ib i to r  
of io d id e  o r g a n i f ic a t io n  w ith in  th e  human th y ro id  g lan d . However, th e  
r e s u l t s  o f more re c e n t  in h ib i t io n  s tu d ie s  fo llo w in g  o r a l  d o ses  o f 35S- 
m ethim azole and carb im azo le  a re  c o n tr a d ic to ry .  These r e s u l t s  a re  
sum m arised in  Table 6.3 . The f i r s t  s tu d y  < L azarus e t  a l . ,  1975 ) i s  in  








































Table 6.2 Plasma and intrathyroidal concentrations of methimazole following
administration of lOmg of carbimazole.
Patien t Tiae a lte r in trathyroidal concentration Plasaa concentration of
no. KKI Dose <b> of KKI (ng/g> KKI (ng/al)










Kean +/- S.D. 518 +/- 90 102 * /-  5










Kean 4/ -  S.D. 727 4 / -  157 16 4 /-  3
Jansson et al., 1983
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carb im azo le  o r m ethim azole, in h ib i t io n  o f io d id e  o r g a n i f ic a t io n  was 
g r e a te r  th a n  90% up to  8 hours a f t e r  a d m in is t ra t io n . However, in  a 
s tu d y  u s in g  th e  p e rc h lo ra te  d isc h a rg e  t e s t  ( McCruden e t  a l . ,  1985 ), 
in h ib i t io n  o f io d id e  o r g a n if ic a t io n  by m ethim azole and carb im azo le  was 
shown to  have d im in ish ed  betw een 5 and 12 hours a f t e r  a d m in is t ra t io n . 
F u r th e r  in v e s t ig a t io n s  by th e  same a u th o rs  over an ex tended  p e rio d  of up 
to  25 hou rs < HcCruden e t  a l . ,  1987) se rv e d  to  confirm  th e  p rev io u s  
r e s u l t s .  Thus, th e r e  rem ains a d i s p a r i t y  between in t r a th y r o id a l  
m ethim azole c o n c e n tra t io n s  and i t s  d u ra tio n  o f e f f e c t  a s  m easured by 
p e rc h lo ra te  d isc h a rg e .
The aim o f t h i s  p re s e n t  s tu d y  i s  to  in v e s t ig a te  i n t r a th y r o id a l  
m ethim azole c o n c e n tra t io n s  in  e u th y ro id  p a t i e n ts  w ith  G raves d is e a s e  who 
a re  undergo ing  s u b to ta l  th y ro id ec to m y . T hy ro id /p lasm a  c o n c e n tra t io n s  a t  
two d i f f e r e n t  d o se s  and a t  d i f f e r e n t  tim e  in te r v a l s  w il l  be compared. 
Exam ination  o f th e  d if f e re n c e s  in  in t r a th y r o id a l  c o n c e n tra t io n s  between 
th e  two d o ses  w il l  be com pared to  g iv e  in s ig h t  in to  th e  e x is te n c e  o f an 
a c t iv e  t r a n s p o r t  p ro c e s s . F in a lly , p e rc h lo ra te  d isc h a rg e  d a ta  from th e se  
p a t i e n ts  w i l l  be com pared w ith  th e  in t r a th y r o id a l  c o n c e n tra t io n s  to  
in v e s t ig a te  f u r th e r  t h i s  a p p a re n t d isc re p a n c y .
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6.2 EXPERIMENTAL
Six  fem ale p a t i e n ts  p re v io u s ly  s tu d ie d  in  C hap ter 5 < S u b jec t numbers 
1, 3, 4, 7, 9 and 11 ) w ith  h y p e rth y ro id ism  due to  d i f fu s e  to x ic  g o i te r ,  
underw ent s u b to ta l  th y ro id ec to m y . A ll p a t i e n ts  were t r e a te d  w ith  
m ethim azole in  one o f two o ra l  reg im ens : 5mg b .d . ( s u b je c ts  1,3 and 
4 ) o r 20mg b.d. ( s u b je c ts  7,9 and 11 ) f o r  a t  l e a s t  two m onths b e fo re  
su rg e ry . A ll p a t i e n ts  were e u th y ro id , based  on th e  c l i n ic a l  
in v e s t ig a t io n s  g iv en  in  Table 6 .4 , a t  th e  tim e of s u b to ta l  th y ro id ec to m y . 
Three p a t i e n ts  were g iven  th e  l a s t  dose  o f m ethim azole a t  a nom inal tim e 
o f 25 hours b e fo re  su rg e ry ; two a t  13 h ou rs  b e fo re  su rg e ry  and one 
p a t i e n t  a t  5 h ou rs  b e fo re  su rg e ry . A ll p a t i e n ts  were h o s p i ta l i s e d  fo r  a t  
l e a s t  24 h ou rs  b e fo re  su rg e ry . The l a s t  d o ses  o f m ethim azole were g iven  
under s u p e rv is io n .
At l e a s t  2g o f th y ro id  g lan d  t i s s u e  were o b ta in ed  from each sam pling  
s i t e  o f th e  g lan d  a t  o p e ra tio n . In each p a t ie n t ,  a  t i s s u e  sam ple was 
o b ta in e d  from  each  lobe  o f th e  g lan d . Blood sam ples were tak e n  a t  th e  
tim e  o f g lan d  e x c is io n  and c o lle c te d  in to  EDTA tu b e s . A fte r  
c e n tr ifu g a t io n , th e  r e s u l ta n t  p lasm a was s to re d , w ith  th e  th y ro id  g land  
t i s s u e ,  a t  -2 0 °C , in  th e  G ard ine r I n s t i tu t e ,  D epartm ent o f M edicine, The 
W estern In firm a ry . A fte r  t r a n s p o r ta t io n  to  th e  D epartm ent o f F o re n s ic  
S cience  and M edicine, Glasgow U n iv e rs ity ; th e  sam ples rem ained  s to re d  a t  
-20°C  u n t i l  a ssa y e d . The p lasm a and th y ro id  t i s s u e  sam ples were 
a ssa y e d  fo r  m ethim azole u s in g  th e  m ethods d e sc r ib e d  in  s e c t io n s  3.5.3.1 
















































































































































































































The t a b l e t s  and c l i n ic a l  d ia g n o s t ic  t e s t s  were su p p lie d  by th e  
m an u fac tu re rs  l i s t e d  in  s e c t io n  5 .2 .1 .
Less th a n  two weeks b e fo re  su rg e ry , and a f t e r  th e  p a t i e n ts  had 
reach ed  e u th y ro id ism , a  p e rc h lo ra te  d isc h a rg e  t e s t  was c a r r ie d  out. The
t e s t  was c a r r ie d  out a s  d e sc r ib e d  in  s e c t io n  5 .2 .1 . Each p a t i e n t  
underw ent th e  t e s t  a t  th e  same tim e  in te r v a l  from  th e  l a s t  m ethim azole 
dose t h a t  th e  th y ro id  e x c is io n  would occur.
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6.3. RESULTS
T y p ical chrom atogram s fo r  m ethim azole e x tra c te d  from  th y ro id  t i s s u e  
from p a t i e n ts  on th e  5mg and 20mg dosage regim en a re  g iv en  in  F ig u res
6.1 and 6 .2 , r e s p e c t iv e ly .  Both chrom atogram s were from sam p les  taken  
13 hou rs a f t e r  th e  l a s t  m ethim azole dose. The p lasm a c o n c e n tra tio n  tim e 
v a lu e s  a long  w ith  th e  th y ro id  t i s s u e  c o n c e n tra tio n  tim e  v a lu e s  ( fo r  
b o th  lo b es  ) a re  p re se n te d  in  Table 6 .5 . The plasm a to  mean th y ro id  
c o n c e n tra tio n  r a t i o s ,  which in c re a se d  w ith  tim e, a re  a ls o  g iven  in  t h i s  
ta b le .  A g ra p h ic a l  d e s c r ip t io n  o f r a t i o  v e rsu s  tim e i s  g iv en  in  F igure  
6 .3.
In th e  5mg dosage group, th e  p a t ie n t  who was o p e ra ted  on 5h a f t e r  
th e  l a s t  dose o f m ethim azole d id  n o t d i f f e r  in  mean in t r a th y r o id a l  
m ethim azole c o n c e n tra t io n s  from  th e  p a t i e n t  o p e ra ted  on 13h a f t e r  th e  
l a s t  dose o f m ethim azole. The p a t i e n t  undergo ing  th y ro id ec to m y  25h a f t e r  
th e  l a s t  dose o f m ethim azole showed a s ig n i f i c a n t  in c re a s e  in  mean 
in t r a th y r o id a l  m ethim azole c o n c e n tra t io n s  when com pared w ith  th e  5h and 
13h p a t ie n ts .  In c o n t r a s t  , th e  plasm a c o n c e n tra t io n s  showed a d e f in i te  
d e c re a se  in  le v e ls  w ith  in c re a s in g  tim e  in te r v a l .
In th e  20mg dosage group th e  p a t ie n t ,  o p e ra ted  on 13h a f t e r  th e  l a s t  
dose o f m ethim azole d id  n o t d i f f e r  s ig n i f ic a n t ly  in  mean in t r a th y r o id a l  
m ethim azole c o n c e n tra tio n  from th e  two p a t i e n ts  who were nom inally  
o p e ra ted  on 24h a f t e r  th e  l a s t  dose o f m ethim azole. In t h i s  c a se  th e  
p lasm a c o n c e n tra t io n s  d id  n o t d e c re a se  a s  th e  tim e in te r v a l  in c re ase d  
and in  f a c t  th e  mean c o n c e n tra tio n  a t  24h was g r e a te r  th a n  th e  value
228
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F ig u re  6.1 T y p ic a l chrom atogram  o f m ethim azole in  th y ro id  t i s s u e  
fo llo w in g  o r a l  a d m in is t r a t io n  o f 5mg o f m ethim azole.
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F ig u re  6 .2  T y p ica l chrom atogram  o f m ethim azole in  th y ro id  t i s s u e  
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Figure 6.3 Thyroid/plasma concentration ra tio  versus time, 
follow ing the 5mg dose
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c a lc u la te d  fo r  th e  13h sam ple. However th e re  was a wide in d iv id u a l 
v a r ia t io n  betw een th e  two 24h sam ples (cv=52%).
A com parison  o f th e  mean in t r a th y r o id a l  c o n c e n tra t io n s  a t  th e  same 
dose in te r v a l  showed th a t  th e  5mg p a t i e n ts  gave s ig n i f i c a n t ly  h ig h e r  
v a lu es  th a n  th e  20mg p a t i e n ts  i .e . 675 + /-  24ng/g  com pared to  202+ /- 
46ng/g  a f t e r  24 h ou rs  and 467 + /-  35ng /g  com pared to  298 + /-  9ng/g  
a f t e r  13 h o u rs , r e s p e c t iv e ly .
The v a r ia t io n  betw een two specim ens from  s e p a ra te  lo b es  in  th e  
p a t i e n ts  was 11%. T h is  in d ic a te d  a homogenous t i s s u e  c o n c e n tra tio n  o f 
m ethim azole. No c o r r e la t io n  betw een in t r a th y r o id a l  and p lasm a 
c o n c e n tra t io n s  o f m ethim azole was found. No c o r r e la t io n  was found 
betw een p re tre a tm e n t p lasm a T3 v a lu es  and in t r a th y r o id a l  m ethim azole 
c o n c e n t ra t io n s .
The sodium p e rc h lo ra te  d isc h a rg e  r e s u l t s  f o r  each p a t i e n t  ( excep t 
p a t ie n t  no. 11 ) a re  p re se n te d  in  T able 6.6 . Fo llow ing  th e  20mg o ra l  
a d m in is t ra t io n , th e  p e rc h lo ra te  d isc h a rg e  r e s u l t s  fo r  th e  two 24 hour 
p a t i e n ts  , showed a wide in d iv id u a l v a r ia t io n  ( c.v.=86% ). T h is  
in te r in d iv id u a l  v a r ia t io n  was in  agreem ent w ith  th e  p lasm a 
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6.4 DISCUSSION
T his s tu d y  p ro v id e s  th e  f i r s t  com bined d a ta  on d i r e c t  m easurem ent of 
in t r a th y r o id a l  c o n c e n tra t io n s  o f m ethim azole to g e th e r  w ith  p e rc e n ta g e  
in h ib i t io n  o f io d id e  o r g a n i f ic a t io n  in  th e  same in d iv id u a ls .
The in te r in d iv id u a l  d i f f e re n c e s  in  in t r a th y r o id a l  c o n c e n tra t io n s  in  
th e  p re s e n t  s tu d y  showed c o n s id e ra b le  v a r ia t io n  which was p o s s ib ly  
r e la te d  to  th e  in t r a th y r o id a l  io d in e  c o n te n t, a s  t h i s  h as  been shown to  
m arkedly  a f f e c t  m ethim azole accum ula tion  in  th e  r a t  ( M archant e t  a l . ,  
1972 ) and in  a model system  ( E n g le r e t  a l . ,  1983 ).
As d isc u s s e d  in  s e c t io n  6 .1 , m ethim azole i s  known to  be a c t iv e ly  
c o n c e n tra te d  in  th e  th y ro id  g lan d  and th e  r e s u l t s  o f t h i s  s tu d y  su p p o rt 
t h i s  co n cep t, in  s e v e ra l  ways. F i r s t l y ,  th e  in t r a th y r o id a l  
c o n c e n tra t io n s  do n o t show any l i n e a r i t y  w ith  dose, g iv in g  in s te a d  
h ig h e r  c o n c e n tra t io n s  fo r  th e  low er dosage group. A lso, th e  r e s u l t s  a re  
w ith in  th e  same ran g e  a s  th o se  quoted  in  Table 6 .2 . (Jan sso n  e t  a l . ,  
1983b) which were m easured a f t e r  o r a l  a d m in is t r a t io n  o f lOmg of 
m ethim azole. T h is  len d s  w eigh t to  th e  n o tio n  o f a  s a tu r a b le  th y ro id a l  
up take  m echanism . The in t r a th y r o id a l  c o n c e n tra t io n s  betw een dose  groups 
a t  th e  24 hour t im e p o in t were com pared w ith  th e  c o rre sp o n d in g  plasm a 
c o n c e n tra t io n s , in  th e  form  o f th y ro id /p la sm a  c o n c e n tra t io n  r a t i o s .  At 
th e  low dose , th e  th y ro id /p la sm a  r a t i o  i s  h ig h , r e f l e c t in g  a c t iv e  
t r a n s p o r t ,  b u t a t  th e  h ig h e r  dose , t h i s  r a t i o  f a l l s  when th e  t r a n s p o r t  
sy stem  i s  s a tu r a te d  by h ig h  p lasm a c o n c e n tra t io n s .
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Exam ples o f o th e r  d ru g s  which a re  invo lved  in  an a c t iv e  t r a n s p o r t  
mechanism a re  g iven  in  s e c t io n  6 .1 . In th e  c a se  o f m ethim azole, i t  i s  
p a r t i c u la r ly  f o r tu i to u s  t h a t  th e  s i t e  o f a c t iv e  t r a n s p o r t  and o f a c tio n  
a re  one and th e  same. The blood flow  to  th e  th y ro id  g lan d  i s  h ig h e r  
th an  th a t  to  m ost o th e r  t i s s u e s  o f th e  body th u s  m ethim azole i s  
c o n c e n tra te d  by th e  th y ro id  v e ry  s h o r t ly  a f t e r  drug  a d m in is tra t io n .
The t r a n s p o r t  system  used by m ethim azole h as  n o t been id e n t if ie d .
The f o l l i c l e  c e l l s  o f th e  th y ro id  g lan d  ta k e  up io d id e  th ro u g h  th e  
a c t i v i t y  o f an en erg y -d ep en d en t pump w ith in  th e  membrane. However, 
m ethim azole b lo ck s  th e  in c o rp o ra t io n  o f io d id e  in to  p ro te in  bu t n o t th e  
io d id e  pump and th e re fo re  i s  n o t in  c o m p e titio n , u n lik e  p e rc h lo ra te  io n s , 
f o r  t h i s  p a r t i c u la r  t r a n s p o r t  sy stem .
V arious m ethods which have been used fo r  id e n t ify in g  t r a n s p o r t  
sy s te m s  m igh t be employed to  in v e s t ig a te  th e  mechanism o f m ethim azole 
c o n c e n tra tio n . In some sy s te m s, t r a n s p o r t  h as  been shown to  be 
in h ib i te d  by compounds t h a t  r e a c t  w ith  p r o te in s ,  such  a s  
p h e n y liso th io c y a n a te . Some d ru g s  a c t  a s  i n h ib i to r s  o f t r a n s p o r t  sy s te m s  
by com peting fo r  c a r r i e r  s i t e s  e.g . some p e n ic i l l in s  a re  r a p id ly  
e lim in a te d  from  th e  body by an a c t iv e  t r a n s p o r t  p ro c e s s  fo r  weak a c id s  
in  th e  k idney  tu b u le s . A s y n th e t ic  weak a c id , p ro b en ec id , com bines w ith  
th e  same c a r r i e r  and so  com petes w ith  p e n ic i l l in  and a s  a r e s u l t ,  b lood 
le v e ls  o f p e n ic i l l in  a re  m ain ta in ed  lo n g er. F in a lly , m e tab o lic  energy  i s  
n e c e ssa ry  to  d r iv e  any movement a c ro s s  c o n c e n tra tio n  g r a d ie n ts ,  th u s  
d ru g s  t h a t  b lock  p ro d u c tio n  o f ATP (e.g. c a rd ia c  g ly c o s id e s  ) w il l  
i n h ib i t  a c t iv e  t r a n s p o r t .  However, t h i s  i s  n o t a  good ch o ice  fo r  th e
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i n v e s t ig a t io n  o f m ethim azole up take  a s  t h i s  would a ls o  i n h ib i t  th e  
io d id e  pump and co n seq u en tly  a f f e c t  th y ro id  hormone p ro d u c tio n .
The mean in t r a th y r o id a l  c o n c e n tra t io n s  d id  n o t v a ry  < r e g a r d le s s  of 
dose ) betw een th e  group re c e iv in g  th e  f in a l  dose  5 h o u rs  ( o r  13 
h ou rs  ) p re o p e ra tiv e ly  and th e  group ta k in g  th e  f in a l  dose  24 hou rs 
b e fo re  e x c is io n . These r e s u l t s  a re  in  agreem ent w ith  th e  p rev io u s  s tu d y  
on in t r a th y r o id a l  le v e ls  ( Ja n sso n  e t  a l . ,  1 9 8 3 b ) and s t r o n g ly  in d ic a te  
t h a t  th e  e lim in a tio n  tim e fo r  m ethim azole in  th e  th y ro id  g lan d  i s  much 
lo n g er th a n  in  b lood . Thus, th e  d a ta  from  th e  d i r e c t  m easurem ent of 
i n t r a th y r o id a l  le v e ls  o f m ethim azole a re  in  agreem ent w ith  p rev io u s  
s tu d ie s  ( B arnes and B ledsoe, 1972; Bouma and Kammer, 1980; Ja n sso n  e t  
a l.,1 9 8 3  ) and in d ic a te  t h a t  a much lo n g e r a n t i th y r o id  e f f e c t  could  be 
expected  th a n  t h a t  su g g ested  by th e  d e c lin e  in  b lood  c o n c e n tra t io n s .
However, th e  r e s u l t s  fo r  th e  p e rc e n ta g e  in h ib i t io n  o f io d id e  
o r g a n i f ic a t io n  a p p e a rs  to  be in  d i r e c t  c o n f l i c t  w ith  th e  i n t r a th y r o id a l  
le v e ls  g iv in g  v i r t u a l l y  no in h ib i t io n  a f t e r  24 h ou rs  on th e  h ig h  dose 
and none a t  a l l  fo llo w in g  th e  low dose . V arious re a s o n s  f o r  t h i s  
a p p a re n t d isc re p a n c y  betw een th e  two s tu d ie s  ( McCruden e t . ,  1987; 
Ja n sso n  e t  a l . ,  1983 )have been su g g e s te d  by one o f th e  a u th o rs  ( 
McCruden e t  a l . ,  1987). I n t r a th y r o id a l  io d in e  c o n te n t i s  th o u g h t to  have 
an a f f e c t  on th e  e x te n t  o f m ethim azole m etabolism  ( Taurog e t  a l . ,  1976; 
E ng le r e t  a l . ,  1983). I f  th e  p a t i e n ts  undergo ing  th e  p e rc h lo ra te  
d isc h a rg e  t e s t  had a h ig h e r  th y ro id a l  c o n c e n tra t io n  o f in o rg a n ic  io d id e  
th a n  th o s e  in  th e  o th e r  s tu d y , th e y  would n o t o x id is e  m ethim azole and 
th u s  s h o r te n  i t s  d u ra tio n  tim e. However, t h i s  th e o ry  h a s  been d isp ro v en
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by th e  p re s e n t  r e s u l t s  which were m easured in  th e  same in d iv id u a ls .  
A nother th e o ry  ( McCruden e t  a l . ,  1987 ) i s  t h a t  m ethim azole m ight have 
a g r e a te r  d u ra tio n  o f e f f e c t  on th e  co u p lin g  of io d o ty ro s in e s  th a n  th e  
in h ib i t io n  o f o rg a n i f ic a t io n  in  which c a se , th e  p e rc h lo ra te  d isc h a rg e  
t e s t  would n o t g iv e  a t ru e  e s t im a te  o f d u ra tio n  o f a c tio n . M ethimazole 
does i n h ib i t  th e  fo rm a tio n  of th y ro x in e  in  c o n c e n tra t io n s  low er th an  
th o se  which d e c re a se  th e  io d in a tio n  o f ty ro s in e ;  i t  th e re fo re  seem s 
l ik e ly  t h a t  sm a ll d o ses  o f m ethim azole have a s e le c t iv e  e f f e c t  on th e  
coup ling  r e a c tio n . However, t h i s  a c tio n  has  been tak en  a s  ev idence  th a t  
th y ro id  p e ro x id a se  may be invo lved  in  th e  cou p lin g  re a c t io n  a s  w ell a s  
in  th e  fo rm a tio n  o f io d o ty ro s in e s . I t  i s  th o u g h t t h a t  th e  coup ling  
re a c tio n  i s  f a c i l i t a t e d  by th e  s tu c tu re  o f th y ro g lo b u lin , and 
a u to ra d io g ra p h ic  ev idence  s u g g e s ts  t h a t  io d in a tio n  o f th y ro g lo b u lin  
ta k e s  p lac e  a t  th e  a p ic a l  c e l l  membrane, in  th e  reg io n  where b iochem ical 
a n a ly s e s  have su g g e ste d  t h a t  th e  th y ro id  p e ro x id a se  i s  bound. These 
f a c t s ,  tak en  to g e th e r  make i t  d i f f i c u l t  to  im agine t h a t  a  change in  
d i s t r ib u t io n  o f m ethim azole would n o t a f f e c t  bo th  s ta g e s  o f hormone 
p ro d u c tio n . A u to rad io g rap h ic  te c h n iq u e s  fo llo w in g  ra d io la b e l le d  
m ethim azole need to  be u n dertaken  to  c l a r i f y  t h i s  p a r t i c u l a r  a re a  o f 
s tu d y .
T h is  s tu d y  h a s  confirm ed  th e  a p p a re n t d i s p a r i t y  betw een 
in t r a th y r o id a l  m ethim azole c o n c e n tra t io n s  and t h e i r  d u ra tio n  o f e f f e c t  
a s  m easured by th e  p e rc h lo ra te  d isc h a rg e  t e s t .  I t  i s  l ik e ly  t h a t  th e  
p e rc h lo ra te  d isc h a rg e  t e s t  u n d e re s tim a te s  th e  d u ra tio n  o f a c tio n  o f 
m ethim azole a s  i t  does n o t gauge th e  e x te n t  o f in h ib i t io n  o f co u p lin g  o f
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io d o ty ro s in e s . However, u n t i l  some m ethod i s  developed  which can 
m easure th e  cou p lin g  e f f e c t  o r a u to ra d io g ra p h y  can  g iv e  ev idence  o f th e  
d i s t r ib u t io n  o f m ethim azole to  d i f f e r e n t  s i t e s  w ith in  th e  th y ro id  g land , 
th e  i n t r a th y r o id a l  c o n c e n tra t io n s  o f m ethim azole a t  24 h o u rs  a re  n o t 
s u f f i c i e n t  ev idence  fo r  th e  in s t i g a t io n  o f a once d a ily  regim en.
In co n c lu s io n , th e  i n t r a th y r o id a l  c o n c e n tra t io n s  have shown a la rg e  
in te r in d iv id u a l  v a r ia t io n  which i s  p o s s ib ly  r e la te d  to  in d iv id u a l 
v a r ia t io n  in  in t r a th y r o id a l  io d in e  c o n te n t. The r e s u l t s  i .e .  non- 
l in e a r i ty  w ith  dose , an in c re a s e  in  th y ro id /p la sm a  c o n c e n tra tio n  r a t i o  
w ith  tim e and i t s  sub seq u en t d e c re a se  w ith  in c re a s in g  dose , su p p o rt th e  
concep t o f a c t iv e  t r a n s p o r t  o f m ethim aozle in  th e  th y ro id  g lan d . The 
m ethim azole th y ro id a l  c o n c e n tra tio n  le v e ls  do n o t c o r r e la te  w ith  i t s  
e f f e c t  on th e  in h ib i t io n  o f th e  o r g a n i f ic a t io n  of io d in e  and i t  i s  
p o s tu la te d  t h a t  a t r u e r  c o r r e la t io n  m igh t be found w ith  i t s  e f f e c t  on 
th e  in h ib i t io n  o f th e  cou p lin g  p ro c e s s .
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CHAPTER 7 
METHIMAZOLE IN BREAST MILK
24JD
7.1 INTRODUCTION
As th e  b e n e f i ts  of b r e a s t - f e e d in g  have become more w idely  rec o g n ised , 
more and more women have chosen  to  b r e a s t - f e e d  t h e i r  newborn in fa n ts .  
T h erefo re , s tu d ie s  c o n cern in g  th e  p h a rm a co k in e tic s  o f drug  e x c re tio n  
in to  b r e a s t  m ilk  and p r e d ic t iv e  m odels e s t im a tin g  drug  c o n c e n tra tio n  in  
m ilk  a re  o f grow ing i n t e r e s t  and im portance  to  th e  c l in ic i a n .
S ev e ra l s tu d ie s  have been u n d ertak en  to  in v e s t ig a te  w hether th e  
t re a tm e n t o f l a c ta t in g  m other w ith  m ethim azole cou ld  have an a d v e rse  
e f f e c t  on th e  i n f a n t 's  th y ro id  fu n c tio n . The r e s u l t s  o f th e s e  s tu d ie s  
a re  l i s t e d  in  Table 7.1.
As was d ic u sse d  in  C hap ter one ( s e c tio n  1 .3 .3 .3 ), s in c e  m ethim azole i s  
a n o n -p ro te in -b o u n d  drug  w ith  a h igh  l ip id  s o lu b i l i t y  and i s  u n io n ised  
in  a  h y d ro p h il ic  env irom en t, an a lm o s t equa l c o n c e n tra t io n  o f 
m ethim azole in  p lasm a and m ilk  could  be a n t ic ip a te d .
A ll s tu d ie s  a re  in  re a so n a b le  agreem ent t h a t  th e  se rum /m ilk  r a t i o  i s  
c lo s e  to  u n i ty  a s  p re d ic te d  from  p h a rm aco k in e tic  c o n s id e ra t io n s .
The dose o f m ethim azole which would be g iven  to  a h y p e r th y ro id  
in f a n t  i s  n o t d i f f e r e n t  from th e  a d u lt  dose  i f  w eigh t r e l a t i o n s  a re  
c o n s id e red  (Howard and H ayles, 1978). T h e re fo re , c o n v e rs io n  o f th e  dose 
re c e iv e d  th ro u g h  m ilk  to  i t s  e q u iv a le n t amount in  an a d u lt  g iv e s  a  more 
r e p r e s e n ta t iv e  p ic tu r e  o f th e  p o s s ib le  e f f e c t  o f t h a t  dose  in  th e  in fa n t .  
For t h i s  re a so n , T able 7.1 g iv e s  a  com parison  o f th e  s tu d i e s ' f in d in g s  in  
te rm s  o f w eigh t r e la te d  p e rc e n ta g e  dose  and e q u iv a le n t do se  f o r  a  70kg 
man.
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Table 7.1 Studies o f  the d istr ib u tion  o f methimazole a fter  adm inistration  












Low e t  a l 1079 - lOag (1) 0.94 9.4
0.88 to  0.58
Tegler 1980 HT 2.5ag (2) 0.18-0.4 7-16 1.16+-0.12
Johanson 1982 £0 «40ag (1) 0.88-1452 2.2-3.8 0.98+-0.13
Cooper 1984 EU 40ag 12 2.6-3.5 1.03+-0.16
lo ta r ia n n l 1986 HT 10-20ag (3) 0.26-0.52 2.6 1.22+-0.16
<1> s in g le  o ra l dose * 40ag carblaazole* 24 .Sag ae th laazo le
<2> b.d. o ra l dose 
(3) da lly  dose
242
Both e a r ly  s tu d ie s  (Low e t  a l . ,  1979; T eg ler e t  a l . ,  1980) show a 
r e l a t i v e ly  h ig h  p e rc e n ta g e  dose in  th e  m ilk . The h ig h e r  p e rc e n ta g e  
o b ta in e d  by Low e t  a l .  cou ld  be due to  th e  a n a ly t ic a l  m ethod employed.
By u s in g  35S - la b e l le d  carb im azo le , any m e ta b o li te s  o f m ethim azole which 
c o n ta in ed  su lp h u r  would a ls o  be in c lu d ed  in  th e  f in a l  m easurem ent. In 
f a c t ,  r a d io a c t iv i t y  m easurem ents a re  n o t n o rm ally  s u i ta b le  fo r  
p h a rm aco k in e tic  a n a ly s i s  u n le s s  no m etabo lism  i s  d em o n stra ted .
High p e rc e n ta g e  v a lu e s , however, were a ls o  o b ta in e d  (T eg ler e t  a l . ,  
1980) in  a  l a t e r  s tu d y . From th e s e  v a lu e s , T eg ler p o s tu la te d  t h a t ,  
assum ing s im i la r  p h a rm a co k in e tic  r e l a t i o n s ,  th e  norm al th e ra p e u t ic  dose 
o f 5mg, fo u r  tim e s  a day, would g iv e  th e  c h i ld  up to  3mg o f m ethim azole 
d a i ly  in  th e  m ilk , which he view ed a s  a r i s k  to  th e  n e o n a te 's  th y ro id  
fu n c tio n .
A lthough Cooper e t  a l .  (1984) found a much reduced  p e rc e n ta g e  
e x c re tio n  s im i la r  to  th o se  o f Johansen  e t  a l .  (1982) and N o ta ria n n i e t  
a l .  (1986), he f e l t  t h a t  a t  t h i s  dosage le v e l  (40mg) th e  amount e x c re te d  
in  th e  m ilk  was a  s ig n i f i c a n t  r i s k  f o r  th e  s u c k lin g  in fa n t .
However such  c a lc u la t io n s  a re  f ra u g h t  w ith  d i f f i c u l t i e s .  I t  i s  
im p o ss ib le  to  m easure a c c u ra te ly  how much m ilk  th e  baby consum es. A lso 
th e  amount o f drug  a v a i la b le  w i l l  v a ry  w ith  th e  fee d in g  tim e  in  r e la t io n  
to  d o s in g  tim e  and th e  m ilk  co m p o sitio n  a t  t h a t  p a r t i c u l a r  s ta g e .  The 
complex n a tu re  o f drug  d o s in g  v ia  b r e a s t  m ilk  i s  sum m arised by a l i s t  
o f  f a c to r s  d e s c r ib e d  in  T able  7 .2 . For a c o n c lu s iv e  answ er to  t h i s  
problem  c l i n i c a l  s tu d ie s  on th e  su c k lin g  in f a n t  a re  n e c e s s a ry .
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Table 7.2 Factors a ffec tin g  excretion of a drug in breast milk and dose 
consumed by in fan t.
1 .Xaternal Pharmacology
a) Drug dose .frequency and route 
b>Clearance rate
c)Plasma protein binding
d)X etabolite p ro file
2 .Breast
a)Blood flow and pH
b)Yield capacity
c)lon  and other transport mechanisms
d)Drug metabolism (and reabsorption)
3.Milk
a)Composition (fat,protein  .water)
b)pH
4 .Infant
a)Suckling behaviour,including equal time on each breast
b)Amount consumed per feeding
c)Feeding in terv a ls  (regular or irregular)
d)Tlme o f feeding in re la tion  to  maternal dosing
5 .Drug
a)pKa (ion isation  a t plasma and milk pH)
b )S o lu b illty  ch a ra c te r is tic s  in fa t  and water




Of th e  s tu d ie s  a lre a d y  m entioned , on ly  N o to ria n n i e t  a l  (1986) used 
any o f th e  common c l in ic a l  in d ic e s  of th e  th y ro id  fu n c tio n  to  a s s e s s  th e  
e f f e c t  o f th e  m ethim azole le v e ls  on th e  c h ild . In th e  fo u r  in f a n t s  
s tu d ie d  a l l  had norm al th y ro id  fu n c tio n  ex c ep t one whose TSH le v e ls  
rem ained h igh  f o r  th e  f i r s t  10 days.
T h e re fo re , i t  i s  c le a r  t h a t  b e fo re  th e r e  i s  a r e v is io n  o f th e  dogma 
o f r e s t r i c t i n g  b r e a s t - f e e d in g  m o thers  to  p ro p y lth io u r a c i l  tre a tm e n t  in  
p re fe re n c e  to  m ethim azole, f u r th e r  p h a rm aco k in e tic  s tu d ie s  m ust be 
u n d e rta k e n .
In p a r t i c u l a r ,  th e r e  i s  a  need to  exam ine bo th  th e  im m ediate and long 
term  e f f e c t s  o f m a te rn a l m ethim azole t re a tm e n t  in  th e  su c k lin g  in f a n ts .  
T h is  m ust in c lu d e  th e  a n a ly s is  o f s e v e ra l  p lasm a o r  u r in e  sam ples from 
th e  in f a n t  in  o rd e r  to  s u b s ta n t ia te  p ro je c te d  exposure  from th e  b r e a s t  
m ilk  d o s in g .
The aim of t h i s  p r e s e n t  s tu d y  was to  p ro v id e  docum en tation  o f 
m ilk /p la sm a  r a t i o s  o f m ethim azole over a dose i n te r v a l ,  b o th  a t  th e  
b eg in n in g  and a t  th e  end o f fe e d s . Plasm a c o n c e n tra t io n s  o f m ethim azole 
in  th e  in f a n t  sh o u ld  re c o rd  t h e i r  le v e l  o f exposure  w hich can  be 
c o r r e la te d  to  th e  m ethim azole m ilk  c o n c e n tra t io n s .
M aternal th y ro id  s t a t u s  and m ain tenance  o f th e  e u th y ro id  s t a t e  in  th e  
b a b ie s  over t h e i r  p e rio d  o f exposu re  to  m ethim azole w i l l  be m on ito red  
u s in g  s ta n d a rd  chem ica l in d ic e s .
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7,2 EXPERIMENTAL
7 .2 .1 . D e sc rip tio n
A th re e  and a h a lf  month s tu d y  in to  th e  e f f e c t  o f t r e a tm e n t  o f a 
l a c ta t in g  m other w ith  ca rb im azo le  and i t s  e f f e c t  on h e r  b a b ie s  was 
und ertak en  a t  The C h ild re n s  H o sp ita l, Birmingham .
The m other developed  th y ro to x ic o s is  two m onths a f t e r  g iv in g  b i r t h  to  
h e a lth y  fem ale  tw in s . In th e  absence  o f any s p e c i f ic  ev idence  o f 
harm fu l e f f e c t s  o f ca rb im azo le  in  t h i s  s i tu a t io n ,  and a f t e r  d e ta i le d  
d is c u s s io n , sh e  was a d v ise d  to  co n tin u e  b r e a s t  fee d in g . She was s t a r t e d  
on ca rb im azo le  when th e  tw in s  were fo u r  and a h a l f  m onths o ld . The 
dose was i n i t i a l l y  30m g/day b u t was l a t e r  reduced  when sh e  became 
e u th y ro id .
7 .2 .2 . Sam ple C o lle c tio n
T ab les 7.3 and 7 .4 . g iv e  th e  tim in g  o f m a te rn a l and in f a n t  sam ples 
r e s p e c t iv e ly .  P lasm a sam ples were o b ta in e d  a s  soon a s  p r a c t ic a b le  a f t e r  
b lood c o l le c t io n  by c e n tr i f u g a t io n  <3000 rpm f o r  15 m in u tes) in  a  
r e f r ig e r a te d  c e n tr ifu g e . Each p lasm a and m ilk  sam ple was p lac e d  in  a 
la b e l le d  tu b e  and fro z e n  im m edia te ly  a t  -20°C .
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Table 7.3 Maternal sample collection data
DATE DOSE (24hr) FREQUEICY BLOOD XILK














29/10/85 30ag Ae previous 10.00 (B>
30/10/85 30»g As previous 9.00 <B>
31/10/85 30ag As previous 10.00 <B)




8/11/85 30ag 15ag b.d. 
10.00, 22.00
10.00
15/11/85 20ag lOag b.d. 
10.00, 22.00
1030
22/11/85 15sg 5ag 10.00 
10ag 22.00
11.00
0/12/85 75»g 22.00 1130
13/1/86 7 3 ag As previous 10.00 <B>
14/2/86 10«g As previous 12.00  a )
<B>« Before P««d 
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7.2.3. Transport of Samples
The sam ples were k e p t f ro z e n  by t r a n s p o r ta t io n  in  an ice -b o x  from 
The C h ild re n s  H o sp ita l, Birmingham to  th e  D epartm ent o f  F o re n s ic  
M edicine and S c ien ce , Glasgow; where th e y  were s to r e d  a t  -20°C  u n t i l  
a ssa y e d .
7 .2 .4 . A ssay o f sam ples
Plasm a and m ilk  sam ples were a ssa y e d  f o r  m ethim azole a s  d e sc r ib e d  in  
s e c t io n  3 .5 .3 .1  and s e c t io n  3 .5 .3 .3 . M ilk sam ples f o r  th e  c a l ib r a t io n  
s ta n d a rd s  were o b ta in e d  from  The Queen M other's  H o sp ita l, Glasgow from 
h e a lth y  l a c t a t i n g  m o thers  who were n o t on any p re s c r ib e d  d rug  regim en.
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7.3 Results
The c l i n i c a l  in d ic e s  fo r  th e  m other and th e  two tw in s  were m onitored  
th ro u g h o u t th e  s tu d y . The r e s u l t s  a re  sum m arised in  T ab les  7.5  to  7.7. 
Changes in  th y ro id  horm onal le v e ls  in  th e  m other were used  a s  a 
r e f l e c t io n  o f a need f o r  dosage reg im en a l t e r a t io n .  In th e  two in fa n ts ,  
th y ro id  s t im u la t in g  hormone, th y ro x in e  and t r i io d o th y ro n in e  rem ained 
norm al th ro u g h o u t th e  s tu d y . F ree  T4 and f re e  T3 were m easured on 
th re e  day s betw een weeks 8 and 16. The f re e  T3 v a lu e s  in  tw in  1 were 
9 .5 , 10.0 and 10.5 pm ol/1, a sm a ll in c re a s e  from  th e  norm al.
M ethim azole was a ssa y e d  in  th e  m o th e r 's  and h e r  b a b ie s  p lasm a and in  
b r e a s t  m ilk . Table 7.8 show s th e  m a te rn a l p lasm a c o n c e n tra t io n s  <ng/ml) 
th ro u g h o u t th e  s tu d y  and i t  i s  a p p a re n t t h a t  th e r e  i s  a  wide 
in t r a in d iv id u a l  v a r ia t io n  o f c o n c e n tra t io n  v a lu e s  a t  th e  same tim e p o in t. 
At 30 m inu tes a f t e r  th e  a d m in is t r a t io n  o f th e  f i r s t  dose  th e  p lasm a 
c o n c e n tra tio n  was 61ng/m l w hereas, a t  th e  same tim e  p o in t  f o r  th e  
second  dose  th e  va lue  was 27ng/m l. The p lasm a c o n c e n tra t io n  a t  th e  
same tim e p o in t  a t  d i f f e r e n t  d o sag es  a ls o  does n o t show any c o n s is te n t  
p a t te r n .  At 30 m in u tes , a f t e r  a dose o f lOmg t .d . ,  th e  p lasm a 
c o n c e n tra tio n  g iv e s  72ng/m l and , a t  a low er dose o f lOmg b .d ., th e  same 
tim e in te r v a l  g iv e s  a  va lu e  o f 173ng/m l. However, i t  i s  u n r e a l i s t i c  to  
a tte m p t com p ariso n s in  t h i s  way when th e  reg im en v a r ie s  so  much, 
r e s u l t in g  in  a  v a r ia t io n  in  th e  amount o f m ethim azole s t i l l  p re s e n t  a t  
th e  n ex t a d m in is t r a t io n . The c o n c e n tra t io n s  rem ain  w e ll w ith in  th e  
th e ra p e u t ic  ran g e  w ith  th e  h ig h e s t  v a lu e s  being  re c o rd e d  a t  th e  h ig h e s t
250













21 /10 /85 HT 161 11.2 <0.3 _
2 5 /10 /85 HT 141 5.2 <0.3 - -
1/11 /85 EU 85 1.0 <0.3 - -
8 /11 /85 EU 53 1.0 <0.3 - -
15/11 /35 EU 41 1.4 <0.3 - -
2 2 /1 1 /8 5 EU 47 1.2 0.8 - -
0 /1 2 /8 5 EU 94 7.1 <0.3 7.1 -
6 / 1 /8 6 EU 144 - <0.3 13.0 32.8
14 /2 /86 EU 143 - 0.3 6.5 24.8
25.1





TSHCau/1) Frae T3<paol/l) Fraa T4Cpaol/l>
21/10/85 113 3.4 2.8 - -
25/10/85 116 4.1 5.1 - -
1/11/85 140 2.1 4.0 - -
8/11/85 148 2.1 4.0 - -
15/11/85 139 3.0 4.7 - -
22/11/85 129 3.3 6.5 - -
9/12/85 125 10.5 2.5 105 -
6/1/86 130 - 5 5 9 5 155
14/2/86 124 - 4.4 10.0 18.0
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T3 (naol/1) TSH (mu/1) Frae T 3(pao l/l) Frae T4(pmol/l)
21/10/65 02 - 1.5 - -
25/10/85 116 5.2 4.1 - -
1/11/85 105 - 3.5 - -
8/11/85 125 1.0 3.5 - -
15/11/85 123 2.4 3.0 - -
22/11/85 133 2.6 3.5 - -
0/12/85 124 0.1 1.0 0.1 -
6/1/66 103 12.0 4.0 6 3 —
14/2/86 122 14.1 2.5 7.4
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Table 7.8 Maternal plasma concentrations of methimazole
Date D06€ Tlae In te rv a l F raa  Dose <hr) Concentration (ng /a l)
25/10/65 15ag 10.30 0.5 61
b.d. 12.00 2.0 114
13.00 3.0 106
14.30 4 5 174
1630 8 5 86
22.30 0 5 27
1/11/85 10ag 12.00 4 5 51
t.b .d . 15.00 7.5 56
15.00 0 5 72
8/11/85 15ag 10.00 12.0 50
b.d.
15/11/65 10ag 1030 0 5 173
b-d.
22/11/85 5ag 10.00 11.00 1.0 55
lOag 22.00
0/12/85 7 5  ag 1130 1 3 5 53
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dosage. F ig u re  7.1 shows th e  c o n c e n tra t io n  v e rs u s  tim e  cu rve  fo r  
m a te rn a l p lasm a over 8 h ou rs  a t  a dosage o f 15mg b.d . The v a lu e s  fo r  
tmax and Cmax a re  3 h ou rs  and 196ng/m l, r e s p e c t iv e ly .
M ethim azole was m easured in  b r e a s t  m ilk  on 10 o c c a s io n s  on 8 s tu d y  
d ay s. T able 7.9 show s th e  m ilk  c o n c e n tra tio n  le v e ls  (ng /m l). The mean 
c o n c e n tra tio n  was 43ng/m l (range 0 -9 2 n g /m l) . On th re e  o c c a s io n s  a m ilk 
c o l le c t io n  was ta k e n  a t  th e  same t im e p o in t  fo llo w in g  th e  same dosage 
regim en and th e s e  gave v a lu e s  o f 54, 92, 53ng/m l. F ig u re  7.2 shows a 
ty p ic a l  c h ro m a to g rap h ic  t r a c e  o f a  b r e a s t  m ilk  sam ple.
Plasm a m ethim azole was m easured on 9 o c c a s io n s  in  tw in  1 and on 7 
o c c a s io n s  in  tw in  2. Table 7.10 g iv e s  th e  p lasm a c o n c e n tra t io n s  found 
in  th e  tw in s . The mean p lasm a c o n c e n tra t io n  o f m ethim azole in  tw in  1 
was 45ng/m l (range  0 -105ng /m l) and t h a t  in  tw in  2 was 52ng/m l (range 
0 -1 5 6 n g /m l). The h ig h e s t  p lasm a c o n c e n tra tio n  were rec o rd e d  when th e  
m other was on th e  l a r g e s t  dose  o f ca rb im azo le  (30mg/day) a t  th e  h igh  
dose le v e l . On th e  f i r s t  sam ple day, p lasm a c o n c e n tra t io n s  in  each 
in f a n t  were com parab le . However, in  l a t e r  weeks th e s e  showed g r e a te r  
d e v ia tio n . T h is  can  be e x p la in ed  by th e  change in  d i e t  a s  th e  in f a n ts  
were in tro d u c ed  to  s o l id  fe e d in g , which would cause  v a r i a t io n  in  t h e i r  












F ig u re  7.1 M aternal p lasm a v e rs u s  tim e  p r o f i le .
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Table 7.9 Maternal milk concentrations of methimazole
Date Doee Saaple Tlae In te rv a l fro a  DoeeChr) Concentration
25/10/85 15ag 10.30 0.5 16
b.d. 13.30 3.5 38
26/10/85 10*g 10.00 2.5 54












14.00 6 J5 38
13/1/86 7J5ag 10.00 12.0 34
14/2/66 lOag 12.00 14.0 0
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Figure 7.2 Typical chromatogram of methimazole in human breast milk.
Table 7.10 Infant plasma concentrations of methimazole
















10.00 0/12 3 0
15/11/65 lOag
b.d
10.45 0.75 9 62
22/11/85 5ag 10.00 
lOag 22.00
10.50 0.75 55 33
6/12/65 7.5ag 11.20 13.33 0 0
14/2/66 lOag 11.30 1 3 5 CMHto*4
2S9
7.4 DISCUSSIOK
E x c re tio n  o f m ethim azole (or any f re e  u n io n ise d  d rug) in  b r e a s t  m ilk  
i s  exp ec ted  to  fo llow  th e  d i s p o s i t io n  model shown in  F ig u re  7,2. 
P h a rm aco k in e tic s  o p e ra t iv e  f o r  m ethim azole need to  be developed  so  t h a t  
th e  p a e d ia t r ic  consequences o f d o s in g  v ia  b r e a s t  m ilk  can be m inim ised .
By a n a ly s in g  in f a n t  p lasm a sam p les, in  co n ju n c tio n  w ith  m a te rn a l 
p lasm a and m ilk  sam p les , t h i s  s tu d y  i s  an a tte m p t to  v e r i f y  th e  
p h a rm aco k in e tic  p r e d ic t io n s  o f p re v io u s  s tu d ie s .
However, by i t ' s  v e ry  n a tu re , such  a s tu d y  in v o lv in g  su c k lin g  in f a n ts  
l im i t s  i t ' s  own c a lc u la t io n  o f p h a rm a co k in e tic  p a ra m e te rs . F i r s t l y ,  th e  
t o t a l  m ilk  volume can n o t be m easured and seco n d ly , because  o f th e  e th ic s  
inv o lv ed  in  f re q u e n t b lood  c o l le c t io n  from  in f a n ts .
However p a ra m e te rs  d e riv e d  from  m ilk  volum es and c o n c e n tra t io n s  have 
been c a lc u la te d  in  p re v io u s  s tu d ie s .  A lso, a lth o u g h  th e  in f a n t  p lasm a 
sam p ling  i s  incom ple te  and can n o t be used to  g e n e ra te  any 
p h a rm a co k in e tic  d a ta , th e  r e s u l t s  can  be used  to  look a t  t r e n d s  in  th e  
c o n te x t o f p r e s e n t  l i t e r a tu r e .
The dosage reg im en i s  c o n s ta n t ly  be in g  re a s s e s s e d  th ro u g h o u t th e  
s tu d y , u s in g  th y ro id  fu n c tio n  t e s t s ,  to  make s u re  t h a t  th e  dosage  i s  a s  
low a s  p o s s ib le  to  f i r s t l y  a ch iev e  and th e n  m a in ta in  e u th y ro id ism  in  th e  
m other. In t h i s  way, a s  l i t t l e  m ethim azole a s  p o s s ib le  w i l l  be p re s e n t  
in  th e  m ilk  and c o n seq u en tly  th e  tw in s .
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3 ■ breast milk
Rate constants 
k»*kei plasma
k* « rate constant for excretion 
with milk (k«t milk)
A th re e -c o m p a rtm e n t model f o r  d rug  e x c re tio n  in  b r e a s t  m ilk .
V ilson  e t  a l . f 1980
Although m a te rn a l blood sam ple c o l le c t io n  was s to p p e d  on th e  l a s t  
day o f b r e a s t  fe e d in g , e lim in a tio n  of th e  drug  cou ld  be a f fe c te d  a t  t h i s  
tim e  in  th e  tre a tm e n t. The lac k  o f n u rs in g  a llo w s accum ula tion  of m ilk 
and drug  in  th e  b r e a s t .  T h is  drug  i s  a v a i la b le  f o r  movement back in to  
th e  i n t e r s t i t i a l  com partm ent (F igu re  7 .3 ). As t h i s  movement from  th e  
i n t e r s t i t i a l  com partm ent to  th e  b lood  i s  presum ed h ig h e r  th a n  from  th e  
m ilk  in to  th e  i n t e r s t i t i a l  com partm ent; k 32 would become th e  r a t e -  
l im it in g  s te p  f o r  drug  e lim in a tio n  from  p lasm a.
F requen t m easurem ents o f drug  c o n c e n tra t io n  in  m ilk  and p lasm a can 
be made d u rin g  b r e a s t  fe e d in g s  which occur a t  d i f f e r e n t  t im e s  in  
r e l a t io n  to  a  d o s in g  in te r v a l .  These m easurem ents p ro v id e  m ean ingfu l 
d a ta  f o r  c a lc u la t io n  o f th e  m ilk /p la sm a  r a t i o  and f o r  a s se s sm e n t of 
averag e  c o n c e n tra t io n s  d u rin g  a fee d in g .
M/P = AUCmilk/AUCplasma Average c o n c e n tra tio n  = AUCmilk/t
D ata to  c a lc u la te  th e  AUC f o r  m ilk  was n o t a v a i la b le  in  t h i s  s tu d y . 
F i r s t l y ,  m ilk  cou ld  n o t be c o lle c te d  f re q u e n tly  th ro u g h o u t a dosage 
in te r v a l  a s  i t  was needed f o r  th e  in f a n t s .  Secondly , i t s  c o l le c t io n  
could  n o t be ev en ly  sp re a d  th ro u g h o u t th e  s tu d y  because o f th e  
v a r i a t io n s  in  dosage reg im en . However, from  T ab les  7.8 and 7 .9 , some 
s in g le  p o in ts  can be com pared. F or 2 5 /1 0 , p a ire d  v a lu e s  o f 61ng/m l fo r  
p lasm a and 18ng/m l f o r  m ilk  which g iv e s  a  m ilk /p la sm a  c o n c e n tra tio n  
r a t i o  o f on ly  0 .3 , however t h i s  tim e  p o in t  i s  on ly  30 m inu tes  a f t e r  
a d m in is t r a t io n  o f th e  o ra l  dose  and th e r e fo r e  i s  p e rh a p s  n o t s u f f ic ie n t
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tim e  to  have e q u il ib r a te d  a c ro s s  th e  membrane. A nother day, 1 /11, has 
sam p les, <14.00 and 15.00) a lth o u g h  n o t p a ire d , c lo s e  enough in  tim e fo r  
re a so n a b le  com parison . These g iv e  a s u b s ta n t ia l l y  h ig h e r  va lu e  of 0.68. 
T h is  va lue  i s  s t i l l  low er th a n  th e  g e n e ra l t r e n d  to  u n ity  shown 
previously in  T able 7.1 . However, d u rin g  m u ltip le  d o s in g , th e  r a t i o  
r e f e r s  to  av e rag e  s t e a d y - s t a t e  c o n c e n tra t io n s  and m ilk /p la sm a  r a t i o  a t  
an y .o n e  tim e  d u rin g  a d o s in g  in te r v a l  may v a ry .
M ilk to  p lasm a c o n c e n tra t io n  r a t i o s  (M/P), f r a c t io n  n o t bound to  m ilk 
p r o te in s  (fm) and skim  to  whole m ilk  c o n c e n tra t io n  r a t i o s  <S/M) o f a 
drug  can  be a f f e c te d  by c o m p o s itio n a l change in  th e  m ilk . M ilk 
com positon  may be a f f e c te d  by f a c to r s  such  a s  th e  s ta g e  o f l a c ta t io n ,  
th e  tim e  o f day and th e  tim e  d u rin g  a fe e d in g . F a t c o n te n t in c re a s e s  
d u rin g  th e  c o u rse  o f a fee d in g  w h ile  p ro te in  co m p o sitio n  rem a in s  f a i r l y  
c o n s ta n t .  From T able  7 .9 , a  com parison  o f c o n c e n tra tio n  le v e ls  bo th  
b e fo re  and a t  th e  end o f fee d in g  can  be made fo r  th e  2 8 /1 0 . There i s  
l i t t l e  d i f f e re n c e  betw een th e  v a lu e s . Thus an in c re a s e  in  f a t  c o n te n t in  
m ilk  h a s  no e f f e c t  on th e  m ethim azole c o n c e n tra t io n  i .e . m ost o f th e  
m ethim azole rem a in s  in  th e  aqueous ph ase  a s  was found by Cooper e t  a l  
(1984).
The m ilk  c o n c e n tra t io n  v a lu e s  can n o t be used  f o r  c a lc u la t io n  o f th e  
amount o f d rug  d e liv e re d  to  th e  b a b ie s  a g a in  because th e r e  a re  n o t 
enough sam ple p o in ts  over one d o s in g  in te r v a l  and a ls o  m ilk  volumes 
were n o t re c o rd a b le  because  o f  b r e a s t - f e e d in g .  E s tim a te s  o f y ie ld  
c a n n o t be made a s  f o r  a  g iv en  in d iv id u a l  th e  volume v a r ie s  each  day and
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a f u r th e r  in f lu e n c e  on y ie ld  in c lu d e  tw in s  a s  com pared w ith  s in g le  
in f a n t  n u rs in g .
However, th e  c o n c e n tra tio n  v a lu e s  th em se lv e s  a p p e a r  to  be in  a 
s im i l i a r  ran g e  to  th o se  found in  p re v io u s  s tu d ie s  and th u s  su g g e s t 
s im i l i a r  e x c re tio n  le v e ls .
C l in ic a l  s tu d ie s  on th e  s u c k lin g  in f a n t  showed th e  h ig h e s t  p lasm a 
c o n c e n tra t io n s  when th e  m other was on 30mg of ca rb im azo le  d a i ly  dose. 
The le v e l  su b se q u e n tly  d e c re a sed  w ith  d e c re a s in g  m a te rn a l dose  and a 
move on to  more s o l id  foo d s. C a lc u la tio n  o f in f a n t  d a i ly  dose i s  n o t 
p o s s ib le  because  o f th e  l im ite d  number o f b lood sam p les  w hich can be 
re a so n a b ly  tak e n  from  an in fa n t .  However, th e  s in g le  v a lu e s  observed  
were a t  th e  low er end o f th e  ran g e  o f c o n c e n tra t io n s  (50-100ng/m l) 
p u rp o rte d  to  cau se  th y ro id  s u p p re s s io n  in  a d u lts  w ith  th y ro to x ic o s is  
(Benker and R einw ein, 1982). These f ig u r e s  a lo n e  seem to  con firm  th e  
p ro je c te d  le v e ls  ex p ec ted  in  in f a n t  p lasm a from  p re v io u s  s tu d ie s  (Table 
7 .1) which were c o n s id e re d  to  r e p r e s e n t  a  s ig n i f i c a n t  r i s k  to  th e  
s u c k lin g  in f a n t s  th y ro id  fu n c tio n .
However, c l i n i c a l  ex am in a tio n  and th y ro id  fu n c tio n  t e s t s  (T ables 7.6 
and 7 .7 ) done on each tw in  th ro u g h o u t th e  s tu d y  showed no ev idence  of 
th y ro id  s u p p re s s io n .
The norm al ran g e  quoted  f o r  t o t a l  serum  T4 i s  60-150nM /L and 1- 
2.6nM /l f o r  serum  T3. I t  i s  g e n e ra lly  ac ce p ted  t h a t  th e  th y ro id  s ta tu s  
i s  d e te rm in ed  by th e  c o n c e n tra t io n  o f f r e e  ( i.e . n o n -p ro te in  bound ) 
th y ro id  horm ones. The norm al ran g e  f o r  f r e e  T4 i s  10-22pM/L and th e  T3
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Time of day
F ig u re  7.4 An id e a l is e d  p r o f i le  fo r  m a te rn a l d o s in g  and in fa n t  
b r e a s t  fe e d in g .
The m ilk  volume p lo t  r e p r e s e n t s  th e  known ra p id  s e c r e t io n  of f lu id
d u rin g  th e  e a r ly  p e rio d  o f b r e a s t  fe e d in g . The 'n o tc h ' in  th e  p lo t  
d e p ic t s  a  change from  one b r e a s t  to  th e  o th e r . P lasm a c o n c e n tra tio n s  
a re  shown f o r  s t e a d y - s t a t e  c o n d it io n s .
W ilson e t  a l M 19S0
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i s  2-8pM/L. The t o t a l  T4:T3 i s  abou t 65:1 and th e  f r e e  T4:T3 i s  about 
2:1 in  norm al man.
An in c re a se d  r a t i o  o f T3:T4 i s  seen  in  h y p o th y ro id ism  a s  a io d in e -  
s p a r in g  mechanism b u t th e  s l i g h t  in c re a s e  in  f re e  T3 v a lu e s  d id  n o t 
cause  a s u b s ta n t ia l  change in  th e  r a t i o .  A lso, a l l  o th e r  v a lu e s  
rem ained  w ith in  th e  norm al ran g e .
B re a s t fee d in g  o cc u rs  a t  d i f f e r e n t  tim e s  in  r e l a t i o n  to  dose  
th ro u g h o u t th e  day and hence m ethim azole c o n c e n tra t io n  in  m ilk  w il l  vary  
a c co rd in g  to  some r e la t io n s h ip  w ith  p lasm a c o n c e n tra t io n s  ( f ig u re  7 .4  ). 
In t h i s  s tu d y , th e  h ig h e s t  p lasm a m ethim azole le v e ls  in  each  tw in  were 
rec o rd e d  2 -4  h o u rs  p o s t-m a te rn a l  d o s in g ; th e  lo w est o ccu rin g  6 o r  more 
p o s t  d o s in g . D isc a rd in g  b r e a s t  m ilk  produced 2 -4  h o u rs  fo llo w in g  a 
ca rb im azo le  dose  would th e r e fo r e  be expected  to  reduce  th e  i n f a n t s  d a ily  
m ethim azole lo ad  c o n s id e ra b ly .
Thus, t h i s  s tu d y  i s  in  agreem ent w ith  s im i l i a r  r e s u l t s  from  a long 
term  s tu d y  o f seven  c h ild re n  (N o to rian n i e t  a l . ,  1986). I t  s u g g e s ts  t h a t  
ca rb im azo le  in  d o se s  o f 30mg o r  l e s s  p e r  day can  be used  to  t r e a t  
th y r o to x ic o s is  in  b r e a s t - f e e d in g  m o th ers  and t h a t  c u r r e n t  a d v ic e  t h a t  
p r o p y lth io u r a c i l  i s  th e  p re fe r r e d  drug  in  t h i s  in s ta n c e  sh o u ld  be 
r e v is e d .
T h is  i s  th e  f i r s t  c l i n i c a l  s tu d y  o f m ethim azole to  th e  s u c k lin g  
in f a n t  and th e  r e s u l t s  o f th e  c o n c e n tra t io n s  o f  m eth im azole found in  





The p re s e n t  in v e s t ig a t io n  was u n d e rtak en  to  a s s i s t  th e  c l in ic i a n  w ith  
th e  tre a tm e n t  o f h y p e rth y ro id ism  u s in g  th e  a n t i th y r o id  d rug , 
m ethim azole. T h is  was done in  o rd e r  to  d e te rm in e  and c o r r e la t e  plasm a 
p h a rm a co k in e tic s  w ith  pharm acodynam ics in  th e  th y ro id  gland-, th e  
th e ra p e u t ic  e f f e c t  and to  in v e s t ig a te  any changes in  p h a rm a co k in e tic s  
w ith  v a r ia t io n  in  th y ro id  s t a t u s .  A lso, a  s tu d y  was u n d e rtak en  to  
a s s e s s  th e  s u i t a b i l i t y  of m ethim azole t re a tm e n t  fo r  h y p e rth y ro id ism  in  
b r e a s t - f e e d in g  m o th e rs . In o rd e r  to  exam ine th e s e  q u e s tio n s  in  d e ta i l ,  a 
s u i ta b ly  s e n s i t iv e  a n a ly t ic a l  method fo r  th e  m easurem ent o f m ethim azole 
needed to  be developed .
An a n a ly t ic a l  method fo r  th e  q u a n t i f ic a t io n  o f m ethim azole was 
developed  u s in g  GC-MS. An in te r n a l  s ta n d a rd ,  tr id e u te ro m e th y lim id a z o le , 
was s u c c e s s fu l ly  s y n th e s is e d  and ch ro m ato g rap h s in  an id e n t ic a l  m anner 
to  m ethim azole w h i ls t  be ing  c le a r ly  d is t in g u is h a b le  by m ass 
sp e c tro m e try . A d e r iv a t iv e  was s e le c te d  w hich, n o t on ly  ch rom atog raphs 
w ell on th e  chosen  column, b u t a ls o  g iv e s  a  lu c id  fra g m e n ta tio n  p a t te rn  
c o n ta in in g  d i s t i n c t  m ajor io n s  f o r  m ethim azole and th e  i n te r n a l  s ta n d a rd  
which a re  a p p ro p r ia te  fo r  SIM GC-MS. Sam ple p re p a ra tio n  in  v a rio u s  
b io lo g ic a l  f lu id s  was o p tim ise d  to  e n a b le  th e  developm ent o f a  s e n s i t iv e ,  
s e le c t iv e  and r o b u s t  m ethod f o r  m ethim azole which i s  s u i ta b le  f o r  use in  
c l i n ic a l  th e ra p e u t ic  m o n ito rin g . In f a c t ,  th e  l im i t  o f d e te c tio n  of 
p lasm a sam p les  was 3ng/m l which i s  com parab le  to  th e  GC-MS method 
developed  by F lo b erg  e t  a l .  (1980). They could  d e te c t  down to  le v e ls  of 
2ng/m l o f m ethim azole in  p lasm a. However, t h a t  m ethod had in h e re n t 
prob lem s w ith  th e  in te r n a l  s ta n d a rd  and w ith  column b leed . Only an
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HPLC m ethod developed  by Hengstmann and Hohn, (1985), which c la im s  to  
d e te c t  picogram  le v e ls  o f m ethim azole, i s  more s e n s i t iv e .
F u rth e r  a n a ly t ic a l  work in  greyhound u r in e  id e n t i f ie d  a m inor 
m e ta b o lite  3 -m e th y l-2 - th io h y d a n to in , which may p la y  a p a r t  in  th e  
a n t i th y r o id  e f f e c t  o f th e  compound. The same d e r iv a t i s a t i o n  re a c tio n  
t h a t  was employed fo r  m ethim azole, a llow ed  s e le c te d  ion  m o n ito rin g  o f 
m ethim azole and 3 -m e th y l-2 - th io h y d a n to in  s im u lta n e o u sly  w ith o u t 
in te r fe re n c e  and t h i s  m ethod cou ld  form  th e  b a s is  o f k in e t ic  s tu d ie s  of 
3 -m e th y l-2 - th io h y d a n to in .
Plasm a p h a rm a c o k in e tic s  can on ly  be used  f o r  c o r r e la t io n  w ith  e f f e c t  
i f  th ey  have been exam ined a t  s te a d y - s t a te .  In t h i s  s tu d y  p a t i e n ts  on 
long term  tre a tm e n t  were in v e s t ig a te d .  P rev io u s s tu d ie s  had 
c o n c e n tra te d  m ain ly  on s in g le  dose p h a rm a co k in e tic s  o r th e  k in e t ic s  
fo llo w in g  only  a s h o r t - te r m  s tu d y  and th e  l i t e r a t u r e  i s  v e ry  s p a r s e  fo r  
m u ltip le  dosage  k in e t ic  s tu d ie s .
Dosage l i n e a r i t y  was shown when p a t i e n ts  on a  low dosage  regim en 
where com pared to  th o se  on a h ig h  dosage reg im en. The r e s u l t s  were in  
agreem ent w ith  two o th e r  s im i l i a r  s tu d ie s  ( Ja n sso n  e t  a l.,1 9 8 3 a ; 
Okamura e t  a l . ,  1986 >The lac k  o f accum ulation  o f m ethim azole was a ls o  
in d ic a te d  a s  th e  p lasm a c o n c e n tra t io n s  re tu rn e d  to  ap p ro x im ate ly  th e  
same le v e ls  a t  th e  end o f th e  d o s in g  in te r v a l  fo llo w in g  e i t h e r  dosage 
( i.e . s t e a d y - s t a t e  c o n d it io n s ) .  Thus, a s  f a r  a s  p lasm a c o n c e n tra t io n s  
a re  p r e d ic t iv e ,  a  dosage regim en of tw ice  d a ily ,  a t  e i t h e r  5mg o r 20mg, 
ach iev e  s t e a d y - s t a t e  p lasm a le v e ls  in  th e  ran g e  t h a t  sh o u ld  be bo th  
e f f ic a c io u s  and n o n - to x ic .
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No s ig n i f ic a n t  d if f e re n c e s  betw een p h a rm aco k in e tic  p a ra m e te rs  a f t e r  
o r a l  a d m in is t r a t io n  to  e u th y ro id  and h y p e r th y ro id  p a t i e n t s  were observed 
which i s  c o n s is te n t  w ith  r e s u l t s  from two p re v io u s ly  p u b lish e d  r e p o r ts  
(Cooper e t  a l.,1 9 8 4 ; Ja n sso n  e t  a l . ,  1985), b u t c o n tr a d ic to ry  to  one 
p rev io u s  s tu d y  (Hengstmann and Hohn, 1985). However i t  would appear 
t h a t  th y ro id  horm ones do n o t d e p re s s  o r in c re a s e  th e  m etabo lism  of 
m ethim azole and th e re fo re  th e re  a re  no p h a rm aco k in e tic  re a s o n s  to  a d ju s t 
th e  dose o f m ethim azole d u rin g  tre a tm e n t  o f th y ro to x ic o s is .  Thus, th e  
s t r a te g y  o f in d iv id u a l is e d  d o ses  based  on th e  a sse ssm e n t o f th e  s e v e r i ty  
o f th e  d is e a s e  su g g e s te d  by some a u th o rs  (Braverm an, 1978 and Solomon, 
1978) i s  n o t j u s t i f i e d .  F u r th e r  r a d io a c t iv e  and m eta b o lic  s tu d ie s  need 
to  be u n d ertak en  to  u n d e rs ta n d  why v a r ia t io n  in  th y ro id  s t a t u s  does no t 
ap p ear to  a f f e c t  th e  k in e t ic s  o f m ethim azole bu t does a f f e c t  o th e r  d ru g s. 
However, b e fo re  t h i s  work can be u n d e rtak en , a l l  th e  m e ta b o li te s  of 
m ethim azole m ust be id e n t i f ie d  and t h e i r  pa thw ays e lu c id a te d .
The p e rc h lo ra te  d isc h a rg e  t e s t  was used to  e s tim a te  th e  d u ra tio n  o f 
a n t i th y r o id  e f f e c t  o f th e  two d o se s  o f m ethim azole. In g e n e ra l, 
d is c h a rg e  o f r a d io io d in e  from  th e  th y ro id  by p e rc h lo ra te  d im in ish e d  in  
bo th  g roups w ith  tim e  a f t e r  a d m in is t r a t io n  o f m ethim azole. Thus, plasm a 
c o n c e n tra t io n s  o f m ethim azole cou ld  be c o r r e la te d  w ith  i t s  e f f e c t  on th e  
in h ib i t io n  o f o r g a n i f ic a t io n .  Yet, p lasm a c o n c e n tra t io n s  have shown no 
c o r r e la t io n  w ith  c l i n i c a l  in d ic e s . C onsequen tly , th e  g r e a t  d iv erg en ce  in  
th e  th e ra p e u t ic  re sp o n se  to  th e  drug  in  th y ro to x ic o s is  i s  o b v io u sly  no t 
due to  d i f f e re n c e s  in  plasm a p h a rm a c o k in e tic s  o r th e  e x te n t  o f 
in h ib i t io n  o f o r g a n i f ic a t io n  o f io d in e .
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However, th e  m ost im p o rta n t a s p e c t  o f th e  pharm acology of 
a n t i th y r o id  d ru g s  i s  t h e i r  c o n c e n tra tio n  le v e l  a t  th e  s i t e  o f a c tio n , th e  
th y ro id  g lan d . T h is  s tu d y  p ro v id e s  th e  f i r s t  com bined d a ta  on d i r e c t  
m easurem ent o f in t r a th y r o id a l  c o n c e n tra t io n s  o f m ethim azole to g e th e r  
w ith  p e rc e n ta g e  in h ib i t io n  o f io d id e  o r g a n i f ic a t io n  in  th e  same 
in d iv id u a ls .  M ethim azole i s  known to  be a c t iv e ly  c o n c e n tra te d  in  th e  
th y ro id  g lan d  and th e  r e s u l t s  of t h i s  s tu d y  su p p o rt  t h i s  co n cep t in  
s e v e ra l  ways. The in t r a th y r o id a l  c o n c e n tra t io n s  do n o t show any 
l i n e a r i ty  w ith  dose , in s te a d , g iv in g  h ig h e r  c o n c e n tra t io n s  fo r  th e  low er 
dosage group. A lso , th e  i n t r a th y r o id a l  c o n c e n tra t io n s  betw een dose 
g roups a t  th e  same tim e p o in t were com pared w ith  th e  c o rre sp o n d in g  
p lasm a c o n c e n tra t io n s , in  th e  form  o f th y ro id /p la sm a  c o n c e n tra t io n  
r a t i o s .  At th e  low dose , th e  th y ro id /p la sm a  r a t i o  i s  h ig h , r e f l e c t in g  
a c t iv e  t r a n s p o r t ,  b u t a t  th e  h ig h e r  dose, t h i s  r a t i o  f e l l  when th e  
t r a n s p o r t  sy stem  i s  s a tu r a te d  by h ig h  p lasm a c o n c e n tra t io n s . The 
t r a n s p o r t  sy stem  used by m ethim azole h as  n o t y e t  been id e n t i f ie d  and 
f u r th e r  s tu d ie s  u s in g  v a r io u s  chem ical i n h ib i to r s  could  be undertaken  to  
id e n t i f y  t h i s  t r a n s p o r t  sy stem .
The in t r a th y r o id a l  c o n c e n tra t io n s  rem ained  h ig h , r e g a r d le s s  o f dose, 
24 h o u rs  a f t e r  a d m in is t r a t io n  o f m ethim azole. T h is  r e s u l t  i s  in  
agreem ent w ith  th e  on ly  o th e r  s im i l i a r  s tu d y  (Jan sso n  e t  a l . ,  1983b) i .e . 
t h a t  th e  e lim in a tio n  tim e  f o r  m eth im azole in  th e  th y ro id  g lan d  i s  much 
lo n g er th a n  in  b lood . T h is  in d ic a te s  t h a t  a  much lo n g e r  a n t i th y r o id  
e f f e c t  cou ld  be expected  th a n  t h a t  su g g e s te d  by th e  d e c lin e  in  blood 
c o n c e n tra t io n s . However, r e s u l t s  fo r  th e  p e rc e n ta g e  in h ib i t io n  o f io d id e
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o rg a n i f ic a t io n  ap p ear to  be in  d i r e c t  c o n f l i c t  w ith  th e  in t r a th y r o id a l  
le v e ls ,  g iv in g  v i r t u a l ly  no in h ib i t io n  a f t e r  24 h o u rs  on th e  h igh  dose 
and none a t  a l l  fo llo w in g  th e  low dose . The f a c t  t h a t  th e  p e rc h lo ra te  
d isc h a rg e  r e s u l t s  and in t r a th y r o id a l  c o n c e n tra t io n s  a re  f ro m -th e  same 
p a t i e n ts  d is p ro v e s  th e  p roposed  th e o ry  < McCruden e t  a l . ,  1987) t h a t  th e  
v a s t  d i f f e re n c e  betw een th e  r e s u l t s  was due to  v a r ia t io n  in  
i n t r a th y r o id a l  io d in e  c o n te n t betw een th e  two s tu d y  g ro u p s ( Ja n sso n  e t  
a l . ,  1983band McCruden e t  a l . ,  1987). I t  i s  more l ik e ly  t h a t  th e  
p e rc h lo ra te  d is c h a rg e  t e s t  u n d e re s tim a te s  th e  d u ra tio n  o f a c tio n  of 
m ethim azole a s  i t  does n o t gauge th e  e x te n t  o f in h ib i t io n  o f co up ling  of 
io d o ty ro s in e s , w hich i s  th e  m ain s i t e  o f a c tio n  o f m ethim azole,
(McCruden e t  a l . ,  1987). T h is  th e o ry  can be exam ined i f  a method i s  
developed which can m easure th e  co u p lin g  e f f e c t  in  a way t h a t  th e  
p e rc h lo ra te  d is c h a rg e  t e s t  m easures io d in a tio n , o r i f  a u to ra d io g ra p h ic  
s tu d ie s  can  g iv e  ev idence  of th e  d i s t r ib u t io n  o f m ethim azole to  d i f f e r e n t  
s i t e s  w ith in  th e  th y ro id  g lan d .
One o f th e  m ajor q u e s tio n s  r e l a t i n g  to  m ethim azole th e ra p y  i s  w hether 
p a t i e n ts  r e q u ir e  s in g le  o r  m u ltip le  d a ily  d o ses  o f m ed ica tio n . In te rm s 
o f th e  r e s u l t s  o f t h i s  s tu d y , a lth o u g h  th e  p lasm a and th y ro id  d a ta  
c o n f l i c t s ,  i n t r a th y r o id a l  drug  c o n c e n tra t io n s  a re  more c le a r ly  r e la te d  to  
a n t i th y r o id  e f f e c t .  A lso, i t  seem s t h a t  th e  p e rc h lo ra te  d is c h a rg e  t e s t  
te n d s  to  u n d e re s tim a te  th e  d u ra tio n  o f a n t i th y r o id  a c tio n . T h erefo re , i t  
would ap p ear t h a t  low s in g le  d a i ly  d o ses  a re  s u f f i c i e n t  to  ach iev e  
m ain tenance  o f th e ra p e u t ic  le v e ls  o f m ethim azole in  th e  body and th a t  
h ig h e r  d o ses  a t  a  s h o r te r  in te r v a l  may on ly  be n e c e s s a ry  in  te rm s  of
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ac h ie v in g  s te a d y  s t a t e  q u ick ly . However, a lo n g -te rm  fo llo w -u p  s tu d y  of 
f o r ty  two m o n th s< R om aldini e t  a l . ,  1983) found th e  r e m is s io n  r a t e  fo r  a 
group re c e iv in g  h ig h -d o se  th e ra p y  was a lm o st tw o fo ld  h ig h e r  th an  
p a t i e n ts  r e c e iv in g  low -dose  th e ra p y . However, th e  r a t e  o f s id e  e f f e c ts  
was a ls o  h ig h e r . Thus th e  q u e s tio n  o f a s in g le  d a i ly  dose regim en 
rem ain s  a  com plex is s u e  and w il l  on ly  be answ ered s a t i s f a c t o r i l y  when a 
more d i r e c t  m ethod of m easuring  th e  a n t i th y r o id  e f f e c t  i s  developed.
Only th en  w il l  i t  be p o s s ib le  to  s e le c t  th e  optimum dosage regim en of 
lo n g -te rm  re m is s io n  w ith  no untow ard  s id e - e f f e c t s .  I f  t h i s  i s  ach ieved , 
m easurem ent o f p lasm a c o n c e n tra t io n s  would only  be recommended in  
p a t i e n ts  re sp o n d in g  p o o rly  fo r  no a p p a re n t re a so n .
The s tu d y  o f drug  e x c re tio n  in  b r e a s t  m ilk  i s  im p o rta n t w ith  re g a rd  
to  th e  s a f e ty  o f th e  su c k lin g  in fa n t .  S e v e ra l s tu d ie s  have been 
und ertak en  to  in v e s t ig a te  w hether th e  t re a tm e n t o f l a c t a t i n g  m others 
w ith  m ethim azole cou ld  have an a d v e rse  e f f e c t  on th e  i n f a n t 's  th y ro id  
fu n c tio n  < Low e t  a l . ,  1979; T eg le r and L indstrom , 1980; Johansen  e t  a l . ,  
1982; Cooper e t  a l . ,  1984 and N o ta ria n n i e t  a l . ,  1986). T h is  p re s e n t  
s tu d y  p ro v id e s  docum entation  o f m ilk /p la sm a  r a t i o s  o f m ethim azole over a 
dose in te r v a l  b o th  a t  th e  b eg in n in g  and a t  th e  end o f fe e d s  a f t e r  th e  
o r a l  a d m in is t r a t io n  o f ca rb im azo le . T h is  i s  a ls o  th e  f i r s t  c l i n ic a l  
s tu d y  o f m ethim azole to  th e  s u c k lin g  in f a n t  and i s  o f s p e c ia l  i n t e r e s t  
a s  th e  s tu d y  h a s  been c a r r ie d  out in  tw in s .
A com parison  o f m ate rn a l m ilk  to  p lasm a c o n c e n tra t io n  r a t i o s ,  
a lth o u g h  s l i g h t l y  low er, tended  to w a rd s  u n ity  a s  was shown in  p rev ious 
s tu d ie s .  In a d d it io n , a  com parison  o f c o n c e n tra tio n  le v e ls  bo th  be fo re
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and a t  th e  end o f feed in g  showed t h a t  an in c re a s e  in  f a t  c o n te n t has  no 
e f f e c t  on th e  m ethim azole m ilk  c o n c e n tra tio n .
Plasm a c o n c e n tra t io n s  of m ethim azole in  th e  in f a n t  sh o u ld  re c o rd  
t h e i r  le v e l  o f exposu re  which can be c o r r e la te d  to  th e  m ethim azole m ilk 
c o n c e n tra t io n s . The v a lu es  o b ta in e d  were a t  th e  low er end o f th e  range 
o f c o n c e n tra t io n s  p u rp o rte d  to  cause  th y ro id  s u p p re s s io n  in  a d u lts  
( Benker and Reinw ein, 1982) and seemed to  confirm  th e  p ro je c te d  le v e ls  
expected  in  in f a n t  p lasm a from  th e  p re v io u s  s tu d ie s .  However c l i n ic a l  
ex am ination  and th y ro id  fu n c tio n  t e s t s  done on each tw in  th ro u g h o u t th e  
s tu d y  showed no ev idence  o f th y ro id  su p p re s s io n . In t h i s  s tu d y , th e  
h ig h e s t  p lasm a m ethim azole le v e ls  in  each tw in  were rec o rd e d  2 -4  hou rs 
p o s t-m a te rn a l  d o s in g ; th e  lo w est o ccu rin g  6 o r more p o s t  dose . 
D isc a rd in g  b r e a s t  m ilk  produced 2 -4  h o u rs  fo llo w in g  a dose would 
th e re fo re  be ex p ec ted  to  reduce  th e  i n f a n t s  d a ily  m ethim azole load  
c o n s id e ra b ly . F in a l ly ,  t h i s  s tu d y  s u g g e s ts  t h a t  c a rb im azo le  in  d o se s  of 
30mg o r  l e s s  p e r  day can be used to  t r e a t  h y p e rth y ro id ism  in  b r e a s t  
feed in g  m o th ers  and t h a t  th e  c u r r e n t  ad v ic e  recom mending 
p ro p y lth io u r a c i l  a s  th e  p re fe r r e d  drug  in  t h i s  in s ta n c e  sh o u ld  be 
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SA FETY  O F  INTRAVENOUS IM M UNOGLOBULIN
S ir ,—D r Thomson and colleague* (March 7 , p  539) describe the 
use of alpha interferon to treat non-A, non-B hepatitis transmitted 
by on intravenous immunoglobulin preparation. Readers may 
conclude that these patients were infected via 'Sandoglobulin', this 
being the only intravenous immunoglobulin referred to in the 
paper. This was not to; they were Infected via another preparation 
(as stated in ref 5 in the March 7 paper). Despite extensive use 
worldwide, no case of post-transfusion hepatitis fulfilling the 
normal criteria for non-A, non-B hepatitis1 has been ascribed to the 
use of sandoglobulin or any other intravenous immunoglobulin 
prepared by the pH4/pepoin method.*
Smfca nurmacnaksk, 
hklsn. MkUImo TWIJ iBf
W. L-Siiaw  
R. R. G  St h w a r t
1. AteHJ. Purcrfl dll.K ahn d  PV, Aste* DW . Kmtal D a  Donor in n M m iw  and
ncipfent tMfadUs JAMA I H 1 ; M  &SO-M.
2. L « n  CLS, Yap PL. Neill O, M iC U b .1  DEL, Vaarwunl A. Sanan ALT Irvtt. «i
paomB w*h primary hjrpagBnraclububnaaiu* r*c*tvm* r c p ln n x n i ihm py  
• a h  b s o a o a  knamrasbbuMe ar frcab fruaan piaatna. I'aa f a  a  ISOA, Miao-u.
CARBLMAZOLE AND BR EA STFEED IN G
SlK,—Moat prescribing information states that thyrotoxic 
mothers treated with carbimazolc should not breastfeed.10 47-16% 
of a maternal carbimozole dose is estimated to reach the child 
through breast milk.*-* These results span a wide range and there U 
little information on the pharmacology of carbimazolc in the young 
infant. Because breastfeeding and carbimazolc therapy for 
thyrotoxicosis are in their separate ways advisable, we report on 
breastfed twins whose mother wss taking carbimazolc.
T he mother had thyrotoxicosis 2 months after giving birth to 
healthy twins. In the absence of any specific evidence of harmful 
effects of carbimazolc in this situation,1 and after detailed 
discussion, she was advised to continue breastfeeding. She was 
started on carbimazolc, initially 30 mg daily, reducing when she 
became euthyroid.
Clinical examinations and thyroid function tests were done on 
each twin over the next 4 months. Methimazolc (the active 
metabolite) was assayed in the mother's and her babies'-plasma and 
in brcastmilk. Thyroid stimulating hormone, thyroxine (T4), and 
triidothyronifte (T3) remained normal throughout weeks 1-16. 
F rccT4 and freeT3 were measufed on three days between weeks 8 
and 16. T he free T 3  values in twin 1 were 9 5,10 0, and 10 5 pmol/1, 
a small increase (normal range unavailable in the paediatric age 
group, adult range 2-8). All other values remained normal.
Free methimazolc was measured in brcastmilk on 10 occasions 
between weeks 2 and 16 and the mean concentration was 43 ng/ml 
.(range 0-92 ng/ml). Milk volumes were not recordable because of 
breastfeeding and breastmilk excretion of methimazolc could not be 
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analysed, giving ratios of 30-70°/*. Plasma methimazolc was 
measured in twin I between weeks 1 and 16 and in twin 2 between 
weeks 2 ard 16. The concentration of methimazolc in twin 1 was 45 
ng/ml (range 0-105 ng/ml) and that in twin 2 was 52 ng/ml (range 
0-156 ng/ml). The higheu_0 l.u5j.wcre recorded when the mother 
was on 30 mg carbimazolc daily. Plasma methimazolc concentra­
tions in the twins were at the lower end of the range of 
concentrations purported to cause thyroid suppression in adults 
with thyrotoxicosis (50-100 ng/ml).4 However, thyroid function 
tests and clinical examination showed no evidence of thyroid 
suppression.
The figure shows the maternal plasma and milk methimazolc 
concentrations, related to time after the dose of carbimazolc. The 
highest plasma methimazolc levels in each twin were recorded 2-4 h 
post dooc; the lowest occurred 6 h or more poat dooe. Discarding 
breastmilk produced 2-4 h after a carbimazolc dooe would therefore 
be expected to reduce the infants' daily load of - methimazolc 
considerably.
These data, together with similar results in a long-term study of 7 
children,' suggest that carbimazolc in dotes of 30 mg or less per day 
can be used to treat thyrotoxicosis in breastfeeding mothers.
G uokcU'. W. Rylance 
C  OitomtiiY Wtxm.s
MARY G  DtlNNUl.t Y 
John S. O liver
W illiam D. At iixanih.k
O u k lrc n 'i fCoaptul.
Birmingham B16 RlTI'
Department v t h r a u i c  M n k w  
Vkl Stimcv.
U o iw u ty  i d  Olae^RW
Department td M cik m c, 
UfUvmity erf (siagira
Tune post dose (h)
M ate rn a l p la tm a  a n d  m ilk  m e th lm aso le  co n cen tra tio n s  a f te r  
cn rb ln iaxo le  doses o f  30 m g  dally .
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R ELEA SE O F ATRIAL N A TR IU RETIC  I’E IT ID E  
DURING PREGNANCY AND LMMIiDLATE 
P U ER PER IU M
S ir ,—Atrial natriuretic peptide (ANP) is a serious candidate lor 
the natriuretic hormone whose existence has been pustulated for 25 
years. However, it is not yet clear how important ANP is for the 
regulation of sodium and water balance under physiological 
conditions.
During pregnancy some 900 mmol sodium progressively 
accumulates and total body water increases by 6-8 litres, distributed 
amongst the fetus, placenta, and increased maternal blood and 
interstitial fluid volumes. After delivery this excess maternal 
sodium and water load is no longer required and is accreted, 
significant diuresis being evident from the third to fourth day post 
portum.1 If ANP has relevance as a natriuretic and diuretic 
hormone one would expect the redistribution of body fluids post 
purtum to be a major stimulus to release of the hormone.
We have measured plasma ANP concentrations serially in seven 
healthy women throughout pregnancy and the early puerperium. 
‘l"hc women gave informed consent to blood sampling. T he women, 
aged between ife to 36 years (mean 31), received no proprietary 
medications during pregnancy other than iron and vitamin 
supplements. All patients had uneventful pregnancies: blood 
pressures remained below 140,90 mm Hg, maternal weight gain 
was normal (mean 10 4 [SE 13] kg); a id  delivery was in the third 
trimester (at 38 4 [SE 0 9] weeks). Six patients were delivered 
vaginally and one had a cocsoreon section for cervical dystocia. 
Although four patients received intravenous sodium chkmde ui 
crystalkud solution during labour, none was given nxire than 250 
mnail, and ANP conccntratKxis at least 72 h later should not have 
been aiTccicd. llkxxl samples were taken during routine antenatal 
clinic visits at the beginning, middle, and end of the second 
trimester, in the last month of pregnancy, and one in the postnatal 
ward 3-5 days post portum. All venesections were done between 
0800 and 0900 hours after the marten had fasted overnight and
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Appendix I
S t a b i l i t y  S tudy
Each d a ta  s e t  was su b je c ted  to  l in e a r  r e g re s s io n  a n a ly s i s  and th e  
su b seq u en t l in e s  o f b e s t  f i t  gave p o s i t iv e  s lo p e s . However, th e r e  was a 
wide v a r ia t io n  in  th e  degree  o f s lo p e  betw een c o n c e n tra t io n s  f o r  b o th  
f lu id s .  In th e  p lasm a s tu d y , th e  0.5ug/m l d a ta  had a s lo p e  a p p ro x im ate ly  a 
f a c to r  o f 10 l e s s  th a n  th e  l.Oug/m l d a ta . In th e  u r in e  s tu d y , th e  2ug/m l 
d a ta  had a s lo p e  a p p ro x im ate ly  a f a c to r  o f 10 le s s  th a n  th e  l.O ug/m l d a ta . 
T h is  wide v a r ia t io n  between th e  s lo p e s  o f th e  c o n c e n tra t io n s  was f u r th e r  
s tu d ie d  in  th e  p lasm a sam ples by a t - t e s t  which gave a va lue  o f 1.133. A 
va lue  o f 2.37 i s  needed fo r  s ig n i f ic a n c e  a t  th e  5% le v e l . Thus, th e r e  i s  
no ev idence  o f c o r r e la t io n  betw een th e  two c o n c e n tra tio n  d a ta  s e t s .  This, 
p o s i t iv e  t re n d  cou ld  be due to  endogenous m a te r ia l  in te r f e r in g  w ith  th e  
m ethim azole ch ro m a to g rap h ic  peak. However, th e  lac k  o f c o r r e la t io n  
betw een th e  two s e t s  o f c o n c e n tra tio n  d a ta  which make t h i s  e x p la n a tio n  
l e s s  l ik e ly .  However, a s  a p re c a u tio n  a g a in s t  e r r o r s  due to  in te r fe re n c e  
from  th e  sam ple m a tr ix , sp ik e d  sam p les (q u a li ty  c o n tr o ls )  shou ld  be s to re d  
w ith  th e  p a t i e n t  sam p les. Any d e v ia t io n  o f th e  q u a l i ty  c o n tr o ls  from  th e  
a c tu a l  sp ik e d  c o n c e n tra tio n  w il l  g iv e  a r e f l e c t io n  o f th e  accu racy  o f th e  
v a lu e s  g e n e ra te d  fo r  th e  p a t ie n t  sam p les.
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